
<html lang="en"     class="pb-page"  data-request-id="37da8930-798b-4e66-a9fe-a34d963d2b8d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b02047;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent" /></meta><meta name="dc.Creator" content="Xing  Lu" /></meta><meta name="dc.Creator" content="Yan-Cheng  Liu" /></meta><meta name="dc.Creator" content="Chris  Orvig" /></meta><meta name="dc.Creator" content="Hong  Liang" /></meta><meta name="dc.Creator" content="Zhen-Feng  Chen" /></meta><meta name="dc.Description" content="Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been reported. H..." /></meta><meta name="Description" content="Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been reported. H..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 14, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02047" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02047" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02047" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02047" /></link>
        
    
    

<title>Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02047" /></meta><meta property="og:title" content="Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0017.jpeg" /></meta><meta property="og:description" content="Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been reported. Herein, we report the preparation of 10 copper complexes with 9-substituted β-carboline ligands that act as metal-based Mcl-1 inhibitors. Complex 14 was identified as a potent and selective Mcl-1 inhibitor with strong in vitro antitumor activity. Mechanistic studies demonstrated that complex 14 disrupted Mcl-1-Bax/Bak heterodimerization and induced Bax/Bak-dependent apoptosis. In addition, complex 14 significantly (P &lt; 0.001) inhibited tumor growth in vivo, induced tumor necrosis, and extended survival time in an NCI-H460 xenograft model. Furthermore, complex 14 showed no apparent toxicity in mice. Together, these findings indicate that complex 14 is a copper-based Mcl-1 inhibitor with high efficacy and low toxicity that could be developed for the treatment of Mcl-1-related cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02047"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02047">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02047&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02047&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02047&amp;href=/doi/10.1021/acs.jmedchem.9b02047" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9154-9167</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01917" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00077" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xing Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xing Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xing++Lu">Xing Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan-Cheng Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan-Cheng Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan-Cheng++Liu">Yan-Cheng Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chris Orvig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chris Orvig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Faculty of Science, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T1Z1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Orvig">Chris Orvig</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2830-5493" title="Orcid link">http://orcid.org/0000-0002-2830-5493</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Liang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#41292d28202f260126392f346f2425346f222f"><span class="__cf_email__" data-cfemail="9ff7f3f6fef1f8dff8e7f1eab1fafbeab1fcf1">[email protected]</span></a>. Phone: (086) 773-2120998. Fax: (086) 773-21209958.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Liang">Hong Liang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Zhen-Feng Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhen-Feng Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#187b707d76627e587f60766d367d7c6d367b76"><span class="__cf_email__" data-cfemail="33505b565d495573544b5d461d5657461d505d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhen-Feng++Chen">Zhen-Feng Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6548-6131" title="Orcid link">http://orcid.org/0000-0002-6548-6131</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02047&amp;href=/doi/10.1021%2Facs.jmedchem.9b02047" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9154–9167</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 14, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 December 2019</li><li><span class="item_label"><b>Published</b> online</span>14 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02047" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02047</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9154%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXing%2BLu%252C%2BYan-Cheng%2BLiu%252C%2BChris%2BOrvig%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b02047%26title%3DDiscovery%2Bof%2Ba%2BCopper-Based%2BMcl-1%2BInhibitor%2Bas%2Ban%2BEffective%2BAntitumor%2BAgent%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9167%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02047"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1370</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02047" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xing&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Yan-Cheng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Orvig&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Zhen-Feng&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9154-9167&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02047&quot;},&quot;abstract&quot;:&quot;Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been reported. Herein, we report the preparation of 10 copper complexes with 9-substituted β-carboline ligands that act as metal-based Mcl-1 inhibitors. Complex 14 was identified as a potent and selective Mcl-1 inhibitor with strong in vitro antitumor activity. Mechanistic studies demonstrated that complex 14 disrupted Mcl-1-Bax/Bak heterodimerization and induced Bax/Bak-dependent apoptosis. In addition, complex 14 significantly (P &lt; 0.001) inhibited tumor growth in vivo, induced tumor necrosis, and extended survival time in an NCI-H460 xenograft model. Furthermore, complex 14 showed no apparent toxicity in mice. Together, these findings indicate that complex 14 is a copper-based Mcl-1 inhibitor with high efficacy and low toxicity that could be developed for the treatment of Mcl-1-related cancers.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02047&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02047" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02047&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02047" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02047&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02047" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02047&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02047&amp;href=/doi/10.1021/acs.jmedchem.9b02047" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02047" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02047" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02047%26sid%3Dliteratum%253Aachs%26pmid%3D32794745%26genre%3Darticle%26aulast%3DLu%26date%3D2020%26atitle%3DDiscovery%2Bof%2Ba%2BCopper-Based%2BMcl-1%2BInhibitor%2Bas%2Ban%2BEffective%2BAntitumor%2BAgent%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9154%26epage%3D9167%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290653" title="Group 11 complexes">Group 11 complexes</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Myeloid cell leukemia 1 (Mcl-1), which belongs to the Bcl-2 family of prosurvival proteins, is a key regulator of cancer cell survival. To date, few drug-like Mcl-1 inhibitors have been reported. Herein, we report the preparation of 10 copper complexes with 9-substituted β-carboline ligands that act as metal-based Mcl-1 inhibitors. Complex <b>14</b> was identified as a potent and selective Mcl-1 inhibitor with strong <i>in vitro</i> antitumor activity. Mechanistic studies demonstrated that complex <b>14</b> disrupted Mcl-1-Bax/Bak heterodimerization and induced Bax/Bak-dependent apoptosis. In addition, complex <b>14</b> significantly (<i>P</i> < 0.001) inhibited tumor growth <i>in vivo</i>, induced tumor necrosis, and extended survival time in an NCI-H460 xenograft model. Furthermore, complex <b>14</b> showed no apparent toxicity in mice. Together, these findings indicate that complex <b>14</b> is a copper-based Mcl-1 inhibitor with high efficacy and low toxicity that could be developed for the treatment of Mcl-1-related cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis, a highly conserved process of cell death, plays key roles in organism development and homeostasis.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Apoptosis inducers can kill cells through extrinsic and intrinsic cell signaling pathways that lead to activation of caspases and irreversible cell death.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Members of the Bcl-2 family of proteins act as the key regulators of intrinsic apoptosis. These proteins can be classified into a prosurvival group (Bcl-2, A1/Bfl-1, Bcl-w, Bcl-xl, and Mcl-1) and two proapoptotic subgroups: the BH3-only protein group (Bim, Bid, Noxa, Puma, and Bad) and the multi-BH domain protein group (Bak, Box, and Bax).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Interactions among these subgroups involving binding of the BH3-only proteins to the prosurvival proteins release the multi-BH domain proteins Bak and Bax. Once activated, Bak and Bax cause mitochondrial membrane permeabilization, cytochrome <i>c</i> release, caspase activation, and apoptosis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Mcl-1 is one of the most commonly amplified genes in cancers. It has been reported that Mcl-1 is critical for the development and growth of a variety of cancers, such as T-cell lymphoma,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> acute myeloid leukemia,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> multiple myeloma,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> breast cancer,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and non-small-cell lung carcinoma.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Moreover, Mcl-1 overexpression is related to both intrinsic and acquired resistance to various antitumor agents, such as ABT-737 and ABT-263.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> Therefore, inhibition of Mcl-1 is a valid therapeutic strategy for cancers.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> However, Mcl-1 inhibitors are difficult to develop because the binding pocket of Mcl-1 is shallow.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Although some compounds show high binding affinity for Mcl-1, such as A-1210477,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> S63845,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and AZD5991,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> drug-like Mcl-1 inhibitors have rarely been reported.</div><div class="NLM_p">DNA is the primary target for most metal-based anticancer agents developed thus far; however, recent studies have sought to develop metal complexes that inhibit protein–protein interactions or enzymes.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31">(24−31)</a> Copper complexes compose one class of promising antitumor agents.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These compounds can target a variety of proteins, such as topoisomerases I and II, proteasome,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and NPL4.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We are interested in the development of novel copper complexes that inhibit Mcl-1.</div><div class="NLM_p last">Herein, we describe the discovery of complex <b>14</b>, a copper-based Mcl-1 inhibitor. Complex <b>14</b> showed potent cytotoxicity against multiple cancer cell lines <i>in vitro</i> and effectively inhibited tumor growth in a nude mouse model. Our results show that complex <b>14</b> could be a promising antitumor agent.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Design, Synthesis, and Characterization of Copper Complexes</h3><div class="NLM_p">In this study, copper complexes with β-carboline ligands were designed on the basis of several previous findings. First, β-carbolines are potential Mcl-1 inhibitors. Fesik’s group identified a β-carboline derivative that inhibits Mcl-1 through fragment-based screening.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Second, the β-carbolines are a class of promising anticancer agents.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In particular, the introduction of substituted groups at the 9-positions of β-carbolines affects their antitumor activities.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Third, Freeman-Cook <i>et al.</i> have reported that lipophilic efficiency plays a critical role in drug discovery. Compounds with relatively mild potency and high lipophilic efficiency can provide good starting points for drug discovery.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Fourth, copper complexes can exhibit multiple molecular geometries depending on the oxidation state of copper and the types of ligands. This molecular complexity allows copper complexes to access regions of chemical space within the binding pocket that are not accessible to other organic molecules. In many cases, copper complexes possessed higher binding affinity for their targets than the corresponding ligands.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Herein, a β-carboline scaffold was selected as a starting point to prepare Mcl-1-targeting metal complexes. Introduction of a pyridine ring at the 1-position of the β-carboline scaffold yielded 1-(2-pyridyl)-β-carboline, a bidentate ligand that could coordinate with metal atoms. To optimize the affinity of this compound for the hydrophobic binding site of Mcl-1, a series of hydrophobic substitutions were introduced at the 9-position of the β-carboline core.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, a number of 9-substituted β-carboline ligands (<b>2–11</b>) were synthesized. The corresponding copper complexes (<b>12–21</b>) were obtained by reaction of Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O with the 9-substituted β-carboline ligands (<b>2–11</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The structures of the ligands and copper complexes were determined by elemental analysis and electrospray ionization-mass spectrometry (ESI-MS) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figures S1–S43</a>). Moreover, complexes <b>12–17</b> and <b>19–21</b> were further characterized by single-crystal X-ray diffraction analysis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). All the copper complexes showed similar geometries. Complex <b>14</b>, a representative compound, had a mononuclear structure. The metal center was four-coordinated with a coordination sphere filled by a 9-substituted β-carboline ligand and two nitrate anions. The structural refinement parameters and selected bond lengths (Å) and bond angles (deg) are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Tables S1–S10</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Single-crystal X-ray structures of complexes <b>12–17</b> and <b>19–21</b>. The solvent molecules and hydrogen atoms were omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>1–11</b>; (a–c) 10% Pd/C, Anisole, Reflux, 24 h; (d) NaH, DMF, r.t., 1 h</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Complexes <b>12–21</b>; (a) Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O, EtOH, 80 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Stability of Complexes <b>13</b> and <b>14</b> in Solution</h3><div class="NLM_p last">The stability of copper complexes <b>13</b> and <b>14</b> under simulated physiological conditions (Tris-HCl buffer solution at pH 7.4 containing 1% DMSO) was assessed by UV–vis spectroscopy (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figure S44</a>) and ESI-MS (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figures S45 and S46</a>). The results suggested that complexes <b>13</b> and <b>14</b> were stable under physiological conditions at room temperature for 72 h.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.3.  Selective Binding of the Copper Complexes to Mcl-1</h3><div class="NLM_p">To explore the ability of these copper complexes to bind to Mcl-1, a fluorescence polarization assay (FPA), enzyme-linked immunosorbent assay (ELISA), and surface plasmon resonance (SPR)-based assay were performed.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the copper complexes <b>12–21</b> exhibited significantly higher binding affinities than their ligands (<b>2–11</b>) or Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O. Among these copper complexes, complex <b>14</b> (inhibitory constant (<i>K</i><sub>i</sub>) = 1.4 ± 0.3 nM in FPA; half-maximal inhibitory concentration (IC<sub>50</sub>) = 7.8 ± 1.4 nM in ELISA; IC<sub>50</sub> = 3.5 ± 0.7 nM in SPR) was more potent than the reference drug A-1210477 (<i>K</i><sub>i</sub> = 4.7 ± 0.7 nM in FPA; IC<sub>50</sub> = 12.5 ± 3.6 nM in ELISA; IC<sub>50</sub> = 8.8 ± 0.5 nM in SPR). The binding affinity of our copper complexes decreased in the following order: <b>14</b> (R = −CH<sub>2</sub>Ph(p-CH<sub>3</sub>)) > <b>15</b> (R = −(CH<sub>2</sub>)<sub>2</sub>Ph) > <b>18</b> (R = −CH<sub>2</sub>Naphth) > <b>12</b> (R = −CH<sub>2</sub>Ph) > <b>17</b> (R = −CH<sub>2</sub>C<sub>3</sub>H<sub>5</sub>) > <b>19</b>(R = −(CH<sub>2</sub>)<sub>2</sub>OPh) > <b>20</b> (R = −(CH<sub>2</sub>)<sub>2</sub>OCH<sub>2</sub>Ph) > <b>16</b> (R = −CH<sub>2</sub>CH<sub>3</sub>) > <b>21</b> (R = −(CH<sub>2</sub>)<sub>2</sub>OCH<sub>2</sub>CH<sub>3</sub>) > <b>13</b> (R = −CH<sub>2</sub>Ph(p-F)). The structure–activity relationships (SARs) of our copper complexes were assessed. In general, aryl substitutions in the β-carboline ligands enhanced binding affinity more profoundly than alkyl substitutions.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities of the Ligands (<b>1</b>–<b>11</b>) and Copper(II) Complexes (<b>12</b>–<b>21</b>) for Mcl-1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0015.gif" alt="" id="GRAPHIC-d7e644-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0016.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values were obtained by FPA, ELISA, and SPR-based Assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Each value with standard deviation (SD) represents the average of three independent experiments.</p></div></div><div></div></div><div class="NLM_p">As complex <b>14</b> showed the highest binding affinity for Mcl-1 in competitive binding assays, its targeting ability was further confirmed by additional direct binding assays. First, SPR analysis was used to evaluate the kinetics of the binding of complex <b>14</b> with Mcl-1. The affinity (<i>K</i><sub>D</sub>), association rate constant (<i>K</i><sub>on</sub>) and dissociation rate constant (<i>K</i><sub>off</sub>) are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figure S47</a>. Complex <b>14</b> exhibited a high affinity for Mcl-1(<i>K</i><sub>D</sub> = 38.9 nM). The kinetics analysis suggested that complex <b>14</b> had a <i>K</i><sub>on</sub> value of 1.03 × 10<sup>6</sup> M<sup>–1</sup> s<sup>–1</sup> and a <i>K</i><sub>off</sub> value of 0.04 s<sup>–1</sup> for binding with Mcl-1. These results confirmed that complex <b>14</b> could form strong noncovalent interactions with Mcl-1.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinetic Characteristics of Complex <b>14</b> Binding to Mcl-1, as Evaluated by SPR</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>D</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>on</sub> (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>off</sub> (s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">38.9</td><td class="colsep0 rowsep0" align="left">1.03 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">0.04</td></tr></tbody></table></div></div><div class="NLM_p">To further confirm the noncovalent interactions of complex <b>14</b> with Mcl-1, Mcl-1 protein was treated with complex <b>14</b> at different concentrations and analyzed by SDS gel electrophoresis. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figure S48</a>, no changes in electrophoretic mobility were observed. The results suggested that complex <b>14</b> participated in noncovalent interactions with Mcl-1.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Next, ultrafiltration studies were performed to assess the amount of free complex <b>14</b> present in solutions of Bcl-2 antiapoptotic proteins (Mcl-1, Bcl-2, Bcl-xl, Bcl-w, and A1/Bfl-1). In the Mcl-1 solution, 93.4% of complex <b>14</b> bound with Mcl-1, while in the solutions of the other Bcl-2 antiapoptotic proteins (Bcl-2, Bcl-xl, Bcl-w, and A1/Bfl-1), 43.7–61.5% of complex <b>14</b> bound with the respective proteins (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Table S11</a>). These results suggested that complex <b>14</b> bound more tightly with Mcl-1 than with other Bcl-2 antiapoptotic proteins.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selectivity Profile against Mcl-1 and Other Bcl-2 Family Proteins<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">Mcl-1 <i>K</i><sub>i</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="±">Bcl-2 <i>K</i><sub>i</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="±">Bcl-xl <i>K</i><sub>i</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="±">Bcl-w <i>K</i><sub>i</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="±">A1/Bfl-1 <i>K</i><sub>i</sub> ± SD (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">747.0 ± 56.2</td><td class="colsep0 rowsep0" align="char" char="±">1098.3 ± 122.7</td><td class="colsep0 rowsep0" align="char" char="±">872.5 ± 91.5</td><td class="colsep0 rowsep0" align="char" char="±">531.4 ± 60.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">45.0 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">930.8 ± 85.3</td><td class="colsep0 rowsep0" align="char" char="±">2451.0 ± 205.4</td><td class="colsep0 rowsep0" align="char" char="±">731.5 ± 85.2</td><td class="colsep0 rowsep0" align="char" char="±">585.5 ± 43.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">781.2 ± 62.1</td><td class="colsep0 rowsep0" align="char" char="±">925.3 ± 104.7</td><td class="colsep0 rowsep0" align="char" char="±">674.3 ± 53.1</td><td class="colsep0 rowsep0" align="char" char="±">504.3 ± 48.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">523.6 ± 71.4</td><td class="colsep0 rowsep0" align="char" char="±">864.8 ± 82.7</td><td class="colsep0 rowsep0" align="char" char="±">684.9 ± 74.7</td><td class="colsep0 rowsep0" align="char" char="±">472.4 ± 53.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">22.5 ± 3.6</td><td class="colsep0 rowsep0" align="char" char="±">1273.5 ± 181.4</td><td class="colsep0 rowsep0" align="char" char="±">1734.2 ± 151.6</td><td class="colsep0 rowsep0" align="char" char="±">957.3 ± 86.0</td><td class="colsep0 rowsep0" align="char" char="±">637.8 ± 54.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">9.8 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">764.3 ± 84.6</td><td class="colsep0 rowsep0" align="char" char="±">637.1 ± 58.4</td><td class="colsep0 rowsep0" align="char" char="±">926.2 ± 85.1</td><td class="colsep0 rowsep0" align="char" char="±">329.6 ± 48.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">859.4 ± 72.9</td><td class="colsep0 rowsep0" align="char" char="±">1049.5 ± 121.8</td><td class="colsep0 rowsep0" align="char" char="±">912.7 ± 75.3</td><td class="colsep0 rowsep0" align="char" char="±">549.1 ± 62.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">11.6 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">748.1 ± 81.2</td><td class="colsep0 rowsep0" align="char" char="±">921.3 ± 85.8</td><td class="colsep0 rowsep0" align="char" char="±">526.5 ± 63.3</td><td class="colsep0 rowsep0" align="char" char="±">326.1 ± 22.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char="±">17.3 ± 2.9</td><td class="colsep0 rowsep0" align="char" char="±">851.3 ± 79.5</td><td class="colsep0 rowsep0" align="char" char="±">1143.7 ± 91.2</td><td class="colsep0 rowsep0" align="char" char="±">503.1 ± 62.6</td><td class="colsep0 rowsep0" align="char" char="±">357.5 ± 43.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">43.9 ± 6.4</td><td class="colsep0 rowsep0" align="char" char="±">951.2 ± 88.4</td><td class="colsep0 rowsep0" align="char" char="±">1537.4 ± 136.5</td><td class="colsep0 rowsep0" align="char" char="±">784.0 ± 87.5</td><td class="colsep0 rowsep0" align="char" char="±">514.8 ± 68.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values were determined by FPA.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Each value with standard deviation (SD) represents the average of three independent experiments.</p></div></div></div><div class="NLM_p">The binding mechanisms of complexes <b>12–14</b> and ligand <b>4</b> were further evaluated through analysis of docking of these entities with Mcl-1 [Protein Data Bank (PDB) ID code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WIX">3WIX</a>].<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The structures of complexes <b>12–14</b> in solution were determined by ESI-MS (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figures S34–S36 and S46</a>). No water molecules were predicted to bind to the copper center. According to the structural analysis, complex <b>14</b> had a docking score of −7.16. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">S49</a>, complex <b>14</b> was predicted to form a cation−π interaction with Arg263 and two H−π interactions with Ala227 and Leu267 of the Mcl-1 protein. The nitrate-Cu coordinate group faced outward, and the 4-methyl benzyl group lay inside the P2 pocket. The corresponding ligand <b>4</b> had a lower docking score (−6.18) than complex <b>14</b>, suggesting a lower binding energy. These data confirm that copper complex <b>14</b> has a higher binding capacity than ligand <b>4</b>. Complex <b>12</b> was predicted to form a cation−π interaction with Arg263 and a weak H bond with Ala227. The docking score of complex <b>12</b> (−6.91) was lower than that of complex <b>14</b>. Complex <b>13</b> was predicted to form a cation−π interaction with Arg263. The docking score of complex <b>13</b> (−6.53) was lower than that of complex <b>12</b>. These results suggested that the binding energies of our copper complexes decreased in the following order: complex <b>14</b> > complex <b>12</b> > complex <b>13</b>. These findings were in agreement with the binding affinity data.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked structures of complexes <b>12</b> (A), <b>13</b> (B), and <b>14</b> (C) and ligand <b>4</b> (D) with the Mcl-1 protein. Docking simulations of the compounds with the Mcl-1 protein (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WIX">3WIX</a>) were carried out with MOE version 2016.08.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We subsequently investigated the selectivity of all copper complexes for antiapoptotic Bcl-2 family members (Bcl-2, Bcl-xl, Mcl-1, Bcl-w, and A1/Bfl-1). FPA revealed that the copper complexes exhibited minimal affinity for Bcl-2, Bcl-xl, Bcl-w, and A1/Bfl-1. Overall, the selectivity of the copper complexes improved with increasing binding affinity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The most potent Mcl-1 inhibitor, complex <b>14</b>, showed a 558-fold greater binding with Mcl-1 than with Bcl-2, 661-fold greater binding with Mcl-1 than with Bcl-xl, 482-fold greater binding with Mcl-1 than with Bcl-w, and 360-fold greater binding with Mcl-1 than with A1/Bfl-1.</div><div class="NLM_p">Having demonstrated the targeting ability of complex <b>14</b> in biochemical assays, we confirmed the cellular target engagement of complex <b>14</b> by using a cellular thermal shift assay (CETSA). A CETSA is a direct binding assay that monitors ligand-mediated thermal stabilization of target proteins in cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> NCI-H929 cells were treated with either complex <b>14</b> (40 μM) or DMSO for 1 h. The treated cells were then heated to the indicated temperature ranging from 45 to 63 °C. Finally, the cells were lysed, and the protein fractions were tested by immunoblotting. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">S50</a>, compared to the vehicle control, complex <b>14</b> increased the melting point of Mcl-1 by 4 °C, suggesting the occurrence of ligand-induced stabilization. A further isothermal dose–response experiment was performed at 57 °C. Complex <b>14</b> significantly enhanced the thermal stability of cellular Mcl-1 protein at low nanomolar concentrations [half-maximal effective concentration (EC<sub>50</sub>) = 6.3 nM], consistent with the biochemical data (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">S50</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CETSA. (A) Mcl-1 melting curve determination in NCI-H929 cells. (B) Isothermal CETSA experiment in NCI-H929 cells treated with complex <b>14</b> at 57 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.4.  Mechanism-Based Cellular Activity of the Copper Complexes</h3><div class="NLM_p">Further studies were carried out to investigate the mechanism-based activity of our copper complexes. First, we assessed the growth inhibitory effects of complexes <b>12–21</b> and cisplatin on five validated Mcl-1-dependent cell lines (MOLP-8, L-363, K562, NCI-H929, and LP-1) and two Mcl-1-independent cell lines (MM.1S and KMS-12-PE) by Cell Counting Kit-8 (CCK8) assay.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> The results showed that copper complexes <b>12–21</b> selectively inhibited the growth of Mcl-1-dependent cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The most effective complex, complex <b>14</b>, exhibited 18–49-fold greater selectivity for Mcl-1-dependent cell lines than for Mcl-1-independent cell lines. In contrast, the cytotoxic drug cisplatin exhibited no selectivity for Mcl-1-dependent cells or Mcl-1-independent cells.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (μM) Values of the Ligands (<b>1</b>–<b>11</b>) and Copper(II) Complexes (<b>12</b>–<b>21</b>) in Five Validated Mcl-1-dependent Cell Lines (MOLP-8, L-363, K562, NCI-H929, and LP-1) and Two Mcl-1-independent Cell Lines (MM.1S and KMS-12-PE)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">MOLP-8</th><th class="colsep0 rowsep0" align="center">L-363</th><th class="colsep0 rowsep0" align="center">K562</th><th class="colsep0 rowsep0" align="center">NCI-H929</th><th class="colsep0 rowsep0" align="center">LP-1</th><th class="colsep0 rowsep0" align="center">MM.1S</th><th class="colsep0 rowsep0" align="center">KMS-12-PE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">32.8 ± 3.9</td><td class="colsep0 rowsep0" align="left">37.4 ± 5.3</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">34.7 ± 4.3</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">28.9 ± 3.1</td><td class="colsep0 rowsep0" align="left">25.4 ± 4.8</td><td class="colsep0 rowsep0" align="left">33.6 ± 5.1</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">27.5 ± 2.9</td><td class="colsep0 rowsep0" align="left">33.5 ± 4.7</td><td class="colsep0 rowsep0" align="left">22.6 ± 2.2</td><td class="colsep0 rowsep0" align="left">17.9 ± 3.7</td><td class="colsep0 rowsep0" align="left">25.8 ± 4.2</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">21.4 ± 3.3</td><td class="colsep0 rowsep0" align="left">24.9 ± 4.6</td><td class="colsep0 rowsep0" align="left">17.9 ± 3.6</td><td class="colsep0 rowsep0" align="left">14.3 ± 2.8</td><td class="colsep0 rowsep0" align="left">18.8 ± 3.1</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3.9 ± 0.5</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.5</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.7</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">33.5 ± 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">14.2 ± 1.9</td><td class="colsep0 rowsep0" align="left">13.3 ± 2.1</td><td class="colsep0 rowsep0" align="left">11.9 ± 1.8</td><td class="colsep0 rowsep0" align="left">8.1 ± 1.5</td><td class="colsep0 rowsep0" align="left">9.4 ± 1.6</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">16.5 ± 2.1</td><td class="colsep0 rowsep0" align="left">19.6 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">1.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.3</td><td class="colsep0 rowsep0" align="left">28.4 ± 2.6</td><td class="colsep0 rowsep0" align="left">21.7 ± 3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">8.6 ± 1.1</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.7</td><td class="colsep0 rowsep0" align="left">6.7 ± 0.8</td><td class="colsep0 rowsep0" align="left">6.0 ± 0.7</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.9</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">4.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">36.9 ± 5.3</td><td class="colsep0 rowsep0" align="left">28.9 ± 6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">2.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.5</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.4</td><td class="colsep0 rowsep0" align="left">31.8 ± 3.5</td><td class="colsep0 rowsep0" align="left">25.7 ± 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">5.6 ± 0.5</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.8</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">3.9 ± 0.7</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">7.1 ± 0.9</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.6</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.7</td><td class="colsep0 rowsep0" align="left">4.6 ± 0.9</td><td class="colsep0 rowsep0" align="left">5.2 ± 0.6</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">11.2 ± 0.8</td><td class="colsep0 rowsep0" align="left">9.7 ± 0.9</td><td class="colsep0 rowsep0" align="left">8.2 ± 1.1</td><td class="colsep0 rowsep0" align="left">6.8 ± 0.8</td><td class="colsep0 rowsep0" align="left">7.3 ± 1.2</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A-1210477</td><td class="colsep0 rowsep0" align="left">9.7 ± 2.1</td><td class="colsep0 rowsep0" align="left">11.8 ± 1.9</td><td class="colsep0 rowsep0" align="left">13.9 ± 2.5</td><td class="colsep0 rowsep0" align="left">8.6 ± 1.7</td><td class="colsep0 rowsep0" align="left">10.6 ± 1.3</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cisplatin<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">14.2 ± 2.3</td><td class="colsep0 rowsep0" align="left">10.7 ± 2.0</td><td class="colsep0 rowsep0" align="left">12.5 ± 2.4</td><td class="colsep0 rowsep0" align="left">11.3 ± 2.1</td><td class="colsep0 rowsep0" align="left">12.4 ± 1.9</td><td class="colsep0 rowsep0" align="left">9.7 ± 2.1</td><td class="colsep0 rowsep0" align="left">13.6 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cu(NO<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Each value with standard deviation (SD) represents the average of three independent experiments.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Cisplatin was dissolved in saline.</p></div></div></div><div class="NLM_p">In addition, copper complexes <b>12–21</b> exerted more potent effects than their ligands (ligands <b>2–11</b>) or Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O on Mcl-1-dependent cells, suggesting that β-carboline ligands exhibit excellent antitumor synergism with copper(II) atoms. The growth inhibitory activities of our copper complexes against Mcl-1-dependent cells decreased in the following order: <b>14</b> (R = −CH<sub>2</sub>Ph(p-CH<sub>3</sub>)) > <b>15</b> (R = −(CH<sub>2</sub>)<sub>2</sub>Ph) > <b>18</b> (R = −CH<sub>2</sub>Naphth) > <b>12</b> (R = −CH<sub>2</sub>Ph) > <b>17</b> (R = −CH<sub>2</sub>C<sub>3</sub>H<sub>5</sub>) > <b>19</b> (R = −(CH<sub>2</sub>)<sub>2</sub>OPh) > <b>20</b> (R = −(CH<sub>2</sub>)<sub>2</sub>OCH<sub>2</sub>Ph) > <b>16</b> (R = −CH<sub>2</sub>CH<sub>3</sub>) > <b>21</b> (R = −(CH<sub>2</sub>)<sub>2</sub>OCH<sub>2</sub>CH<sub>3</sub>) > <b>13</b> (R = −CH<sub>2</sub>Ph(p-F)). The cytotoxic activity and the binding affinity values followed the same SARs, suggesting that these copper complexes exerted their cellular activity though inhibition of Mcl-1. The most potent complex, complex <b>14</b>, had low IC<sub>50</sub> values (0.4–0.9 μM) in Mcl-1-dependent cell lines and was 11–35-fold more potent than A-1210477.</div><div class="NLM_p">The cytotoxic activity of complexes <b>12–21</b> was also determined in four solid tumor cell lines (T-24, HepG2, MGC80-3, and NCI-H460) as well as the normal human hepatocyte line LO2 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Table S12</a>). Similar synergistic effects were also observed in these solid tumor cell lines. In addition, copper complexes <b>12–14</b> were less cytotoxic toward LO2 cells than toward the tumor cell lines. The safety of these complexes was further investigated in a mouse model.</div><div class="NLM_p">Bax and Bak are important proapoptotic effector proteins that are crucial for Mcl-1-mediated apoptosis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> To further demonstrate that the observed activity of copper complex <b>14</b> was caused by inhibition of Mcl-1 in cells, we silenced the Bax and Bak genes and evaluated whether complex <b>14</b> killed tumor cells in a Bax/Bak-dependent manner. Specifically, K562 cells were treated with short interfering (si) RNA targeting Bax and Bak for 48 h. The efficacy of gene silencing was confirmed by immunoblot analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Next, the ability of complex <b>14</b> to induce apoptosis in these Bax/Bak-deficient cells was tested by using Annexin V-PI staining and flow cytometry analysis. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, complex <b>14</b> was less effective in Bax/Bak-deficient cells than in control cells, indicating that it killed tumor cells through a Bax/Bak-dependent process. For comparison, the cytotoxic agent staurosporine was also tested. Staurosporine showed no selectivity for Bax/Bak-deficient cells or K562 cells. These results suggested that complex <b>14</b> induced apoptosis through an on-target mechanism.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Complex <b>14</b> induced apoptosis in a Bax/Bak-dependent manner. (A) Immunoblotting was used to confirm the expression levels of Bak and Bax in K562 cells. (B) Induction of apoptosis in Bak/Bax-deficient K562 cells by complex <b>14</b>. (C) Induction of apoptosis in Bak/Bax-deficient K562 cells by staurosporine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further confirm the on-target activity of complex <b>14</b> in solid tumor cells, a procedure similar to that performed on K562 cells was performed on NCI-H460 cells. The results showed that complex <b>14</b> also induced Bax/Bak-dependent apoptosis in NCI-H460 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figure S51</a>).</div><div class="NLM_p">Next, we investigated whether complex <b>14</b> induced apoptosis by disrupting Mcl-1-Bax and Mcl-1-Bak complexes. We exposed K562 cells to complex <b>14</b> for 4 h and detected Mcl-1 complexes by coimmunoprecipitation (Co-IP) and immunoblotting (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The results suggested that complex <b>14</b> concentration-dependently induced release of Bax and Bak from Mcl-1 complexes. However, treatment with complex <b>14</b> did not affect the protein expression levels of Mcl-1, Bax, and Bak, suggesting that the decreases in Mcl-1-Bax and Mcl-1-Bak complex levels were not caused by changes in the expression of Mcl-1, Bax, or Bak. Thus, complex <b>14</b> disrupted the binding of Bax and Bak to Mcl-1 in K562 cells.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Impact of complex <b>14</b> on the interaction of Mcl-1 with Bax and Bak. (A) K562 cells were treated with complex <b>14</b> (0, 1, 2, or 4 μM) for 4 h. The immunoprecipitates were analyzed by western blot for Mcl-1, Bax, and Bak. (B) Total inputs were analyzed by western blot for Mcl-1, Bax, and Bak.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having demonstrated that complex <b>14</b> can disrupt Mcl-1 complexes and induce Bax/Bak-mediated apoptosis, we further investigated the impact of complex <b>14</b> on the mitochondrial apoptosis pathway. We exposed NCI-H460 cells to complex <b>14</b> (0, 1, 2, or 4 μM) and extracted proteins for immunoblot analysis. Treatment with complex <b>14</b> increased the level of cytochrome <i>c</i> in the cytosol and decreased the level in the mitochondria (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), suggesting that complex <b>14</b> induced cytochrome <i>c</i> release. In addition, the total levels of pro-PARP [poly (adenosine diphosphate–ribose) polymerase (PARP)] and cleaved PARP in NCI-H460 cells were detected by immunoblot analysis. Complex <b>14</b> upregulated cleaved PARP and downregulated pro-PARP in cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), suggesting that complex <b>14</b> induced PARP cleavage in NCI-H460 cells.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Western blot analysis of cytochrome <i>c</i> release and PARP cleavage in complex <b>14</b> (0, 1, 2, or 4 μM, 6 h)-treated NCI-H460 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Caspases are key apoptosis executors in the intrinsic apoptosis pathway. The abilities of complexes <b>13</b> and <b>14</b> to activate caspase-3 and caspase-9 in NCI-H460 cells were tested by using flow cytometry analysis. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, compared with the control treatment (0 μM complex <b>14</b>), treatment with complex <b>14</b> (2 or 4 μM) for 6 h dose-dependently activated caspase-3/9 in NCI-H460 cells. The effects of complex <b>14</b> on caspase-3/9 activation were stronger than those of complex <b>13</b>, consistent with the cellular IC<sub>50</sub> data. To further verify that the observed cellular activity was caused by an on-target effect, the ability of complex <b>14</b> to induce apoptosis in either the absence or the presence of the caspase inhibitor QVD-OPh was tested. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C,D, the efficacy of complex <b>14</b> was attenuated by the addition of QVD-OPh, indicating that complex <b>14</b> rapidly induced caspase-dependent apoptosis in NCI-H460 cells.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Caspase-3/9 activity in NCI-H460 cells treated with complex <b>13</b> or <b>14</b> for 6 h. (A) Caspase-3 activation was assayed by flow cytometry. (B) Caspase-9 activation was assayed by flow cytometry. (C) Induction of apoptosis in NCI-H460 cells treated with complex <b>14</b> in either the absence or presence of the caspase inhibitor QVD-OPh. (D) NCI-H460 cells were treated with complex <b>14</b> for 4, 6, or 8 h and analyzed by flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.5.  Acute Toxicity of Copper Complexes in Mice</h3><div class="NLM_p">In cellular experiments, complex <b>14</b> showed modest selectivity for tumor cells over normal cells. However, cells and animals are different systems. Thus, we further investigated the <i>in vivo</i> safety of complex <b>14</b>.</div><div class="NLM_p">The acute toxicity of copper complexes <b>13</b> and <b>14</b> was assessed to evaluate the safety profiles of these compounds. Kunming mice (<i>n</i> = 10, half male and half female) were randomized and dosed intraperitoneally with vehicle, complex <b>13</b>, complex <b>14</b>, or cisplatin. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Table S13</a>, the acute toxicity of complexes <b>13</b> and <b>14</b> [median lethal dose (LD<sub>50</sub>) = 91.6 and 79.5 mg/kg, respectively] was much lower than that of cisplatin (LD<sub>50</sub> = 11.1 mg/kg). In addition, blood biochemistry analysis was used to evaluate the renal toxicity and hepatotoxicity of complexes <b>13</b> and <b>14</b> in mice. Three days after intraperitoneal injection of complex <b>13</b> or <b>14</b> (10 mg/kg), blood samples were collected to determine the levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), creatine kinase (CK), creatinine (Cr), uric acid (UA), and blood urea nitrogen (BUN). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, complexes <b>13</b> and <b>14</b> did not obviously affect the levels of ALT, ALP, AST, CK, Cr, UA, and BUN, suggesting that these complexes had low kidney and liver toxicity in the mice.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute toxicity of complexes <b>13</b> and <b>14</b>. Kunming mice (<i>n</i> = 10, half male and half female) were grouped and treated intraperitoneally with either complex <b>13</b> or complex <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Blood Biochemistry Analysis of Mice Treated with Complexes <b>13</b> and <b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter (units)</th><th class="colsep0 rowsep0" align="center" char="±">control</th><th class="colsep0 rowsep0" align="center" char="±">complex <b>13</b></th><th class="colsep0 rowsep0" align="center" char="±">complex <b>14</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALT (U/L)</td><td class="colsep0 rowsep0" align="char" char="±">25.3 ± 7.1</td><td class="colsep0 rowsep0" align="char" char="±">26.3 ± 4.7</td><td class="colsep0 rowsep0" align="char" char="±">25.7 ± 4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALP (U/L)</td><td class="colsep0 rowsep0" align="char" char="±">114.7 ± 12.2</td><td class="colsep0 rowsep0" align="char" char="±">110.7 ± 24.6</td><td class="colsep0 rowsep0" align="char" char="±">109.3 ± 13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AST (U/L)</td><td class="colsep0 rowsep0" align="char" char="±">57.3 ± 6.5</td><td class="colsep0 rowsep0" align="char" char="±">56.1 ± 6.5</td><td class="colsep0 rowsep0" align="char" char="±">55.9 ± 6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CK (U/L)</td><td class="colsep0 rowsep0" align="char" char="±">518.0 ± 28.5</td><td class="colsep0 rowsep0" align="char" char="±">512.3 ± 24.0</td><td class="colsep0 rowsep0" align="char" char="±">475.7 ± 37.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cr (μmol/L)</td><td class="colsep0 rowsep0" align="char" char="±">19.8 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">18.2 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">18.9 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UA (μmol/L)</td><td class="colsep0 rowsep0" align="char" char="±">102.3 ± 6.5</td><td class="colsep0 rowsep0" align="char" char="±">107.0 ± 15.1</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BUN (mmol/L)</td><td class="colsep0 rowsep0" align="char" char="±">9.2 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">8.2 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">8.5 ± 2.3</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">2.6.  Pathological Examination of Mice Treated with Complexes <b>13</b> and <b>14</b></h3><div class="NLM_p">To further evaluate the safety profiles of complexes <b>13</b> and <b>14</b> in mice, 4-week-old Kunming mice (<i>n</i> = 6, half male and half female) were divided randomly into three groups and treated with vehicle, complex <b>13</b> (10 mg/kg, once daily), or complex <b>14</b> (10 mg/kg, once daily) by intraperitoneal injection. Their body weights were monitored every 2 days. No body weight loss was observed among the treated mice during 2 weeks of treatment (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). After treatment, the mice were euthanized, and their hearts, livers, and kidneys were harvested for hematoxylin and eosin (H&E) staining. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, the complex <b>13</b>- and complex <b>14</b>-treated mice showed heart, liver, and kidney weights similar to those of the control mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). Pathological examination showed that no drug-related side effects occurred in the hearts, livers, or kidneys of complex <b>13</b>- or complex <b>14</b>-treated mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). These results indicated that complexes <b>13</b> and <b>14</b> were safe in mice.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Safety profile of complexes <b>13</b> and <b>14</b> in a mouse model. (A) Body weight evaluation of Kunming mice (<i>n</i> = 6, half male and half female) that were treated intraperitoneally with vehicle, complex <b>13</b> (10 mg/kg, once a day), or complex <b>14</b> (10 mg/kg, once a day). (B) Weights of hearts, livers, and kidneys from treated Kunming mice at the end point. (C) H&E-stained sections (400×, scale bar: 100 μm) of hearts, livers, and kidneys from treated Kunming mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">2.7.  Pharmacokinetic Study</h3><div class="NLM_p">The pharmacokinetic profiles of complexes <b>13</b> and <b>14</b> in Kunming mice were investigated. Complexes <b>13</b> and <b>14</b> were administered through intraperitoneal injection at doses of 10 mg/kg. After injection, blood was collected from the treated mice at 10, 20, 60, 120, 180, 320, and 640 min. The blood samples were tested by inductively coupled plasma mass spectrometry (ICP–MS).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figure S52</a>, the plasma concentration of complex <b>14</b> reached a peak of 8.4 μM at 0.33 h. This drug concentration was much higher than the cellular IC<sub>50</sub> values, indicating that the dose of complex <b>14</b> used in the mouse model was adequate. The maximum plasma concentration (<i>C</i><sub>max</sub>), area under the plasma concentration–time curve until time <i>t</i> (AUC<sub>0–<i>t</i></sub>), and area under the plasma concentration–time curve until infinite time (AUC<sub>0–∞</sub>) values of complex <b>13</b> were lower than those of complex <b>14</b>. These results suggested that complex <b>14</b> was absorbed more efficiently by mice than complex <b>13</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters of Complexes <b>13</b> and <b>14</b> in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">complex <b>13</b></th><th class="colsep0 rowsep0" align="center" char=".">complex <b>14</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>t</i></sub> (μM h)</td><td class="colsep0 rowsep0" align="char" char=".">20.0</td><td class="colsep0 rowsep0" align="char" char=".">31.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (μM h)</td><td class="colsep0 rowsep0" align="char" char=".">20.2</td><td class="colsep0 rowsep0" align="char" char=".">32.1</td></tr></tbody></table></div></div><div class="NLM_p last">We further explored the molecular structures of complexes <b>13</b> and <b>14</b> in blood. The ESI-MS spectra showed that complexes <b>13</b> and <b>14</b> existed in their native forms as [CuL(NO<sub>3</sub>)]<sup>+</sup> in blood, suggesting that the copper center remained chelated with the β-carboline ligand (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Figures S53 and S54</a>).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.8.  <i>In Vivo</i> Antitumor Activity of Complexes <b>13</b> and <b>14</b> in NCI-H460 Xenograft Mice</h3><div class="NLM_p">The <i>in vivo</i> antitumor activity of complexes <b>13</b> and <b>14</b> was tested in an NCI-H460 xenograft mouse model. NCI-H460 cells were selected because they express Mcl-1 protein and grow faster than other cell lines (K562, NCI-H929, and LP-1) in xenograft models.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The NCI-H460 tumor-bearing mice were divided randomly into five groups and intraperitoneally treated with vehicle, complex <b>13</b>, or complex <b>14</b> (5 or 10 mg/kg, once daily). The tumor volumes and body weights of the mice were recorded every 2 days over 7 days of treatment. On the seventh day of treatment, the mice were euthanized, and the relative tumor growth rates [treatment group/control group (<i>T</i>/<i>C</i>) ratios] were calculated. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A, complexes <b>13</b> and <b>14</b> (10 mg/kg) effectively inhibited tumor growth with <i>T</i>/<i>C</i> values of 62.6 and 46.2%, respectively. However, complex <b>14</b> showed a higher tumor growth inhibition (TGI) value than complex <b>13</b> (53.5 <i>vs</i> 32.9%, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C), suggesting that complex <b>14</b> was more potent than complex <b>13</b> in this mouse model. This result is consistent with the SARs revealed in the cellular experiments. In addition, no body weight loss was observed in complex <b>13</b>- or complex <b>14</b>-treated mice (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B), suggesting that complexes <b>13</b> and <b>14</b> were well tolerated by the mice.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <i>In vivo</i> antitumor efficacy of complexes 13 and <b>14</b> in an NCI-H460 non-small-cell lung cancer xenograft mouse model. (A) Effects of intraperitoneally administered complex <b>13</b> and complex <b>14</b> on the growth of NCI-H460 tumors in mice. (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001. (B) Body weights of control and treated NCI-H460 xenograft model mice. (C) TGI rates of complexes <b>13</b> and <b>14</b>. (D) Tissue distribution of complexes <b>13</b> and <b>14</b> in the NCI-H460 xenograft mouse model. (E) H&E staining of tumor tissue from treated nude mice (200×, scale bar: 200 μm). (F) TUNEL staining of tumor tissue from treated nude mice (200×, scale bar: 200 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">2.9.  Tissue Distribution and Tumor Pathology</h3><div class="NLM_p">After 7 days of treatment, the mice were euthanized, and organs (hearts, livers and kidneys) and tumor tissues were collected for tissue distribution analysis <i>via</i> ICP–MS. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D, the concentrations of complexes <b>13</b> and <b>14</b> in tumor tissue were higher than those in heart, liver, and kidney tissue, suggesting that complexes <b>13</b> and <b>14</b> accumulate in tumors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In addition, the drug concentration of complex <b>14</b> in tumor tissue was higher than the cellular IC<sub>50</sub> values, indicating that the dose of complex <b>14</b> used was adequate for the treatment of tumor tissues.</div><div class="NLM_p last">Tumor tissue was also excised for histologic examination. H&E staining (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>E) indicated the presence of large areas of necrosis (homogeneous pink-stained areas) in tumor tissue after treatment with complexes <b>13</b> and <b>14</b>. However, complex <b>14</b> showed higher tumor necrosis-inducing activity than complex <b>13</b>, suggesting that complex <b>14</b> exerted stronger <i>in vivo</i> antitumor activity than complex <b>13</b>. In addition, a TUNEL assay yielded similar results. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>F, large areas of necrosis (homogeneous brown-stained areas) were present in tumor tissue after treatment with complexes <b>13</b> and <b>14</b>. Consistent with the findings of H&E staining, this result suggested that complexes <b>13</b> and <b>14</b> induced tumor tissue necrosis.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2.10.  Survival Analysis</h3><div class="NLM_p">After demonstrating that complex <b>14</b> significantly inhibited tumor growth and induced tumor necrosis, we further evaluated the impact of complex <b>14</b> on mouse survival in a xenograft mouse model. NCI-H460 xenograft mice (<i>n</i> = 6) were intraperitoneally treated with complex <b>14</b> (0, 5, 10, or 15 mg/kg) once daily. As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, mice treated with 15 mg/kg complex <b>14</b> had 33% longer mean survival times (48 days, <i>P</i> < 0.001) than control mice (36 days). These results indicated that complex <b>14</b> extended the survival times of the NCI-H460 xenograft mice.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Kaplan–Meier survival analysis. (A) Tumor volumes of NCI-H460 xenograft mice treated with vehicle or complex <b>14</b> (5, 10, or 15 mg/kg, once a day). (B) Survival of complex <b>14</b> (5, 10, or 15 mg/kg, once a day)- <i>vs</i> vehicle-treated mice with NCI-H460 xenografts. (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we identified a novel copper-based Mcl-1 inhibitor complex <b>14</b> that was effective in inhibiting cancer cell growth in cancer models. <i>In vitro</i> studies demonstrated that complex <b>14</b> selectively bound to Mcl-1 and inhibited the growth of Mcl-1-dependent cancer cells. In addition, complex <b>14</b> disrupted Mcl-1-Bax and Mcl-1-Bak complexes and induced Bax/Bak-dependent apoptosis in cells. <i>In vivo</i>, complex <b>14</b> significantly suppressed the growth of NCI-H460 xenograft tumors and induced tumor tissue necrosis. Furthermore, complex <b>14</b> extended the survival times of tumor-bearing mice and showed a good safety profile. In summary, complex <b>14</b> is a promising copper-based Mcl-1 inhibitor with high efficacy and low toxicity. Our findings indicate that the use of metal-based Mcl-1 inhibitors is an effective strategy for the treatment of Mcl-1-dependent cancers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.1.  Materials</h3><div class="NLM_p last">All chemical reagents were purchased from commercial suppliers and used without further purification. NMR spectra were recorded on a Bruker AV-500 instrument. Elemental analysis was performed on a PerkinElmer series II CHNS/O 2400 elemental analyzer. ESI-MS data were collected on a Thermo Fisher Scientific Q Exactive mass spectrometer. Cancer cell lines and normal human cell lines were obtained from the China Center for Type Culture Collection (CCTCC), the German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ), and the American Type Culture Collection (ATCC). BALB/C nude mice and Kunming mice were purchased from Hunan SJA Laboratory Animal Co., Ltd. (Hunan, China, Approval no. SCXK 2019-0004).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.2.  Methods</h3><div class="NLM_p last">Crystal structures were solved by a direct method using Sheldrick software.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The purities of all compounds were ≥95% as determined by elemental analysis. All animal experimental procedures were conducted in compliance with the NIH Guidelines for the Care and Use of Laboratory Animals. All <i>in vivo</i> experiments were approved by the Animal Ethics Committee of the 181st Hospital of the Chinese People’s Liberation Army (Guilin, China, Approval no. SYXK2018-0005). FPAs, SPR assays, and ELISAs were performed as described previously.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> The methods used for MTT assays, flow cytometry, western blotting, and statistical analysis were similar to those described in a previous work.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Docking studies were performed using the Molecular Operating Environment (MOE) Dock Module.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> RNA interference (RNAi) and Co-IP experiments were carried out as reported by Akcay.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The experimental procedures are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02047" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02047?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02047</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures, <sup>1</sup>H NMR spectra, <sup>13</sup>C NMR spectra, ESI-MS data, X-ray crystal data (CCDC no: 1894320–1894328), UV–vis spectra, stability values for the copper complexes, LD<sub>50</sub> values of the tested compounds, pharmacokinetic study data, mass spectra of the complexes in blood, additional data from the binding experiments, additional data regarding the cellular IC<sub>50</sub> values, references, and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf">jm9b02047_si_001.pdf (2.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_002.csv">jm9b02047_si_002.csv (3.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_003.pdf">jm9b02047_si_003.pdf (152.51 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02047" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Liang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry
and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9af2f6f3fbf4fddafde2f4efb4fffeefb4f9f4"><span class="__cf_email__" data-cfemail="2e4642474f40496e4956405b004b4a5b004d40">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen-Feng Chen</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry
and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6548-6131" title="Orcid link">http://orcid.org/0000-0002-6548-6131</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d3b0bbb6bda9b593b4abbda6fdb6b7a6fdb0bd"><span class="__cf_email__" data-cfemail="204348454e5a466047584e550e4544550e434e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xing Lu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry
and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan-Cheng Liu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry
and Pharmacy, Guangxi Normal University, Guilin 541004, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Orvig</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Faculty of Science, University
of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T1Z1, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2830-5493" title="Orcid link">http://orcid.org/0000-0002-2830-5493</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the National Natural Science Foundation of China (grants 21431001, 81473102), IRT_16R15, the Natural Science Foundation of Guangxi Province (grants 2016GXNSFGA380005, AD17129007), the “BAGUI Scholar” Program of Guangxi Province of China, and the Innovation Project of Guangxi Graduate Education (YCBZ2017029).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">A1/Bfl1</td><td class="NLM_def"><p class="first last">Bcl-2-related protein A1</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">ALP</td><td class="NLM_def"><p class="first last">alkaline phosphatase</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">aspartate aminotransferase</p></td></tr><tr><td class="NLM_term">Bax</td><td class="NLM_def"><p class="first last">Bcl-2-associated X protein</p></td></tr><tr><td class="NLM_term">Bak</td><td class="NLM_def"><p class="first last">Bcl-2 homologous antagonist-killer protein</p></td></tr><tr><td class="NLM_term">Bcl-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">Bcl-xl</td><td class="NLM_def"><p class="first last">B-cell lymphoma x long isoform</p></td></tr><tr><td class="NLM_term">Bcl-w</td><td class="NLM_def"><p class="first last">Bcl-2-like-2</p></td></tr><tr><td class="NLM_term">BUN</td><td class="NLM_def"><p class="first last">blood urea nitrogen</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">creatine kinase</p></td></tr><tr><td class="NLM_term">Co-IP</td><td class="NLM_def"><p class="first last">coimmunoprecipitation</p></td></tr><tr><td class="NLM_term">Cr</td><td class="NLM_def"><p class="first last">creatinine</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">H&E</td><td class="NLM_def"><p class="first last">hematoxylin and eosin</p></td></tr><tr><td class="NLM_term">Mcl-1</td><td class="NLM_def"><p class="first last">myeloid cell leukemia 1</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">UA</td><td class="NLM_def"><p class="first last">uric acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llambi, F.</span></span> <span> </span><span class="NLM_article-title">Cell death signaling</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a006080</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1101%2Fcshperspect.a006080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=26626938" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=a006080&author=D.+R.+Greenauthor=F.+Llambi&title=Cell+death+signaling&doi=10.1101%2Fcshperspect.a006080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006080%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DLlambi%26aufirst%3DF.%26atitle%3DCell%2520death%2520signaling%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2015%26volume%3D7%26spage%3Da006080%26doi%3D10.1101%2Fcshperspect.a006080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szlavik, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Toumelin-Braizat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csekei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paczal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proszenyak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studeny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysiak-Auvity, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, L. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guasconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauquil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigal-Stephan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span> <span> </span><span class="NLM_article-title">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>538</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1038/nature19830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature19830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27760111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2016&pages=477-482&author=A.+Kotschyauthor=Z.+Szlavikauthor=J.+Murrayauthor=J.+Davidsonauthor=A.+L.+Maragnoauthor=G.+Le+Toumelin-Braizatauthor=M.+Chanrionauthor=G.+L.+Kellyauthor=J.-N.+Gongauthor=D.+M.+Moujalledauthor=A.+Brunoauthor=M.+Csekeiauthor=A.+Paczalauthor=Z.+B.+Szaboauthor=S.+Siposauthor=G.+Radicsauthor=A.+Proszenyakauthor=B.+Balintauthor=L.+Ondiauthor=G.+Blaskoauthor=A.+Robertsonauthor=A.+Surgenorauthor=P.+Dokurnoauthor=I.+Chenauthor=N.+Matassovaauthor=J.+Smithauthor=C.+Pedderauthor=C.+Grahamauthor=A.+Studenyauthor=G.+Lysiak-Auvityauthor=A.-M.+Girardauthor=F.+Grav%C3%A9author=D.+Segalauthor=C.+D.+Riffkinauthor=G.+Pomilioauthor=L.+C.+A.+Galbraithauthor=B.+J.+Aubreyauthor=M.+S.+Brennanauthor=M.+J.+Heroldauthor=C.+Changauthor=G.+Guasconiauthor=N.+Cauquilauthor=F.+Melchioreauthor=N.+Guigal-Stephanauthor=B.+Lockhartauthor=F.+Collandauthor=J.+A.+Hickmanauthor=A.+W.+Robertsauthor=D.+C.+S.+Huangauthor=A.+H.+Weiauthor=A.+Strasserauthor=G.+Lesseneauthor=O.+Geneste&title=The+MCL1+inhibitor+S63845+is+tolerable+and+effective+in+diverse+cancer+models&doi=10.1038%2Fnature19830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span></div><div class="casAuthors">Kotschy Andras; Szlavik Zoltan; Csekei Marton; Paczal Attila; Szabo Zoltan B; Sipos Szabolcs; Radics Gabor; Proszenyak Agnes; Balint Balazs; Ondi Levente; Blasko Gabor; Murray James; Davidson James; Robertson Alan; Surgenor Allan; Dokurno Pawel; Chen Ijen; Matassova Natalia; Smith Julia; Pedder Christopher; Graham Christopher; Maragno Ana Leticia; Le Toumelin-Braizat Gaetane; Chanrion Maia; Bruno Alain; Studeny Aurelie; Lysiak-Auvity Gaelle; Girard Anne-Marie; Grave Fabienne; Guasconi Ghislaine; Cauquil Nicolas; Colland Frederic; Hickman John A; Geneste Olivier; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Moujalled Donia M; Pomilio Giovanna; Wei Andrew H; Aubrey Brandon J; Roberts Andrew W; Melchiore Fabien; Guigal-Stephan Nolwen; Lockhart Brian; Roberts Andrew W; Wei Andrew H; Lessene Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">538</span>
        (<span class="NLM_cas:issue">7626</span>),
    <span class="NLM_cas:pages">477-482</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Avoidance of apoptosis is critical for the development and sustained growth of tumours.  The pro-survival protein myeloid cell leukemia 1 (MCL1) is overexpressed in many cancers, but the development of small molecules targeting this protein that are amenable for clinical testing has been challenging.  Here we describe S63845, a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1.  Our mechanistic studies demonstrate that S63845 potently kills MCL1-dependent cancer cells, including multiple myeloma, leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway.  In vivo, S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers.  Moreover, MCL1 inhibition, either alone or in combination with other anti-cancer drugs, proved effective against several solid cancer-derived cell lines.  These results point towards MCL1 as a target for the treatment of a wide range of tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7C_gQBh3bx0EgZCMqtRBifW6udTcc2eYEye5AMdS6SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D&md5=c435a7621b84063133e41e0cdbad3ac8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature19830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19830%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DSzlavik%26aufirst%3DZ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DJ.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DLe%2BToumelin-Braizat%26aufirst%3DG.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DGong%26aufirst%3DJ.-N.%26aulast%3DMoujalled%26aufirst%3DD.%2BM.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DCsekei%26aufirst%3DM.%26aulast%3DPaczal%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DZ.%2BB.%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DRadics%26aufirst%3DG.%26aulast%3DProszenyak%26aufirst%3DA.%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DOndi%26aufirst%3DL.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPedder%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DC.%26aulast%3DStudeny%26aufirst%3DA.%26aulast%3DLysiak-Auvity%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DA.-M.%26aulast%3DGrav%25C3%25A9%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGalbraith%26aufirst%3DL.%2BC.%2BA.%26aulast%3DAubrey%26aufirst%3DB.%2BJ.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGuasconi%26aufirst%3DG.%26aulast%3DCauquil%26aufirst%3DN.%26aulast%3DMelchiore%26aufirst%3DF.%26aulast%3DGuigal-Stephan%26aufirst%3DN.%26aulast%3DLockhart%26aufirst%3DB.%26aulast%3DColland%26aufirst%3DF.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DGeneste%26aufirst%3DO.%26atitle%3DThe%2520MCL1%2520inhibitor%2520S63845%2520is%2520tolerable%2520and%2520effective%2520in%2520diverse%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D538%26spage%3D477%26epage%3D482%26doi%3D10.1038%2Fnature19830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis signaling pathways for anticancer therapy</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3389/fonc.2011.00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.3389%2Ffonc.2011.00023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=22655234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC38notFWgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=23&author=S.+Fulda&title=Targeting+apoptosis+signaling+pathways+for+anticancer+therapy&doi=10.3389%2Ffonc.2011.00023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis signaling pathways for anticancer therapy</span></div><div class="casAuthors">Fulda Simone</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment approaches for cancer, for example chemotherapy, radiotherapy, or immunotherapy, primarily act by inducing cell death in cancer cells.  Consequently, the inability to trigger cell death pathways or alternatively, evasion of cancer cells to the induction of cell death pathways can result in resistance of cancers to current treatment protocols.  Therefore, in order to overcome treatment resistance a better understanding of the underlying mechanisms that regulate cell death and survival pathways in cancers and in response to cancer therapy is necessary to develop molecular-targeted therapies.  This strategy should lead to more effective and individualized treatment strategies that selectively target deregulated signaling pathways in a tumor type- and patient-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGOjJJch7cs5SWdIdmEou5fW6udTcc2eYEye5AMdS6SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38notFWgsw%253D%253D&md5=7314a863cc22f7fc8b88494e47b33d4b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2011.00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2011.00023%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTargeting%2520apoptosis%2520signaling%2520pathways%2520for%2520anticancer%2520therapy%26jtitle%3DFront.%2520Oncol.%26date%3D2011%26volume%3D1%26spage%3D23%26doi%3D10.3389%2Ffonc.2011.00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span></span> <span> </span><span class="NLM_article-title">Small molecules targeting Mcl-1: The search for a silver bullet in cancer therapy</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">778</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1039/c5md00582e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC5MD00582E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=778-787&author=D.+Nhuauthor=G.+Lesseneauthor=D.+C.+S.+Huangauthor=C.+J.+Burns&title=Small+molecules+targeting+Mcl-1%3A+The+search+for+a+silver+bullet+in+cancer+therapy&doi=10.1039%2Fc5md00582e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC5MD00582E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00582E%26sid%3Dliteratum%253Aachs%26aulast%3DNhu%26aufirst%3DD.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DSmall%2520molecules%2520targeting%2520Mcl-1%253A%2520The%2520search%2520for%2520a%2520silver%2520bullet%2520in%2520cancer%2520therapy%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D778%26epage%3D787%26doi%3D10.1039%2Fc5md00582e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span> <span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0lgkGkfe8HheCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1987</span>, <span class="refDoi"> DOI: 10.1111/bph.12431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1111%2Fbph.12431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=24117105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1973-1987&author=M.+J.+Royauthor=A.+Vomauthor=P.+E.+Czabotarauthor=G.+Lessene&title=Cell+death+and+the+mitochondria%3A+therapeutic+targeting+of+the+BCL-2+family-driven+pathway&doi=10.1111%2Fbph.12431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span></div><div class="casAuthors">Roy, M. J.; Vom, A.; Czabotar, P. E.; Lessene, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1973-1987</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The principal biol. role of mitochondria is to supply energy to cells; although intriguingly, evolution has bestowed another essential function upon these cellular organelles: under physiol. stress, mitochondria become the cornerstone of apoptotic cell death.  Specifically, mitochondrial outer membrane permeabilization (MOMP) allows cell death factors such as cytochrome c to be released into the cytoplasm, thus inducing caspase activation and the eventual destruction of essential cellular components.  Proteins of the B-cell lymphoma 2 (BCL-2) family control the tightly regulated pathway that causes MOMP.  The equil. between pro-survival and pro-apoptotic members of the BCL-2 family dictates the fate of cells, the homeostasis of organs and, by extension, the health of whole organisms.  Dysregulation of this equil. is involved in a large no. of diseases such as cancer, autoimmunity and neurodegenerative conditions.  Modulating the activity of the BCL-2 family of proteins with small mols. or peptides is an attractive but challenging therapeutic goal.  This review highlights the latest developments in this field and provides evidence that this strategy is likely to have a pos. effect on the treatment of still poorly addressed medical conditions.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6jmhqr3darVg90H21EOLACvtfcHk0lgkGkfe8HheCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D&md5=001a31bfa87a2f4864bd8606a9e61ab4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fbph.12431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12431%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DCell%2520death%2520and%2520the%2520mitochondria%253A%2520therapeutic%2520targeting%2520of%2520the%2520BCL-2%2520family-driven%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1973%26epage%3D1987%26doi%3D10.1111%2Fbph.12431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbridge, A. R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3939</span>– <span class="NLM_lpage">3946</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-09-601567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1182%2Fblood-2014-09-601567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25368374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFegsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3939-3946&author=S.+Grabowauthor=A.+R.+D.+Delbridgeauthor=L.+J.+Valenteauthor=A.+Strasser&title=MCL-1+but+not+BCL-XL+is+critical+for+the+development+and+sustained+expansion+of+thymic+lymphoma+in+p53-deficient+mice&doi=10.1182%2Fblood-2014-09-601567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice</span></div><div class="casAuthors">Grabow, Stephanie; Delbridge, Alex R. D.; Valente, Liz J.; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3939-3946</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Apoptosis plays a role in normal lymphopoiesis and lymphoid malignancies.  Pro-survival MCL-1 is essential for survival of T-cell progenitors, BCL-XL for immature thymocytes, and BCL-2 for mature T cells.  Conversely, little is known about the regulators that are required for the survival of T-cell lymphomas.  We used constitutive and conditionally gene-targeted mice to investigate which pro-survival BCL-2 family member is required for the sustained survival of thymic lymphomas initiated by loss of p53.  Constitutive loss of a single Mcl-1 allele delayed tumor onset.  In contrast, lymphomas emerging in p53-/- mice in which Mcl-1 could be conditionally deleted had been selected for retention of MCL-1 expression.  In contrast, complete loss of BCL-XL had no impact on lymphoma development in p53-/- mice.  These results demonstrate that thymic lymphomas elicited by loss of p53 must arise from cancer-initiating cells that require MCL-1 for their survival.  Acute deletion of both Mcl-1 alleles abrogated the expansion of p53-/- lymphomas in mice, whereas inducible loss of BCL-XL had little impact.  This reveals that MCL-1 is essential for the sustained survival of these malignant cells and suggests that targeting MCL-1 may be an attractive strategy for the treatment of T-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7j4ji48usKLVg90H21EOLACvtfcHk0lgjpi7bpiHoiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFegsg%253D%253D&md5=3d3071861e23771bf38a760308dfd886</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-09-601567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-09-601567%26sid%3Dliteratum%253Aachs%26aulast%3DGrabow%26aufirst%3DS.%26aulast%3DDelbridge%26aufirst%3DA.%2BR.%2BD.%26aulast%3DValente%26aufirst%3DL.%2BJ.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DMCL-1%2520but%2520not%2520BCL-XL%2520is%2520critical%2520for%2520the%2520development%2520and%2520sustained%2520expansion%2520of%2520thymic%2520lymphoma%2520in%2520p53-deficient%2520mice%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3939%26epage%3D3946%26doi%3D10.1182%2Fblood-2014-09-601567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spinner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispatzu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkhbaatar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höckendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pechloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikenwalder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansmann, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newrzela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span> <span> </span><span class="NLM_article-title">Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1530</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fleu.2016.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27055871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1ejsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1520-1530&author=S.+Spinnerauthor=G.+Crispatzuauthor=J.-H.+Yiauthor=E.+Munkhbaatarauthor=P.+Mayerauthor=U.+H%C3%B6ckendorfauthor=N.+M%C3%BCllerauthor=Z.+Liauthor=T.+Schaderauthor=H.+Bendzauthor=S.+Hartmannauthor=M.+Yabalauthor=K.+Pechloffauthor=M.+Heikenwalderauthor=G.+L.+Kellyauthor=A.+Strasserauthor=C.+Peschelauthor=M.-L.+Hansmannauthor=J.+Rulandauthor=U.+Kellerauthor=S.+Newrzelaauthor=M.+Herlingauthor=P.+J.+Jost&title=Re-activation+of+mitochondrial+apoptosis+inhibits+T-cell+lymphoma+survival+and+treatment+resistance&doi=10.1038%2Fleu.2016.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance</span></div><div class="casAuthors">Spinner, S.; Crispatzu, G.; Yi, J.-H.; Munkhbaatar, E.; Mayer, P.; Hoeckendorf, U.; Mueller, N.; Li, Z.; Schader, T.; Bendz, H.; Hartmann, S.; Yabal, M.; Pechloff, K.; Heikenwalder, M.; Kelly, G. L.; Strasser, A.; Peschel, C.; Hansmann, M.-L.; Ruland, J.; Keller, U.; Newrzela, S.; Herling, M.; Jost, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1520-1530</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">T lymphocyte non-Hodgkin's lymphoma (T-NHL) represents an aggressive and largely therapy-resistant subtype of lymphoid malignancies.  As deregulated apoptosis is a frequent hallmark of lymphomagenesis, we analyzed gene expression profiles and protein levels of primary human T-NHL samples for various apoptotic regulators.  We identified the apoptotic regulator MCL-1 as the only pro-survival BCL-2 family member to be highly expressed throughout all human T-NHL subtypes.  Functional validation of pro-survival protein members of the BCL-2 family in two independent T-NHL mouse models identified that the partial loss of Mcl-1 significantly delayed T-NHL development in vivo.  Moreover, the inducible redn. of MCL-1 protein levels in lymphoma-burdened mice severely impaired the continued survival of T-NHL cells, increased their susceptibility to chemotherapeutics and delayed lymphoma progression.  Lymphoma viability remained unaffected by the genetic deletion or pharmacol. inhibition of all alternative BCL-2 family members.  Consistent with a therapeutic window for MCL-1 treatment within the context of the whole organism, we obsd. an only minimal toxicity after systemic heterozygous loss of Mcl-1 in vivo.  We conclude that re-activation of mitochondrial apoptosis by blockade of MCL-1 represents a promising therapeutic strategy to treat T-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSXD7w8Hwu1rVg90H21EOLACvtfcHk0lgjpi7bpiHoiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1ejsLY%253D&md5=632c69921952fc9f222b2d72eb2fe6b6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.49%26sid%3Dliteratum%253Aachs%26aulast%3DSpinner%26aufirst%3DS.%26aulast%3DCrispatzu%26aufirst%3DG.%26aulast%3DYi%26aufirst%3DJ.-H.%26aulast%3DMunkhbaatar%26aufirst%3DE.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DH%25C3%25B6ckendorf%26aufirst%3DU.%26aulast%3DM%25C3%25BCller%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DBendz%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DYabal%26aufirst%3DM.%26aulast%3DPechloff%26aufirst%3DK.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DHansmann%26aufirst%3DM.-L.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DNewrzela%26aufirst%3DS.%26aulast%3DHerling%26aufirst%3DM.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26atitle%3DRe-activation%2520of%2520mitochondrial%2520apoptosis%2520inhibits%2520T-cell%2520lymphoma%2520survival%2520and%2520treatment%2520resistance%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D1520%26epage%3D1530%26doi%3D10.1038%2Fleu.2016.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trounson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappaport, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1101/gad.182980.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1101%2Fgad.182980.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=22279045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFOjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=120-125&author=S.+P.+Glaserauthor=E.+F.+Leeauthor=E.+Trounsonauthor=P.+Bouilletauthor=A.+Weiauthor=W.+D.+Fairlieauthor=D.+J.+Izonauthor=J.+Zuberauthor=A.+R.+Rappaportauthor=M.+J.+Heroldauthor=W.+S.+Alexanderauthor=S.+W.+Loweauthor=L.+Robbauthor=A.+Strasser&title=Anti-apoptotic+Mcl-1+is+essential+for+the+development+and+sustained+growth+of+acute+myeloid+leukemia&doi=10.1101%2Fgad.182980.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia</span></div><div class="casAuthors">Glaser, Stefan P.; Lee, Erinna F.; Trounson, Evelyn; Bouillet, Philippe; Wei, Andrew; Fairlie, W. Douglas; Izon, David J.; Zuber, Johannes; Rappaport, Amy R.; Herold, Marco J.; Alexander, Warren S.; Lowe, Scott W.; Robb, Lorraine; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-125</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Acute myeloid leukemia (AML) frequently relapses after initial treatment.  Drug resistance in AML has been attributed to high levels of the anti-apoptotic Bcl-2 family members Bcl-xL and Mcl-1.  Here we report that removal of Mcl-1, but not loss or pharmacol. blockade of Bcl-xL, Bcl-2, or Bcl-w, caused the death of transformed AML and could cure disease in AML-afflicted mice.  Enforced expression of selective inhibitors of prosurvival Bcl-2 family members revealed that Mcl-1 is crit. for survival of human AML cells.  Thus, targeting of Mcl-1 or regulators of its expression may be a useful strategy for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6z2Lgi2YuK7Vg90H21EOLACvtfcHk0lgjpi7bpiHoiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFOjs78%253D&md5=5f0cc61da50fddb262d30e243a7e6837</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.182980.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.182980.111%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DTrounson%26aufirst%3DE.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DIzon%26aufirst%3DD.%2BJ.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DRappaport%26aufirst%3DA.%2BR.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DW.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DRobb%26aufirst%3DL.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DAnti-apoptotic%2520Mcl-1%2520is%2520essential%2520for%2520the%2520development%2520and%2520sustained%2520growth%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D120%26epage%3D125%26doi%3D10.1101%2Fgad.182980.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span> <span> </span><span class="NLM_article-title">Hierarchy for targeting pro-survival BCL2 family proteins in multiple myeloma: pivotal role of MCL1</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1844</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-03-704908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1182%2Fblood-2016-03-704908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27465916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCjtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=1834-1844&author=J.-N.+Gongauthor=T.+Khongauthor=D.+Segalauthor=Y.+Yaoauthor=C.+D.+Riffkinauthor=J.-M.+Garnierauthor=S.+L.+Khawauthor=G.+Lesseneauthor=A.+Spencerauthor=M.+J.+Heroldauthor=A.+W.+Robertsauthor=D.+C.+S.+Huang&title=Hierarchy+for+targeting+pro-survival+BCL2+family+proteins+in+multiple+myeloma%3A+pivotal+role+of+MCL1&doi=10.1182%2Fblood-2016-03-704908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1</span></div><div class="casAuthors">Gong, Jia-Nan; Khong, Tiffany; Segal, David; Yao, Yuan; Riffkin, Chris D.; Garnier, Jean-Marc; Lin, Khaw Seong; Lessene, Guillaume; Spencer, Andrew; Herold, Marco J.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1834-1844</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">New therapeutic targets are needed to address the poor prognosis of patients with high-risk multiple myeloma.  Myeloma cells usually express a range of the prosurvival BCL2 proteins.  To define the hierarchy of their relative importance for maintaining the survival of myeloma cells, we targeted each of them in a large panel of cell lines, using pharmacol. inhibitors or gene editing or by peptide-based approaches, alone or in combination.  The majority of well-established immortalized cell lines (17/25) or low-passage myeloma cell lines (5/7) are readily killed when MCL1 is targeted, even including those cell lines sensitive to BCL2 inhibition.  Targeting MCL1 also constrained the growth of myeloma in vivo.  We also identified a previously unrecognized subset of myeloma that is highly BCLXL-dependent, and has the potential for cotargeting MCL1 and BCLXL.  As MCL1 is pivotal for maintaining survival of most myelomas, it should be prioritized for targeting in the clinic once high-quality, validated inhibitors become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu0tJVIusFMrVg90H21EOLACvtfcHk0lhJ6MQSsEk4BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCjtr%252FF&md5=b84e7e664e0bc34e4507803935c20551</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-03-704908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-03-704908%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DJ.-N.%26aulast%3DKhong%26aufirst%3DT.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DGarnier%26aufirst%3DJ.-M.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DSpencer%26aufirst%3DA.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26atitle%3DHierarchy%2520for%2520targeting%2520pro-survival%2520BCL2%2520family%2520proteins%2520in%2520multiple%2520myeloma%253A%2520pivotal%2520role%2520of%2520MCL1%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D1834%26epage%3D1844%26doi%3D10.1182%2Fblood-2016-03-704908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, R. S.</span></span> <span> </span><span class="NLM_article-title">Bcl-2 family proteins in breast development and cancer: Could Mcl-1 targeting overcome therapeutic resistance?</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3519</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.18632%2Foncotarget.2792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25784482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnls1ShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3519-3530&author=M.+M.+Williamsauthor=R.+S.+Cook&title=Bcl-2+family+proteins+in+breast+development+and+cancer%3A+Could+Mcl-1+targeting+overcome+therapeutic+resistance%3F&doi=10.18632%2Foncotarget.2792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</span></div><div class="casAuthors">Williams Michelle M; Cook Rebecca S; Cook Rebecca S</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3519-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis.  Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells.  Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies.  The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis.  Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways.  This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvDoMDseirLH6HPRus0rAafW6udTcc2eaMeVd1t0jhpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnls1ShsQ%253D%253D&md5=22e6af0dd2e25832cedc3dffac2e5a84</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2792%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%2BM.%26aulast%3DCook%26aufirst%3DR.%2BS.%26atitle%3DBcl-2%2520family%2520proteins%2520in%2520breast%2520development%2520and%2520cancer%253A%2520Could%2520Mcl-1%2520targeting%2520overcome%2520therapeutic%2520resistance%253F%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D3519%26epage%3D3530%26doi%3D10.18632%2Foncotarget.2792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barretina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mc Henry, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinchback, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligon, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prensner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liefeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yecies, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demichelis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nucera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonescu, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">True, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span> <span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1038/nature08822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+Mc+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.-J.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.-S.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers&doi=10.1038%2Fnature08822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0lhJ6MQSsEk4BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DMc%2BHenry%26aufirst%3DK.%2BT.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.-J.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905%26doi%3D10.1038%2Fnature08822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helgason, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminker, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueber, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>471</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nature09779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature09779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=21368834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1Cku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=110-114&author=I.+E.+Wertzauthor=S.+Kusamauthor=C.+Lamauthor=T.+Okamotoauthor=W.+Sandovalauthor=D.+J.+Andersonauthor=E.+Helgasonauthor=J.+A.+Ernstauthor=M.+Ebyauthor=J.+Liuauthor=L.+D.+Belmontauthor=J.+S.+Kaminkerauthor=K.+M.+O%E2%80%99Rourkeauthor=K.+Pujaraauthor=P.+B.+Kohliauthor=A.+R.+Johnsonauthor=M.+L.+Chiuauthor=J.+R.+Lillauthor=P.+K.+Jacksonauthor=W.+J.+Fairbrotherauthor=S.+Seshagiriauthor=M.+J.+C.+Ludlamauthor=K.+G.+Leongauthor=E.+C.+Dueberauthor=H.+Maeckerauthor=D.+C.+S.+Huangauthor=V.+M.+Dixit&title=Sensitivity+to+antitubulin+chemotherapeutics+is+regulated+by+MCL1+and+FBW7&doi=10.1038%2Fnature09779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7</span></div><div class="casAuthors">Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Okamoto, Toru; Sandoval, Wendy; Anderson, Daniel J.; Helgason, Elizabeth; Ernst, James A.; Eby, Mike; Liu, Jinfeng; Belmont, Lisa D.; Kaminker, Josh S.; O'Rourke, Karen M.; Pujara, Kanan; Kohli, Pawan Bir; Johnson, Adam R.; Chiu, Mark L.; Lill, Jennie R.; Jackson, Peter K.; Fairbrother, Wayne J.; Seshagiri, Somasekar; Ludlam, Mary J. C.; Leong, Kevin G.; Dueber, Erin C.; Maecker, Heather; Huang, David C. S.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7336</span>),
    <span class="NLM_cas:pages">110-114</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules have pivotal roles in fundamental cellular processes and are targets of antitubulin chemotherapeutics.  Microtubule-targeted agents such as Taxol and vincristine are prescribed widely for various malignancies, including ovarian and breast adenocarcinomas, non-small-cell lung cancer, leukemias and lymphomas.  These agents arrest cells in mitosis and subsequently induce cell death through poorly defined mechanisms.  The strategies that resistant tumor cells use to evade death induced by antitubulin agents are also unclear.  Here we show that the pro-survival protein MCL1 is a crucial regulator of apoptosis triggered by antitubulin chemotherapeutics.  During mitotic arrest, MCL1 protein levels decline markedly, through a post-translational mechanism, potentiating cell death.  Phosphorylation of MCL1 directs its interaction with the tumor-suppressor protein FBW7, which is the substrate-binding component of a ubiquitin ligase complex.  The polyubiquitylation of MCL1 then targets it for proteasomal degrdn.  The degrdn. of MCL1 was blocked in patient-derived tumor cells that lacked FBW7 or had loss-of-function mutations in FBW7, conferring resistance to antitubulin agents and promoting chemotherapeutic-induced polyploidy.  Addnl., primary tumor samples were enriched for FBW7 inactivation and elevated MCL1 levels, underscoring the prominent roles of these proteins in oncogenesis.  Our findings suggest that profiling the FBW7 and MCL1 status of tumors, in terms of protein levels, mRNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFiH1HCl46H7Vg90H21EOLACvtfcHk0liGi_QzmHH5iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1Cku7g%253D&md5=9b06764b31a4b2e4597c76e9138b0a34</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09779%26sid%3Dliteratum%253Aachs%26aulast%3DWertz%26aufirst%3DI.%2BE.%26aulast%3DKusam%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DSandoval%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DHelgason%26aufirst%3DE.%26aulast%3DErnst%26aufirst%3DJ.%2BA.%26aulast%3DEby%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BM.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DChiu%26aufirst%3DM.%2BL.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DLeong%26aufirst%3DK.%2BG.%26aulast%3DDueber%26aufirst%3DE.%2BC.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DSensitivity%2520to%2520antitubulin%2520chemotherapeutics%2520is%2520regulated%2520by%2520MCL1%2520and%2520FBW7%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D110%26epage%3D114%26doi%3D10.1038%2Fnature09779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Z.</span></span> <span> </span><span class="NLM_article-title">Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting MCL-1 gene in pancreatic carcinoma cell</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1064</span>, <span class="refDoi"> DOI: 10.1007/s00280-008-0697-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1007%2Fs00280-008-0697-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18297287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaju7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1055-1064&author=S.-H.+Weiauthor=K.+Dongauthor=F.+Linauthor=X.+Wangauthor=B.+Liauthor=J.-j.+Shenauthor=Q.+Zhangauthor=R.+Wangauthor=H.-Z.+Zhang&title=Inducing+apoptosis+and+enhancing+chemosensitivity+to+gemcitabine+via+RNA+interference+targeting+MCL-1+gene+in+pancreatic+carcinoma+cell&doi=10.1007%2Fs00280-008-0697-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell</span></div><div class="casAuthors">Wei, San-Hua; Dong, Ke; Lin, Fang; Wang, Xi; Li, Bin; Shen, Jian-jun; Zhang, Qing; Wang, Rui; Zhang, Hui-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1055-1064</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Resistance to chemotherapy is a major cause of treatment failure and poor prognosis in pancreatic carcinoma.  Myeloid cell leukemia-1 (Mcl-1) is highly up-regulated in pancreatic carcinoma and is assocd. with the anti-apoptosis and the resistance to chemotherapy drugs.  Suppression of Mcl-1 would be an approach to induce apoptosis and enhance the chemosensitivity.  Methods: In this study, three pancreatic cancer cell lines (PANC-1, BxPC-3 and SW1900) stably expressing shRNAs targeting Mcl-1 gene were established and gene expression inhibition was assessed by Real-Time QPCR and Western blotting.  The effects of Mcl-1 downregulation mediated by RNAi were explored in vitro and in vivo.  Results: We showed that the specific downregulation of Mcl-1 strikingly inhibited cell growth, colony formation, cell cycle arrest and induced apoptosis in pancreatic cancer cells in vitro, and markedly decreased the tumorigenicity in a mouse xenograft model.  Moreover, knockdown of Mcl-1 significantly increased the chemosensitivity to Gemcitabine in pancreatic carcinoma cells.  Conclusions: Our data suggests that the specific downregulation of Mcl-1 by RNAi is a promising approach to induce apoptosis and enhance the chemosensitivity for pancreatic carcinoma gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqCKHcBd_GybVg90H21EOLACvtfcHk0liGi_QzmHH5iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaju7%252FI&md5=0048e8f6955dedf442aa0328ba6ebfcb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00280-008-0697-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-008-0697-7%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.-H.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DJ.-j.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.-Z.%26atitle%3DInducing%2520apoptosis%2520and%2520enhancing%2520chemosensitivity%2520to%2520gemcitabine%2520via%2520RNA%2520interference%2520targeting%2520MCL-1%2520gene%2520in%2520pancreatic%2520carcinoma%2520cell%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D62%26spage%3D1055%26epage%3D1064%26doi%3D10.1007%2Fs00280-008-0697-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricci, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span> <span> </span><span class="NLM_article-title">MCL-1: a gateway to TRAIL sensitization</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2062</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-07-6278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1158%2F0008-5472.CAN-07-6278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18381408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2062-2064&author=S.-H.+Kimauthor=M.+S.+Ricciauthor=W.+S.+El-Deiry&title=MCL-1%3A+a+gateway+to+TRAIL+sensitization&doi=10.1158%2F0008-5472.can-07-6278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mcl-1: A Gateway to TRAIL Sensitization</span></div><div class="casAuthors">Kim, Seok-Hyun; Ricci, M. Stacey; El-Deiry, Wafik S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2062-2064</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The proapoptotic cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is being evaluated presently as a selective anticancer agent, but its limited effects against cancer cell lines has raised some concerns about its ultimate clin. utility.  Here, we review recent findings that cancer cell sensitivity to TRAIL is greatly increased when the Bcl-2 family protein Mcl-1 is down-regulated by the Raf/vascular endothelial growth factor kinase inhibitor sorafenib, a Food and Drug Administration-approved cancer drug.  Using the TRAIL-sorafenib combination as a tactic to more effectively kill cancer cells may provide an effective tool to attack a variety of human cancers that are largely presently untreatable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyxFXqGsPbibVg90H21EOLACvtfcHk0lhV9rI5nU6ASw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb4%253D&md5=3beede491d2bb0dc671fcf36060ee341</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6278%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DRicci%26aufirst%3DM.%2BS.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26atitle%3DMCL-1%253A%2520a%2520gateway%2520to%2520TRAIL%2520sensitization%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2062%26epage%3D2064%26doi%3D10.1158%2F0008-5472.can-07-6278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan-Lappe, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarthy, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span> <span> </span><span class="NLM_article-title">Influence of BCL-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-06-2203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1158%2F0008-5472.CAN-06-2203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=17283153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.-C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+BCL-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737&doi=10.1158%2F0008-5472.can-06-2203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737</span></div><div class="casAuthors">Tahir, Stephen K.; Yang, Xiufen; Anderson, Mark G.; Morgan-Lappe, Susan E.; Sarthy, Aparna V.; Chen, Jun; Warner, Robert B.; Ng, Shi-Chung; Fesik, Stephen W.; Elmore, Steve W.; Rosenberg, Saul H.; Tse, Christin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1176-1183</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-737 is a novel and potent Bcl-2 antagonist with single-agent activity against small-cell lung cancer (SCLC) cell lines.  Here, we evaluated the contribution of Bcl-2 family members to the in vitro cellular response of several SCLC cell lines to ABT-737.  Relatively higher levels of Bcl-2, Bcl-XL, Bim and Noxa, and lower levels of Mcl-1 characterized naive SCLC cell lines that were sensitive to ABT-737.  Conversely, a progressive decrease in the relative levels of Bcl-2 and Noxa and a progressive increase in Mcl-1 levels characterized the increased resistance of H146 cells following chronic exposure to ABT-737.  Knockdown of Mcl-1 with small interfering RNA sensitized 2 resistant SCLC cell lines H196 and DMS114 to ABT-737 by enhancing the induction of apoptosis.  Likewise, up-regulation of Noxa sensitized H196 cells to ABT-737.  Combination treatment with DNA-damaging agents was extremely synergistic with ABT-737 and was assocd. with the down-regulation of Mcl-1 and the up-regulation of Noxa, Puma, and Bim in H196 cells.  Thus, SCLC cells sensitive to ABT-737 expressed the target proteins Bcl-2 and Bcl-XL, whereas Mcl-1 and factors regulating Mcl-1 function seem to contribute to the overall resistance of SCLC cells to ABT-737.  Overall, these observations provide further insight as to the mechanistic bases for ABT-737 efficacy in SCLC and will be helpful for profiling patients and aiding in the rational design of combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVmNPxcT2cAbVg90H21EOLACvtfcHk0lhV9rI5nU6ASw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb8%253D&md5=f621db8247defb237e1b4772e8bcaa20</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2203%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.-C.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520BCL-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183%26doi%3D10.1158%2F0008-5472.can-06-2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christov, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerasamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogarty, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis Millin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhraja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opferman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arteaga, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savona, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia-1 (Mcl-1) inhibitors that demonstrate in vivo activity in mouse xenograft models of human cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3971</span>– <span class="NLM_lpage">3988</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01991</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01991" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtlWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3971-3988&author=T.+Leeauthor=P.+P.+Christovauthor=S.+Shawauthor=J.+C.+Tarrauthor=B.+Zhaoauthor=N.+Veerasamyauthor=K.+O.+Jeonauthor=J.+J.+Millsauthor=Z.+Bianauthor=J.+L.+Sensintaffarauthor=A.+L.+Arnoldauthor=S.+A.+Fogartyauthor=E.+Perryauthor=H.+E.+Ramseyauthor=R.+S.+Cookauthor=M.+Hollingsheadauthor=M.+Davis+Millinauthor=K.-m.+Leeauthor=B.+Kossauthor=A.+Budhrajaauthor=J.+T.+Opfermanauthor=K.+Kimauthor=C.+L.+Arteagaauthor=W.+J.+Mooreauthor=E.+T.+Olejniczakauthor=M.+R.+Savonaauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia-1+%28Mcl-1%29+inhibitors+that+demonstrate+in+vivo+activity+in+mouse+xenograft+models+of+human+cancer&doi=10.1021%2Facs.jmedchem.8b01991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer</span></div><div class="casAuthors">Lee, Taekyu; Christov, Plamen P.; Shaw, Subrata; Tarr, James C.; Zhao, Bin; Veerasamy, Nagarathanam; Jeon, Kyu Ok; Mills, Jonathan J.; Bian, Zhiguo; Sensintaffar, John L.; Arnold, Allison L.; Fogarty, Stuart A.; Perry, Evan; Ramsey, Haley E.; Cook, Rebecca S.; Hollingshead, Melinda; Davis Millin, Myrtle; Lee, Kyung-min; Koss, Brian; Budhraja, Amit; Opferman, Joseph T.; Kim, Kwangho; Arteaga, Carlos L.; Moore, William J.; Olejniczak, Edward T.; Savona, Michael R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3971-3988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of myeloid cell leukemia-1 (Mcl-1) in cancers correlates with high tumor grade and poor survival.  Addnl., Mcl-1 drives intrinsic and acquired resistance to many cancer therapeutics, including B cell lymphoma 2 family inhibitors, proteasome inhibitors, and antitubulins.  Therefore, Mcl-1 inhibition could serve as a strategy to target cancers that require Mcl-1 to evade apoptosis.  Herein, we describe the use of structure-based design to discover a novel compd. (42) that robustly and specifically inhibits Mcl-1 in cell culture and animal xenograft models.  Compd. 42 binds to Mcl-1 with picomolar affinity and inhibited growth of Mcl-1-dependent tumor cell lines in the nanomolar range.  Compd. 42 also inhibited the growth of hematol. and triple neg. breast cancer xenografts at well-tolerated doses.  These findings highlight the use of structure-based design to identify small mol. Mcl-1 inhibitors and support the use of 42 as a potential treatment strategy to block Mcl-1 activity and induce apoptosis in Mcl-1-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzJLMFWtbKl7Vg90H21EOLACvtfcHk0lhAG6rZE3K_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtlWitb0%253D&md5=a3e80ec8c20cc39a71c78beb85d2ec90</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01991%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DChristov%26aufirst%3DP.%2BP.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVeerasamy%26aufirst%3DN.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DMills%26aufirst%3DJ.%2BJ.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DFogarty%26aufirst%3DS.%2BA.%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DH.%2BE.%26aulast%3DCook%26aufirst%3DR.%2BS.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DDavis%2BMillin%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.-m.%26aulast%3DKoss%26aufirst%3DB.%26aulast%3DBudhraja%26aufirst%3DA.%26aulast%3DOpferman%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DSavona%26aufirst%3DM.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia-1%2520%2528Mcl-1%2529%2520inhibitors%2520that%2520demonstrate%2520in%2520vivo%2520activity%2520in%2520mouse%2520xenograft%2520models%2520of%2520human%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3971%26epage%3D3988%26doi%3D10.1021%2Facs.jmedchem.8b01991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerasamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogarty, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Optimization of potent and selective tricyclic indole diazepinone myeloid cell leukemia-1 inhibitors using structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2410-2421&author=S.+Shawauthor=Z.+Bianauthor=B.+Zhaoauthor=J.+C.+Tarrauthor=N.+Veerasamyauthor=K.+O.+Jeonauthor=J.+Belmarauthor=A.+L.+Arnoldauthor=S.+A.+Fogartyauthor=E.+Perryauthor=J.+L.+Sensintaffarauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Optimization+of+potent+and+selective+tricyclic+indole+diazepinone+myeloid+cell+leukemia-1+inhibitors+using+structure-based+design&doi=10.1021%2Facs.jmedchem.7b01155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design</span></div><div class="casAuthors">Shaw, Subrata; Bian, Zhiguo; Zhao, Bin; Tarr, James C.; Veerasamy, Nagarathanam; Jeon, Kyu Ok; Belmar, Johannes; Arnold, Allison L.; Fogarty, Stuart A.; Perry, Evan; Sensintaffar, John L.; Camper, DeMarco V.; Rossanese, Olivia W.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2410-2421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family of proteins, has emerged as an attractive target for cancer therapy.  Mcl-1 upregulation is often found in many human cancers and is assocd. with high tumor grade, poor survival, and resistance to chemotherapy.  Here, we describe a series of potent and selective tricyclic indole diazepinone Mcl-1 inhibitors that were discovered and further optimized using structure-based design.  These compds. exhibit picomolar binding affinity and mechanism-based cellular efficacy, including growth inhibition and caspase induction in Mcl-1-sensitive cells.  Thus, they represent useful compds. to study the implication of Mcl-1 inhibition in cancer and serve as potentially useful starting points toward the discovery of anti-Mcl-1 therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6DFBno6H-LVg90H21EOLACvtfcHk0lhAG6rZE3K_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyktA%253D%253D&md5=719511e2b52849e2bff5cf1de6d6c2be</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01155%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DVeerasamy%26aufirst%3DN.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DBelmar%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DFogarty%26aufirst%3DS.%2BA.%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOptimization%2520of%2520potent%2520and%2520selective%2520tricyclic%2520indole%2520diazepinone%2520myeloid%2520cell%2520leukemia-1%2520inhibitors%2520using%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2410%26epage%3D2421%26doi%3D10.1021%2Facs.jmedchem.7b01155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd1343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnrd1343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=15060526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein-protein+interactions%3A+progressing+towards+the+dream&doi=10.1038%2Fnrd1343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span></div><div class="casAuthors">Arkin, Michelle R.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions have a key role in most biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is difficult, owing to issues such as the lack of well-defined binding pockets.  Nevertheless, there was important progress in this endeavor in recent years.  Here, the authors use illustrative examples to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MiFDdLJu27Vg90H21EOLACvtfcHk0lhAG6rZE3K_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D&md5=3e102c6207be420b4232056b4acdea12</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1343%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317%26doi%3D10.1038%2Fnrd1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelz, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2054</span>– <span class="NLM_lpage">2066</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01660</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01660" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVygsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2054-2066&author=N.+F.+Pelzauthor=Z.+Bianauthor=B.+Zhaoauthor=S.+Shawauthor=J.+C.+Tarrauthor=J.+Belmarauthor=C.+Greggauthor=D.+V.+Camperauthor=C.+M.+Goodwinauthor=A.+L.+Arnoldauthor=J.+L.+Sensintaffarauthor=A.+Fribergauthor=O.+W.+Rossaneseauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+2-indole-acylsulfonamide+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods&doi=10.1021%2Facs.jmedchem.5b01660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods</span></div><div class="casAuthors">Pelz, Nicholas F.; Bian, Zhiguo; Zhao, Bin; Shaw, Subrata; Tarr, James C.; Belmar, Johannes; Gregg, Claire; Camper, DeMarco V.; Goodwin, Craig M.; Arnold, Allison L.; Sensintaffar, John L.; Friberg, Anders; Rossanese, Olivia W.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2054-2066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia-1 (Mcl-1) is a member of the Bcl-2 family of proteins responsible for the regulation of programmed cell death.  Amplification of Mcl-1 is a common genetic aberration in human cancer whose overexpression contributes to the evasion of apoptosis and is one of the major resistance mechanisms for many chemotherapies.  Mcl-1 mediates its effects primarily through interactions with pro-apoptotic BH3 contg. proteins that achieve high affinity for the target by utilizing four hydrophobic pockets in its binding groove.  Here we describe the discovery of Mcl-1 inhibitors using fragment-based methods and structure-based design.  These novel inhibitors exhibit low nanomolar binding affinities to Mcl-1 and >500-fold selectivity over Bcl-xL.  X-ray structures of lead Mcl-1 inhibitors when complexed to Mcl-1 provided detailed information on how these small-mols. bind to the target and were used extensively to guide compd. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2AYHv7Eaw57Vg90H21EOLACvtfcHk0lgtofOkBiDMRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVygsbs%253D&md5=e667fa5bc866d29ad02d6d52c679f47a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01660%26sid%3Dliteratum%253Aachs%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DBelmar%26aufirst%3DJ.%26aulast%3DGregg%26aufirst%3DC.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DGoodwin%26aufirst%3DC.%2BM.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%25202-indole-acylsulfonamide%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2054%26epage%3D2066%26doi%3D10.1021%2Facs.jmedchem.5b01660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2180</span>– <span class="NLM_lpage">2194</span>, <span class="refDoi"> DOI: 10.1021/jm501258m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501258m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2180-2194&author=M.+Brunckoauthor=L.+Wangauthor=G.+S.+Sheppardauthor=D.+C.+Phillipsauthor=S.+K.+Tahirauthor=J.+Xueauthor=S.+Ericksonauthor=S.+Fidanzeauthor=E.+Fryauthor=L.+Hasvoldauthor=G.+J.+Jenkinsauthor=S.+Jinauthor=R.+A.+Judgeauthor=P.+J.+Kovarauthor=D.+Madarauthor=P.+Nimmerauthor=C.+Parkauthor=A.+M.+Petrosauthor=S.+H.+Rosenbergauthor=M.+L.+Smithauthor=X.+Songauthor=C.+Sunauthor=Z.-F.+Taoauthor=X.+Wangauthor=Y.+Xiaoauthor=H.+Zhangauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Structure-guided+design+of+a+series+of+MCL-1+inhibitors+with+high+affinity+and+selectivity&doi=10.1021%2Fjm501258m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity</span></div><div class="casAuthors">Bruncko, Milan; Wang, Le; Sheppard, George S.; Phillips, Darren C.; Tahir, Stephen K.; Xue, John; Erickson, Scott; Fidanze, Steve; Fry, Elizabeth; Hasvold, Lisa; Jenkins, Gary J.; Jin, Sha; Judge, Russell A.; Kovar, Peter J.; Madar, David; Nimmer, Paul; Park, Chang; Petros, Andrew M.; Rosenberg, Saul H.; Smith, Morey L.; Song, Xiaohong; Sun, Chaohong; Tao, Zhi-Fu; Wang, Xilu; Xiao, Yu; Zhang, Haichao; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2180-2194</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (MCL-1) is a BCL-2 family protein that has been implicated in the progression and survival of multiple tumor types.  Herein the authors report a series of MCL-1 inhibitors that emanated from a high throughput screening (HTS) hit and progressed via iterative cycles of structure-guided design.  Advanced compds. from this series exhibited subnanomolar affinity for MCL-1 and excellent selectivity over other BCL-2 family proteins as well as multiple kinases and GPCRs.  In a MCL-1 dependent human tumor cell line, administration of compd. I rapidly induced caspase activation with assocd. loss in cell viability.  The small mols. described herein thus comprise effective tools for studying MCL-1 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohu29VX9mE0bVg90H21EOLACvtfcHk0lgtofOkBiDMRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGjt70%253D&md5=e8c575a04fecaf47e4a9fc5c8348e034</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501258m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501258m%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DErickson%26aufirst%3DS.%26aulast%3DFidanze%26aufirst%3DS.%26aulast%3DFry%26aufirst%3DE.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DG.%2BJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520series%2520of%2520MCL-1%2520inhibitors%2520with%2520high%2520affinity%2520and%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2180%26epage%3D2194%26doi%3D10.1021%2Fjm501258m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1590</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fcddis.2014.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25590800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=J.+D.+Leversonauthor=H.+Zhangauthor=J.+Chenauthor=S.+K.+Tahirauthor=D.+C.+Phillipsauthor=J.+Xueauthor=P.+Nimmerauthor=S.+Jinauthor=M.+Smithauthor=Y.+Xiaoauthor=P.+Kovarauthor=A.+Tanakaauthor=M.+Brunckoauthor=G.+S.+Sheppardauthor=L.+Wangauthor=S.+Gierkeauthor=L.+Kategayaauthor=D.+J.+Andersonauthor=C.+Wongauthor=J.+Eastham-Andersonauthor=M.+J.+C.+Ludlamauthor=D.+Sampathauthor=W.+J.+Fairbrotherauthor=I.+Wertzauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Potent+and+selective+small-molecule+MCL-1+inhibitors+demonstrate+on-target+cancer+cell+killing+activity+as+single+agents+and+in+combination+with+ABT-263+%28navitoclax%29&doi=10.1038%2Fcddis.2014.561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)</span></div><div class="casAuthors">Leverson, J. D.; Zhang, H.; Chen, J.; Tahir, S. K.; Phillips, D. C.; Xue, J.; Nimmer, P.; Jin, S.; Smith, M.; Xiao, Y.; Kovar, P.; Tanaka, A.; Bruncko, M.; Sheppard, G. S.; Wang, L.; Gierke, S.; Kategaya, L.; Anderson, D. J.; Wong, C.; Eastham-Anderson, J.; Ludlam, M. J. C.; Sampath, D.; Fairbrother, W. J.; Wertz, I.; Rosenberg, S. H.; Tse, C.; Elmore, S. W.; Souers, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1590</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The anti-apoptotic protein MCL-1 is a key regulator of cancer cell survival and a known resistance factor for small-mol. BCL-2 family inhibitors such as ABT-263 (navitoclax), making it an attractive therapeutic target.  However, directly inhibiting this target requires the disruption of high-affinity protein-protein interactions, and therefore designing small mols. potent enough to inhibit MCL-1 in cells has proven extremely challenging.  Here, we describe a series of indole-2-carboxylic acids, exemplified by the compd. A-1210477, that bind to MCL-1 selectively and with sufficient affinity to disrupt MCL-1-BIM complexes in living cells.  A-1210477 induces the hallmarks of intrinsic apoptosis and demonstrates single agent killing of multiple myeloma and non-small cell lung cancer cell lines demonstrated to be MCL-1 dependent by BH3 profiling or siRNA rescue expts.  As predicted, A-1210477 synergizes with the BCL-2/BCL-XL inhibitor navitoclax to kill a variety of cancer cell lines.  This work represents the first description of small-mol. MCL-1 inhibitors with sufficient potency to induce clear on-target cellular activity.  It also demonstrates the utility of these mols. as chem. tools for dissecting the basic biol. of MCL-1 and the promise of small-mol. MCL-1 inhibitors as potential therapeutics for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprNysoaS5QY7Vg90H21EOLACvtfcHk0lgtofOkBiDMRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrurg%253D&md5=8ceb779fc6868fc0828757364d529e34</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.561%26sid%3Dliteratum%253Aachs%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGierke%26aufirst%3DS.%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DWertz%26aufirst%3DI.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small-molecule%2520MCL-1%2520inhibitors%2520demonstrate%2520on-target%2520cancer%2520cell%2520killing%2520activity%2520as%2520single%2520agents%2520and%2520in%2520combination%2520with%2520ABT-263%2520%2528navitoclax%2529%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2014.561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tron, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam Hendricks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5341</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07551-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fs41467-018-07551-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=30559424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5341&author=A.+E.+Tronauthor=M.+A.+Belmonteauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+H.+Boiseauthor=E.+Chiarparinauthor=J.+Cidadoauthor=K.+J.+Embreyauthor=E.+Ganglauthor=F.+D.+Gibbonsauthor=G.+P.+Gregoryauthor=D.+Hargreavesauthor=J.+Adam+Hendricksauthor=J.+W.+Johannesauthor=R.+W.+Johnstoneauthor=S.+L.+Kazmirskiauthor=J.+G.+Kettleauthor=M.+L.+Lambauthor=S.+M.+Matulisauthor=A.+K.+Nookaauthor=M.+J.+Packerauthor=B.+Pengauthor=P.+B.+Rawlinsauthor=D.+W.+Robbinsauthor=A.+G.+Schullerauthor=N.+Suauthor=W.+Yangauthor=Q.+Yeauthor=X.+Zhengauthor=J.+P.+Secristauthor=E.+A.+Clarkauthor=D.+M.+Wilsonauthor=S.+E.+Fawellauthor=A.+W.+Hird&title=Discovery+of+Mcl-1-specific+inhibitor+AZD5991+and+preclinical+activity+in+multiple+myeloma+and+acute+myeloid+leukemia&doi=10.1038%2Fs41467-018-07551-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span></div><div class="casAuthors">Tron, Adriana E.; Belmonte, Matthew A.; Adam, Ammar; Aquila, Brian M.; Boise, Lawrence H.; Chiarparin, Elisabetta; Cidado, Justin; Embrey, Kevin J.; Gangl, Eric; Gibbons, Francis D.; Gregory, Gareth P.; Hargreaves, David; Hendricks, J. Adam; Johannes, Jeffrey W.; Johnstone, Ricky W.; Kazmirski, Steven L.; Kettle, Jason G.; Lamb, Michelle L.; Matulis, Shannon M.; Nooka, Ajay K.; Packer, Martin J.; Peng, Bo; Rawlins, Philip B.; Robbins, Daniel W.; Schuller, Alwin G.; Su, Nancy; Yang, Wenzhan; Ye, Qing; Zheng, Xiaolan; Secrist, J. Paul; Clark, Edwin A.; Wilson, David M.; Fawell, Stephen E.; Hird, Alexander W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5341</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers.  High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 inhibitors as anticancer drugs.  Here, we describe AZD5991, a rationally designed macrocyclic mol. with high selectivity and affinity for Mcl-1 currently in clin. development.  Our studies demonstrate that AZD5991 binds directly to Mcl-1 and induces rapid apoptosis in cancer cells, most notably myeloma and acute myeloid leukemia, by activating the Bak-dependent mitochondrial apoptotic pathway.  AZD5991 shows potent antitumor activity in vivo with complete tumor regression in several models of multiple myeloma and acute myeloid leukemia after a single tolerated dose as monotherapy or in combination with bortezomib or venetoclax.  Based on these promising data, a Phase I clin. trial has been launched for evaluation of AZD5991 in patients with hematol. malignancies (NCT03218683).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLv1vdwF2TY7Vg90H21EOLACvtfcHk0ljdiQYArdSl7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK&md5=10ccf1fda947aca212bede3927eaabfa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07551-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07551-w%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DA.%2BE.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DAdam%2BHendricks%26aufirst%3DJ.%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DKazmirski%26aufirst%3DS.%2BL.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMatulis%26aufirst%3DS.%2BM.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobbins%26aufirst%3DD.%2BW.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DClark%26aufirst%3DE.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DHird%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520Mcl-1-specific%2520inhibitor%2520AZD5991%2520and%2520preclinical%2520activity%2520in%2520multiple%2520myeloma%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D5341%26doi%3D10.1038%2Fs41467-018-07551-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. H.</span></span> <span> </span><span class="NLM_article-title">Molecular medicine and neurodegenerative diseases</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6668</span>– <span class="NLM_lpage">6671</span>, <span class="refDoi"> DOI: 10.1039/c4cs90065k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC4CS90065K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25105517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6668-6671&author=C.+J.+Changauthor=B.+F.+Cravattauthor=D.+S.+Johnsonauthor=M.+H.+Lim&title=Molecular+medicine+and+neurodegenerative+diseases&doi=10.1039%2Fc4cs90065k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular medicine and neurodegenerative diseases</span></div><div class="casAuthors">Chang, Christopher J.; Cravatt, Benjamin F.; Johnson, Douglas S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6668-6671</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews on mol. medicine and neurodegenerative diseases, several areas within the neurodegenerative field are explored, including mechanistic/structural studies of neurodegenerative processes, pathol. relevant biol. pathways/factors, as well as the development of chem. tools, diagnostic/imaging agents, and potential therapeutic agents.  The article discusses the use of metal complexes for inhibiting Aβ aggregation formation and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Yqbx9EHw2LVg90H21EOLACvtfcHk0ljdiQYArdSl7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt7nL&md5=2f7b204cfd572a5f6eea222c66418548</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC4CS90065K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS90065K%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DMolecular%2520medicine%2520and%2520neurodegenerative%2520diseases%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6668%26epage%3D6671%26doi%3D10.1039%2Fc4cs90065k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehninger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spreckelmeyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Can, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alborzinia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span> <span> </span><span class="NLM_article-title">Rhodium(I) N-heterocyclic carbene bioorganometallics as in-vitro antiproliferative agents with distinct effects on cellular signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9591</span>– <span class="NLM_lpage">9600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFSmtL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9591-9600&author=L.+Oehningerauthor=S.+Spreckelmeyerauthor=P.+Holenyaauthor=S.+M.+Meierauthor=S.+Canauthor=H.+Alborziniaauthor=J.+Schurauthor=B.+K.+Kepplerauthor=S.+W%C3%B6lflauthor=I.+Ott&title=Rhodium%28I%29+N-heterocyclic+carbene+bioorganometallics+as+in-vitro+antiproliferative+agents+with+distinct+effects+on+cellular+signaling&doi=10.1021%2Facs.jmedchem.5b01159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling</span></div><div class="casAuthors">Oehninger, Luciano; Spreckelmeyer, Sarah; Holenya, Pavlo; Meier, Samuel M.; Can, Suzan; Alborzinia, Hamed; Schur, Julia; Keppler, Bernhard K.; Woelfl, Stefan; Ott, Ingo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9591-9600</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallics with N-heterocyclic carbene (NHC) ligands have triggered major interest in inorg. medicinal chem.  Complexes of the type Rh(I)(NHC)(COD)X (X = Cl, I; COD = cyclooctadiene; NHC = dimethylbenzimidazolylidene) represent a promising type of new metallodrugs that have been explored by advanced biomedical methods only recently.  In this work, the authors have synthesized and characterized several complexes of this type.  As obsd. by mass spectrometry, these complexes remained stable over at least 3 h in aq. soln., after which hydrolysis of the halido ligands occurred and release of the NHC ligand was evident.  Effects against mitochondria and general cell tumor metab. were noted at higher concns., whereas phosphorylation of HSP27, p38, ERK1/2, FAK, and p70S6K was induced substantially already at lower exposure levels.  Regarding the antiproliferative activity in tumor cells, a clear preference for iodido over chlorido secondary ligands was noted, as well as effects of the substituents of the NHC ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqFzee2Mpc_rVg90H21EOLACvtfcHk0ljdiQYArdSl7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFSmtL7F&md5=95998efe4a6a20c535397e675723274d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01159%26sid%3Dliteratum%253Aachs%26aulast%3DOehninger%26aufirst%3DL.%26aulast%3DSpreckelmeyer%26aufirst%3DS.%26aulast%3DHolenya%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DS.%2BM.%26aulast%3DCan%26aufirst%3DS.%26aulast%3DAlborzinia%26aufirst%3DH.%26aulast%3DSchur%26aufirst%3DJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DW%25C3%25B6lfl%26aufirst%3DS.%26aulast%3DOtt%26aufirst%3DI.%26atitle%3DRhodium%2528I%2529%2520N-heterocyclic%2520carbene%2520bioorganometallics%2520as%2520in-vitro%2520antiproliferative%2520agents%2520with%2520distinct%2520effects%2520on%2520cellular%2520signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9591%26epage%3D9600%26doi%3D10.1021%2Facs.jmedchem.5b01159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13965</span>– <span class="NLM_lpage">13975</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.18632%2Foncotarget.7369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=26883110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtlWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13965-13975&author=L.-J.+Liuauthor=B.+Heauthor=J.+A.+Milesauthor=W.+Wangauthor=Z.+Maoauthor=W.+I.+Cheauthor=J.-J.+Luauthor=X.-P.+Chenauthor=A.+J.+Wilsonauthor=D.-L.+Maauthor=C.-H.+Leung&title=Inhibition+of+the+p53%2FhDM2+protein-protein+interaction+by+cyclometallated+iridium%28III%29+compounds&doi=10.18632%2Foncotarget.7369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds</span></div><div class="casAuthors">Liu Li-Juan; Che Weng Ian; Lu Jin-Jian; Chen Xiu-Ping; Leung Chung-Hang; He Bingyong; Wang Wanhe; Mao Zhifeng; Ma Dik-Lung; Miles Jennifer A; Wilson Andrew J; Miles Jennifer A; Wilson Andrew J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">13965-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inactivation of the p53 transcription factor by mutation or other mechanisms is a frequent event in tumorigenesis.  One of the major endogenous negative regulators of p53 in humans is hDM2, a ubiquitin E3 ligase that binds to p53 causing proteasomal p53 degradation.  In this work, a library of organometallic iridium(III) compounds were synthesized and evaluated for their ability to disrupt the p53/hDM2 protein-protein interaction.  The novel cyclometallated iridium(III) compound 1 [Ir(eppy)2(dcphen)](PF6) (where eppy = 2-(4-ethylphenyl)pyridine and dcphen = 4, 7-dichloro-1, 10-phenanthroline) blocked the interaction of p53/hDM2 in human amelanotic melanoma cells.  Finally, 1 exhibited anti-proliferative activity and induced apoptosis in cancer cell lines consistent with inhibition of the p53/hDM2 interaction.  Compound 1 represents the first reported organometallic p53/hDM2 protein-protein interaction inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcjS03BbQ78YJKJbLTgsvCfW6udTcc2eZPeolmniqbirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtlWjsw%253D%253D&md5=3cfd840ffe2f65e039a200efbb70608a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7369%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DMiles%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DChe%26aufirst%3DW.%2BI.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DInhibition%2520of%2520the%2520p53%252FhDM2%2520protein-protein%2520interaction%2520by%2520cyclometallated%2520iridium%2528III%2529%2520compounds%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D13965%26epage%3D13975%26doi%3D10.18632%2Foncotarget.7369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David Wang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">5400</span>– <span class="NLM_lpage">5408</span>, <span class="refDoi"> DOI: 10.1039/c5sc02321a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC5SC02321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=28757943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=5400-5408&author=H.-J.+Zhongauthor=L.+Luauthor=K.-H.+Leungauthor=C.+C.+L.+Wongauthor=C.+Pengauthor=S.-C.+Yanauthor=D.-L.+Maauthor=Z.+Caiauthor=H.-M.+David+Wangauthor=C.-H.+Leung&title=An+iridium%28III%29-based+irreversible+protein-protein+interaction+inhibitor+of+BRD4+as+a+potent+anticancer+agent&doi=10.1039%2Fc5sc02321a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span></div><div class="casAuthors">Zhong, Hai-Jing; Lu, Lihua; Leung, Ka-Ho; Wong, Catherine C. L.; Peng, Chao; Yan, Siu-Cheong; Ma, Dik-Lung; Cai, Zongwei; David Wang, Hui-Min; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5400-5408</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy.  In this study, an iridium(III) complex is reported as the first metal-based, irreversible inhibitor of BRD4.  Complex 1a is able to antagonize the BRD4-acetylated histone protein-protein interaction (PPI) in vitro, and to bind BRD4 and down-regulate c-myc oncogenic expression in cellulo.  Chromatin immunopptn. (ChIP) anal. revealed that 1a could modulate the interaction between BRD4 and chromatin in melanoma cells, particular at the MYC promoter.  Finally, the complex showed potent activity against melanoma xenografts in an in vivo mouse model.  To our knowledge, this is the first report of a Group 9 metal complex inhibiting the PPI of a member of the bromodomain and extraterminal domain (BET) family.  We envision that complex 1a may serve as a useful scaffold for the development of more potent epigenetic agents against cancers such as melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMXspNfXFlbVg90H21EOLACvtfcHk0ljyHheo83m4uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E&md5=ae176cbfd3621dd7939c234d643db84e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC5SC02321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC02321A%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DK.-H.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DS.-C.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DDavid%2BWang%26aufirst%3DH.-M.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DAn%2520iridium%2528III%2529-based%2520irreversible%2520protein-protein%2520interaction%2520inhibitor%2520of%2520BRD4%2520as%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D5400%26epage%3D5408%26doi%3D10.1039%2Fc5sc02321a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">A metal-based Tumour Necrosis Factor-Alpha converting enzyme inhibitor</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3973</span>– <span class="NLM_lpage">3976</span>, <span class="refDoi"> DOI: 10.1039/c4cc09251a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC4CC09251A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25610924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVSmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=3973-3976&author=C.-H.+Leungauthor=L.-J.+Liuauthor=L.+Luauthor=B.+Heauthor=D.+W.+J.+Kwongauthor=C.-Y.+Wongauthor=D.-L.+Ma&title=A+metal-based+Tumour+Necrosis+Factor-Alpha+converting+enzyme+inhibitor&doi=10.1039%2Fc4cc09251a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A metal-based tumour necrosis factor-alpha converting enzyme inhibitor</span></div><div class="casAuthors">Leung, Chung-Hang; Liu, Li-Juan; Lu, Lihua; He, Bingyong; Kwong, Daniel W. J.; Wong, Chun-Yuen; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3973-3976</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report herein a novel iridium(III) complex as an anti-TNF-α agent and the first metal-based inhibitor of TACE enzymic activity.  The complex inhibited TNF-α secretion and p38 phosphorylation in human monocytic THP-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9MYGAwPt2bVg90H21EOLACvtfcHk0ljyHheo83m4uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVSmsw%253D%253D&md5=61b79255befd9fa2080cb2b1beddea51</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4CC09251A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09251A%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DWong%26aufirst%3DC.-Y.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DA%2520metal-based%2520Tumour%2520Necrosis%2520Factor-Alpha%2520converting%2520enzyme%2520inhibitor%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D3973%26epage%3D3976%26doi%3D10.1039%2Fc4cc09251a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">An iridium (III) complex inhibits JMJD2 activities and acts as a potential epigenetic modulator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6697</span>– <span class="NLM_lpage">6703</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KitL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6697-6703&author=L.-J.+Liuauthor=L.+Luauthor=H.-J.+Zhongauthor=B.+Heauthor=D.+W.+J.+Kwongauthor=D.-L.+Maauthor=C.-H.+Leung&title=An+iridium+%28III%29+complex+inhibits+JMJD2+activities+and+acts+as+a+potential+epigenetic+modulator&doi=10.1021%2Facs.jmedchem.5b00375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator</span></div><div class="casAuthors">Liu, Li-Juan; Lu, Lihua; Zhong, Hai-Jing; He, Bingyong; Kwong, Daniel W. J.; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6697-6703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel iridium(III) complex was synthesized and evaluated for its ability to target JMJD2 enzymic activity.  The iridium(III) complex can inhibit JMJD2 activity and was selective for JMJD2 activity over JARID, JMJD3, and HDAC activities.  Moreover, it suppressed the trimethylation of the p21 promoter on H3K9me3 and interrupted the JMJD2D-H3K9me3 interactions in human cells, suggesting that it could act as an epigenetic modulator.  To our knowledge, this complex represents the first metal-based JMJD2 inhibitor reported in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsrA54CBHkgbVg90H21EOLACvtfcHk0ljyZJ_OJ_csGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KitL7L&md5=047f66cc1c1b063b4a20f3abcf50a151</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00375%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DAn%2520iridium%2520%2528III%2529%2520complex%2520inhibits%2520JMJD2%2520activities%2520and%2520acts%2520as%2520a%2520potential%2520epigenetic%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6697%26epage%3D6703%26doi%3D10.1021%2Facs.jmedchem.5b00375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">A rhodium (III)-based inhibitor of autotaxin with antiproliferative activity</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.bbagen.2016.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27888146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOisLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=256-263&author=T.-S.+Kangauthor=W.+Wangauthor=H.-J.+Zhongauthor=J.-X.+Liangauthor=C.-N.+Koauthor=J.-J.+Luauthor=X.-P.+Chenauthor=D.-L.+Maauthor=C.-H.+Leung&title=A+rhodium+%28III%29-based+inhibitor+of+autotaxin+with+antiproliferative+activity&doi=10.1016%2Fj.bbagen.2016.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity</span></div><div class="casAuthors">Kang, Tian-Shu; Wang, Wanhe; Zhong, Hai-Jing; Liang, Jia-Xin; Ko, Chung-Nga; Lu, Jin-Jian; Chen, Xiu-Ping; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-263</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer of the skin is by far the most common of all cancers.  Melanoma accounts for only about 1% of skin cancers but causes a large majority of skin cancer deaths.  Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), regulates physiol. and pathol. functions of lysophosphatidic acid (LPA), and is thus an important therapeutic target.  The authors synthesized ten metal-based complexes and a novel cyclometalated rhodium(III) complex I was identified as an ATX enzymic inhibitor using multiple methods, including ATX enzymic assay, thermal shift assay, western immunoblotting and so on.  Protein thermal shift assays showed that I increased the melting temp. (Tm) of ATX by 3.5°.  I also reduced ATX-LPA mediated downstream survival signal pathway proteins such as ERK and AKT, and inhibited the activation of the transcription factor nuclear factor κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3).  I also exhibited strong antiproliferative activity against A2058 melanoma cells (IC50 = 0.58 μM).  Structure-activity relationship indicated that both the rhodium(III) center and the auxiliary ligands of complex I are important for bioactivity.  1 Represents a promising scaffold for the development of small-mol. ATX inhibitors for antitumor applications.  To the knowledge, complex I is the first metal-based ATX inhibitor reported to date.  Rhodium complexes will have the increased attention in therapeutic and bioanal. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8K2YuTAocLVg90H21EOLACvtfcHk0ljyZJ_OJ_csGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOisLvP&md5=0acbda56c782955d9dd28c3b383a2166</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DT.-S.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DLiang%26aufirst%3DJ.-X.%26aulast%3DKo%26aufirst%3DC.-N.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DA%2520rhodium%2520%2528III%2529-based%2520inhibitor%2520of%2520autotaxin%2520with%2520antiproliferative%2520activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D256%26epage%3D263%26doi%3D10.1016%2Fj.bbagen.2016.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellaisamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">A rhodium(III)-based inhibitor of lysine-specific histone demethylase 1 as an epigenetic modulator in prostate cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2603</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVajtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2597-2603&author=C.+Yangauthor=W.+Wangauthor=J.-X.+Liangauthor=G.+Liauthor=K.+Vellaisamyauthor=C.-Y.+Wongauthor=D.-L.+Maauthor=C.-H.+Leung&title=A+rhodium%28III%29-based+inhibitor+of+lysine-specific+histone+demethylase+1+as+an+epigenetic+modulator+in+prostate+cancer+cells&doi=10.1021%2Facs.jmedchem.7b00133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells</span></div><div class="casAuthors">Yang, Chao; Wang, Wanhe; Liang, Jia-Xin; Li, Guodong; Vellaisamy, Kasipandi; Wong, Chun-Yuen; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2597-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report herein a novel rhodium(III) complex 1 (I) as a new LSD1 targeting agent and epigenetic modulator.  Complex 1 disrupted the interaction of LSD1-H3K4me2 in human prostate carcinoma cells, and enhanced the amplification of p21, FOXA2 and BMP2 gene promoters.  Complex 1 was selective for LSD1 over other histone demethylases, such as KDM2b, KDM7 and MAO activities, and also showed anti-proliferative activity towards human cancer cells.  To date, complex 1 is the first metal-based inhibitor of LSD1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobbBaU5SOfBrVg90H21EOLACvtfcHk0ljyZJ_OJ_csGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVajtr8%253D&md5=6c9c9729423cf36a645c0f77ccf186b9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00133%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DJ.-X.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DVellaisamy%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DC.-Y.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DA%2520rhodium%2528III%2529-based%2520inhibitor%2520of%2520lysine-specific%2520histone%2520demethylase%25201%2520as%2520an%2520epigenetic%2520modulator%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2597%26epage%3D2603%26doi%3D10.1021%2Facs.jmedchem.7b00133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span> <span> </span><span class="NLM_article-title">Advances in copper complexes as anticancer agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/cr400135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2013&pages=815-862&author=C.+Santiniauthor=M.+Pelleiauthor=V.+Gandinauthor=M.+Porchiaauthor=F.+Tisatoauthor=C.+Marzano&title=Advances+in+copper+complexes+as+anticancer+agents&doi=10.1021%2Fcr400135x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr400135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400135x%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520copper%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D114%26spage%3D815%26epage%3D862%26doi%3D10.1021%2Fcr400135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrott, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistrik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gursky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozdian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moudry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaclavkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrobel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouckova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlacek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklovicova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span> <span> </span><span class="NLM_article-title">Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1038/nature25016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature25016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=29211715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=194-199&author=Z.+Skrottauthor=M.+Mistrikauthor=K.+K.+Andersenauthor=S.+Friisauthor=D.+Majeraauthor=J.+Gurskyauthor=T.+Ozdianauthor=J.+Bartkovaauthor=Z.+Turiauthor=P.+Moudryauthor=M.+Krausauthor=M.+Michalovaauthor=J.+Vaclavkovaauthor=P.+Dzubakauthor=I.+Vrobelauthor=P.+Pouckovaauthor=J.+Sedlacekauthor=A.+Miklovicovaauthor=A.+Kuttauthor=J.+Liauthor=J.+Mattovaauthor=C.+Driessenauthor=Q.+P.+Douauthor=J.+Olsenauthor=M.+Hajduchauthor=B.+Cvekauthor=R.+J.+Deshaiesauthor=J.+Bartek&title=Alcohol-abuse+drug+disulfiram+targets+cancer+via+p97+segregase+adaptor+NPL4&doi=10.1038%2Fnature25016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4</span></div><div class="casAuthors">Skrott, Zdenek; Mistrik, Martin; Andersen, Klaus Kaae; Friis, Soeren; Majera, Dusana; Gursky, Jan; Ozdian, Tomas; Bartkova, Jirina; Turi, Zsofia; Moudry, Pavel; Kraus, Marianne; Michalova, Martina; Vaclavkova, Jana; Dzubak, Petr; Vrobel, Ivo; Pouckova, Pavla; Sedlacek, Jindrich; Miklovicova, Andrea; Kutt, Anne; Li, Jing; Mattova, Jana; Driessen, Christoph; Dou, Q. Ping; Olsen, Joergen; Hajduch, Marian; Cvek, Boris; Deshaies, Raymond J.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">194-199</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Cancer incidence is rising and this global challenge is further exacerbated by tumor resistance to available medicines.  A promising approach to meet the need for improved cancer treatment is drug repurposing.  Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alc.-aversion drug that has been shown to be effective against diverse cancer types in preclin. studies.  Our nationwide epidemiol. study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis.  Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumors and candidate biomarkers to analyze its effect on cells and tissues.  Finally, our functional and biophys. analyses reveal the mol. target of disulfiram's tumor-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_sAn4LKB57Vg90H21EOLACvtfcHk0liU0n1_0L_TmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbrN&md5=b53235723e8478ab49b7d569d0dd35ac</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature25016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25016%26sid%3Dliteratum%253Aachs%26aulast%3DSkrott%26aufirst%3DZ.%26aulast%3DMistrik%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DK.%2BK.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DMajera%26aufirst%3DD.%26aulast%3DGursky%26aufirst%3DJ.%26aulast%3DOzdian%26aufirst%3DT.%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DTuri%26aufirst%3DZ.%26aulast%3DMoudry%26aufirst%3DP.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DMichalova%26aufirst%3DM.%26aulast%3DVaclavkova%26aufirst%3DJ.%26aulast%3DDzubak%26aufirst%3DP.%26aulast%3DVrobel%26aufirst%3DI.%26aulast%3DPouckova%26aufirst%3DP.%26aulast%3DSedlacek%26aufirst%3DJ.%26aulast%3DMiklovicova%26aufirst%3DA.%26aulast%3DKutt%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMattova%26aufirst%3DJ.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DOlsen%26aufirst%3DJ.%26aulast%3DHajduch%26aufirst%3DM.%26aulast%3DCvek%26aufirst%3DB.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DAlcohol-abuse%2520drug%2520disulfiram%2520targets%2520cancer%2520via%2520p97%2520segregase%2520adaptor%2520NPL4%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D194%26epage%3D199%26doi%3D10.1038%2Fnature25016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">Recent insights into synthetic β-carbolines with anti-cancer activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.05.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.ejmech.2017.05.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=28583770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=48-73&author=S.+Kumarauthor=A.+Singhauthor=K.+Kumarauthor=V.+Kumar&title=Recent+insights+into+synthetic+%CE%B2-carbolines+with+anti-cancer+activities&doi=10.1016%2Fj.ejmech.2017.05.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into synthetic β-carbolines with anti-cancer activities</span></div><div class="casAuthors">Kumar, Sumit; Singh, Amandeep; Kumar, Kewal; Kumar, Vipan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-73</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cancer, an uncontrolled and rapid proliferation of abnormal cells, has become one of the leading cause of death worldwide.  The development of resistance among the numerous drugs in clin. use has provided strong impetus for the identification and development of novel cancer therapeutics.  β-Carbolines constitute an important class of pharmacol. active scaffolds known to exert their anticancer activities via diverse mechanisms.  The purpose of present review article is to update the readers on the current developments in β-carbolines with an emphasis on synthetic strategies, structure-activity relationships, mechanism of action and in vivo studies wherever possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrii8G14_qYYbVg90H21EOLACvtfcHk0liU0n1_0L_TmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVCisLk%253D&md5=b0be525833f91e39834efae7b8ff5466</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.05.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DRecent%2520insights%2520into%2520synthetic%2520%25CE%25B2-carbolines%2520with%2520anti-cancer%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D142%26spage%3D48%26epage%3D73%26doi%3D10.1016%2Fj.ejmech.2017.05.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.ejmech.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=15725494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=249-257&author=R.+Caoauthor=W.+Pengauthor=H.+Chenauthor=X.+Houauthor=H.+Guanauthor=Q.+Chenauthor=Y.+Maauthor=A.+Xu&title=Synthesis+and+in+vitro+cytotoxic+evaluation+of+1%2C3-bisubstituted+and+1%2C3%2C9-trisubstituted+beta-carboline+derivatives&doi=10.1016%2Fj.ejmech.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro cytotoxic evaluation of 1,3-disubstituted and 1,3,9-trisubstituted β-carboline derivatives</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Chen, Hongsheng; Hou, Xuerui; Guan, Huaji; Chen, Qi; Ma, Yan; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel 1,3-disubstituted and 1,3,9-trisubstituted β-carbolines was synthesized from L-tryptophan.  Cytotoxic activities of these compds. were investigated in vitro.  The results showed that 1,3,9-trisubstituted β-carbolines had higher cytotoxic activities in vitro than the corresponding 1,3-disubstituted compds.  The 1,3,9-trisubstituted β-carbolines with a Me substituent at position 1 displayed more potent cytotoxic activities, I being the most potent compds. of this series with IC50 4 uM against BGC-823 cell lines.  These data suggested that (1) the cytotoxic potencies of β-carbolines were enhanced by the introduction of appropriate substituents into position 1 and position 9 in β-carboline; (2) the β-carboline structure might be an important basis for the design and synthesis of new antitumor drugs; (3) the Me substituent at position 1, the pentafluorobenzyl group at position 9 and the ethoxycarbonyl substituent at position 3 were the optimal combination for the improvement of cytotoxic activity of the β-carboline derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_WNRnc760LVg90H21EOLACvtfcHk0lhJFUfVf4N9MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12itL0%253D&md5=255bcb5cd796c56df5ef90176b6b5141</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxic%2520evaluation%2520of%25201%252C3-bisubstituted%2520and%25201%252C3%252C9-trisubstituted%2520beta-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D249%26epage%3D257%26doi%3D10.1016%2Fj.ejmech.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+the+most+important+efficiency+metric+in+medicinal+chemistry&doi=10.4155%2Ffmc.12.208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0lhJFUfVf4N9MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520the%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D113%26epage%3D115%26doi%3D10.4155%2Ffmc.12.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abulwerdi, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mady, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span> <span> </span><span class="NLM_article-title">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4111</span>– <span class="NLM_lpage">4133</span>, <span class="refDoi"> DOI: 10.1021/jm500010b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500010b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4111-4133&author=F.+A.+Abulwerdiauthor=C.+Liaoauthor=A.+S.+Madyauthor=J.+Gavinauthor=C.+Shenauthor=T.+Cierpickiauthor=J.+A.+Stuckeyauthor=H.+D.+H.+Showalterauthor=Z.+Nikolovska-Coleska&title=3-Substituted-N-%284-Hydroxynaphthalen-1-yl%29arylsulfonamides+as+a+novel+class+of+selective+Mcl-1+inhibitors%3A+structure-based+design%2C+synthesis%2C+SAR%2C+and+biological+evaluation&doi=10.1021%2Fjm500010b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation</span></div><div class="casAuthors">Abulwerdi, Fardokht A.; Liao, Chenzhong; Mady, Ahmed S.; Gavin, Jordan; Shen, Chenxi; Cierpicki, Tomasz; Stuckey, Jeanne A.; Showalter, H. D. Hollis; Nikolovska-Coleska, Zaneta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4111-4133</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mcl-1, an antiapoptotic member of the Bcl-2 family of proteins, is a validated and attractive target for cancer therapy.  Overexpression of Mcl-1 in many cancers results in disease progression and resistance to current chemotherapeutics.  Utilizing high-throughput screening, compd. I was identified as a selective Mcl-1 inhibitor and its binding to the BH3 binding groove of Mcl-1 was confirmed by several different, but complementary, biochem. and biophys. assays.  Guided by structure-based drug design and supported by NMR expts., comprehensive SAR studies were undertaken and a potent and selective inhibitor, compd. II, was designed which binds to Mcl-1 with a Ki of 180 nM.  Biol. characterization of II showed that it disrupts the interaction of endogenous Mcl-1 and biotinylated Noxa-BH3 peptide, causes cell death through a Bak/Bax-dependent mechanism, and selectively sensitizes Eμ-myc lymphomas overexpressing Mcl-1, but not Eμ-myc lymphoma cells overexpressing Bcl-2.  Treatment of human leukemic cell lines with compd. II resulted in cell death through activation of caspase-3 and induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd24MDP_8ww7Vg90H21EOLACvtfcHk0lhJFUfVf4N9MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgt7c%253D&md5=56174b467eba7dba4bdc33c75bfce473</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500010b%26sid%3Dliteratum%253Aachs%26aulast%3DAbulwerdi%26aufirst%3DF.%2BA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26atitle%3D3-Substituted-N-%25284-Hydroxynaphthalen-1-yl%2529arylsulfonamides%2520as%2520a%2520novel%2520class%2520of%2520selective%2520Mcl-1%2520inhibitors%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520SAR%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4111%26epage%3D4133%26doi%3D10.1021%2Fjm500010b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span> <span> </span><span class="NLM_article-title">3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): Structure-based design and structure–activity relationship studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1021/jm101181u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101181u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1101-1105&author=Z.+Zhangauthor=G.+Wuauthor=F.+Xieauthor=T.+Songauthor=X.+Chang&title=3-Thiomorpholin-8-oxo-8H-acenaphtho%5B1%2C2-b%5Dpyrrole-9-carbonitrile+%28S1%29+based+molecules+as+potent%2C+dual+inhibitors+of+B-cell+lymphoma+2+%28Bcl-2%29+and+myeloid+cell+leukemia+sequence+1+%28Mcl-1%29%3A+Structure-based+design+and+structure%E2%80%93activity+relationship+studies&doi=10.1021%2Fjm101181u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) Based Molecules as Potent, Dual Inhibitors of B-Cell Lymphoma 2 (Bcl-2) and Myeloid Cell Leukemia Sequence 1 (Mcl-1): Structure-Based Design and Structure-Activity Relationship Studies</span></div><div class="casAuthors">Zhang, Zhichao; Wu, Guiye; Xie, Feibo; Song, Ting; Chang, Xilong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1101-1105</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">the authors recently described the discovery of a dual inhibitor of Bcl-2 and Mcl-1, 3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (3, S1).  Here the authors report a structure-guided design in combination with structure-activity relationship studies to exploit the difference in the p2 binding pocket of Bcl-2 and Mcl-1, from which a novel dual inhibitor 3-(4-aminophenylthio)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (6h) was obtained, which showed significant enhanced IC50 value against Mcl-1 (5 nM), greater Mcl-1/Bak disruption potential, and accordingly a 10-fold increased cytotoxicity over 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuLvoBDBxBbVg90H21EOLACvtfcHk0lg7SWrpkYasFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVeiuw%253D%253D&md5=08ad63a3a7bfb4afd477f63572d2f16c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm101181u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101181u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%26atitle%3D3-Thiomorpholin-8-oxo-8H-acenaphtho%255B1%252C2-b%255Dpyrrole-9-carbonitrile%2520%2528S1%2529%2520based%2520molecules%2520as%2520potent%252C%2520dual%2520inhibitors%2520of%2520B-cell%2520lymphoma%25202%2520%2528Bcl-2%2529%2520and%2520myeloid%2520cell%2520leukemia%2520sequence%25201%2520%2528Mcl-1%2529%253A%2520Structure-based%2520design%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1101%26epage%3D1105%26doi%3D10.1021%2Fjm101181u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udompholkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jossart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors of protein–protein interactions targeting lysine, tyrosine, or histidine residues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5616</span>– <span class="NLM_lpage">5627</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5616-5627&author=L.+Gambiniauthor=C.+Baggioauthor=P.+Udompholkulauthor=J.+Jossartauthor=A.+F.+Salemauthor=J.+J.+P.+Perryauthor=M.+Pellecchia&title=Covalent+inhibitors+of+protein%E2%80%93protein+interactions+targeting+lysine%2C+tyrosine%2C+or+histidine+residues&doi=10.1021%2Facs.jmedchem.9b00561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues</span></div><div class="casAuthors">Gambini, Luca; Baggio, Carlo; Udompholkul, Parima; Jossart, Jennifer; Salem, Ahmed F.; Perry, J. Jefferson P.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5616-5627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently reported a series of Lys-covalent agents targeting the BIR3 domain of the X-linked inhibitor of apoptosis protein (XIAP) using a benzamide-sulfonyl fluoride warhead.  Using XIAP as a model system, we further investigated a variety of addnl. warheads that can be easily incorporated into binding peptides and analyzed their ability to form covalent adducts with lysine and other amino acids, including tyrosine, histidine, serine, and threonine, using biochem. and biophys. assays.  Moreover, we tested aq., plasma stability, cell permeability, and cellular efficacy of the most effective agents.  These studies identified aryl-fluoro sulfates as likely the most suitable electrophiles to effectively form covalent adducts with Lys, Tyr, and His residues, given that these agents were cell permeable and stable in aq. buffer and in plasma.  Our studies contain a no. of general findings that open new possible avenues for the design of potent covalent protein-protein interaction antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gJvmpArk6LVg90H21EOLACvtfcHk0lg7SWrpkYasFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOkur0%253D&md5=820cf16d34a3230e9629991a3bca240d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00561%26sid%3Dliteratum%253Aachs%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DBaggio%26aufirst%3DC.%26aulast%3DUdompholkul%26aufirst%3DP.%26aulast%3DJossart%26aufirst%3DJ.%26aulast%3DSalem%26aufirst%3DA.%2BF.%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DCovalent%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520targeting%2520lysine%252C%2520tyrosine%252C%2520or%2520histidine%2520residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5616%26epage%3D5627%26doi%3D10.1021%2Facs.jmedchem.9b00561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahisa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9635</span>– <span class="NLM_lpage">9645</span>, <span class="refDoi"> DOI: 10.1021/jm401170c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401170c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9635-9645&author=Y.+Tanakaauthor=K.+Aikawaauthor=G.+Nishidaauthor=M.+Hommaauthor=S.+Sogabeauthor=S.+Igakiauthor=Y.+Hayanoauthor=T.+Sameshimaauthor=I.+Miyahisaauthor=T.+Kawamotoauthor=M.+Tawadaauthor=Y.+Imaiauthor=M.+Inazukaauthor=N.+Choauthor=Y.+Imaedaauthor=T.+Ishikawa&title=Discovery+of+potent+Mcl-1%2FBcl-xL+dual+inhibitors+by+using+a+hybridization+strategy+based+on+structural+analysis+of+target+proteins&doi=10.1021%2Fjm401170c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins</span></div><div class="casAuthors">Tanaka, Yuta; Aikawa, Katsuji; Nishida, Goushi; Homma, Misaki; Sogabe, Satoshi; Igaki, Shigeru; Hayano, Yumi; Sameshima, Tomoya; Miyahisa, Ikuo; Kawamoto, Tomohiro; Tawada, Michiko; Imai, Yumi; Inazuka, Masakazu; Cho, Nobuo; Imaeda, Yasuhiro; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9635-9645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mcl-1 and Bcl-xL are crucial regulators of apoptosis, therefore dual inhibitors of both proteins could serve as promising new anticancer drugs.  To design Mcl-1/Bcl-xL dual inhibitors, we performed structure-guided analyses of the corresponding selective Mcl-1 and Bcl-xL inhibitors.  A cocrystal structure of a pyrazolo-[1,5-a]-pyridine deriv. with Mcl-1 protein was successfully detd. and revealed the protein-ligand binding mode.  The key structure for Bcl-xL inhibition was further confirmed through the substructural anal. of ABT-263, a representative Bcl-xL/Bcl-2/Bcl-w inhibitor developed by Abbott Labs.  On the basis of the structural data from this anal., we designed hybrid compds. by tethering the Mcl-1 and Bcl-xL inhibitors together.  The results of X-ray crystallog. anal. of hybrid compd. 10 in complexes with both Mcl-1 and Bcl-xL demonstrated its binding mode with each protein.  Following further optimization, compd. 11 showed potent Mcl-1/Bcl-xL dual inhibitory activity (Mcl-1, IC50 = 0.088 μM; and Bcl-xL, IC50 = 0.0037 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydBzhRc5fGrVg90H21EOLACvtfcHk0lg7SWrpkYasFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7bP&md5=53b60cdb559e6b402f9cc3f96fbb8d9d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm401170c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401170c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DAikawa%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DG.%26aulast%3DHomma%26aufirst%3DM.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DIgaki%26aufirst%3DS.%26aulast%3DHayano%26aufirst%3DY.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DMiyahisa%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DInazuka%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520potent%2520Mcl-1%252FBcl-xL%2520dual%2520inhibitors%2520by%2520using%2520a%2520hybridization%2520strategy%2520based%2520on%2520structural%2520analysis%2520of%2520target%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9635%26epage%3D9645%26doi%3D10.1021%2Fjm401170c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekumar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0lhPUBZqSvNXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akçay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tentarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimster, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Q.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnchembio.2174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27595327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKqtb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=931-936&author=G.+Ak%C3%A7ayauthor=M.+A.+Belmonteauthor=B.+Aquilaauthor=C.+Chuaquiauthor=A.+W.+Hirdauthor=M.+L.+Lambauthor=P.+B.+Rawlinsauthor=N.+Suauthor=S.+Tentarelliauthor=N.+P.+Grimsterauthor=Q.+Su&title=Inhibition+of+Mcl-1+through+covalent+modification+of+a+noncatalytic+lysine+side+chain&doi=10.1038%2Fnchembio.2174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain</span></div><div class="casAuthors">Akcay, Gizem; Belmonte, Matthew A.; Aquila, Brian; Chuaqui, Claudio; Hird, Alexander W.; Lamb, Michelle L.; Rawlins, Philip B.; Su, Nancy; Tentarelli, Sharon; Grimster, Neil P.; Su, Qibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-936</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeted covalent inhibition of disease-assocd. proteins has become a powerful methodol. in the field of drug discovery, leading to the approval of new therapeutics.  Nevertheless, current approaches are often limited owing to their reliance on a cysteine residue to generate the covalent linkage.  Here the authors used aryl boronic acid carbonyl warheads to covalently target a noncatalytic lysine side chain, and generated to the knowledge the first reversible covalent inhibitors for Mcl-1, a protein-protein interaction (PPI) target that has proven difficult to inhibit via traditional medicinal chem. strategies.  These covalent binders exhibited improved potency in comparison to noncovalent congeners, as demonstrated in biochem. and cell-based assays.  The authors identified Lys234 as the residue involved in covalent modification, via point mutation.  The covalent binders discovered in this study will serve as useful starting points for the development of Mcl-1 therapeutics and probes to interrogate Mcl-1-dependent biol. phenomena.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUd1TOo4XkarVg90H21EOLACvtfcHk0lhPUBZqSvNXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKqtb3P&md5=bda5720579a9b5e6027632d2cffba2e1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2174%26sid%3Dliteratum%253Aachs%26aulast%3DAk%25C3%25A7ay%26aufirst%3DG.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAquila%26aufirst%3DB.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DTentarelli%26aufirst%3DS.%26aulast%3DGrimster%26aufirst%3DN.%2BP.%26aulast%3DSu%26aufirst%3DQ.%26atitle%3DInhibition%2520of%2520Mcl-1%2520through%2520covalent%2520modification%2520of%2520a%2520noncatalytic%2520lysine%2520side%2520chain%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D931%26epage%3D936%26doi%3D10.1038%2Fnchembio.2174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Deactivation of Mcl-1 by dual-function small-molecule inhibitors targeting the Bcl-2 homology 3 domain and facilitating Mcl-1 ubiquitination</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">14250</span>– <span class="NLM_lpage">14256</span>, <span class="refDoi"> DOI: 10.1002/anie.201606543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1002%2Fanie.201606543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Slt7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=14250-14256&author=T.+Songauthor=Z.+Wangauthor=F.+Jiauthor=Y.+Fengauthor=Y.+Fanauthor=G.+Chaiauthor=X.+Liauthor=Z.+Liauthor=Z.+Zhang&title=Deactivation+of+Mcl-1+by+dual-function+small-molecule+inhibitors+targeting+the+Bcl-2+homology+3+domain+and+facilitating+Mcl-1+ubiquitination&doi=10.1002%2Fanie.201606543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Deactivation of Mcl-1 by Dual-Function Small-Molecule Inhibitors Targeting the Bcl-2 Homology 3 Domain and Facilitating Mcl-1 Ubiquitination</span></div><div class="casAuthors">Song, Ting; Wang, Ziqian; Ji, Fangling; Feng, Yingang; Fan, Yudan; Chai, Gaobo; Li, Xiangqian; Li, Zhiqiang; Zhang, Zhichao</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14250-14256</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">By means of limited proteolysis assay, three-dimensional NMR, X-ray crystallog. and alanine mutations, a dynamic region at the Q221R222N223 motif in the Bcl-2 homol. 3 (BH3) domain of Mcl-1 has been identified as a conformational switch which controls Mcl-1 ubiquitination.  NoxaBH3 binding biases the QRN motif toward a helical conformation, thus leading to an enhanced in vitro ubiquitination of Mcl-1.  In contrast, BimBH3 binding biases the QRN motif toward a nonhelical conformation, thus leading to the inhibition of ubiquitination.  A dual function Mcl-1 inhibitor, which locates at the BH3 domain of Mcl-1 and forms hydrogen bond with His224 to drive a helical QRN conformation, so that it not only interferes with the pro-apoptotic partners, but also facilitates Mcl-1 ubiquitination in living cells, is described.  As a result, this inhibitor manifests a more effective apoptosis induction in Mcl-1-dependent cancer cells than other inhibitors exhibiting a similar binding affinity with it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB49Pd1nHcrVg90H21EOLACvtfcHk0lhPUBZqSvNXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Slt7fO&md5=35c7cdc47a2e58b3bd3dc4310ec41d1e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606543%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DChai%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDeactivation%2520of%2520Mcl-1%2520by%2520dual-function%2520small-molecule%2520inhibitors%2520targeting%2520the%2520Bcl-2%2520homology%25203%2520domain%2520and%2520facilitating%2520Mcl-1%2520ubiquitination%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D14250%26epage%3D14256%26doi%3D10.1002%2Fanie.201606543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najajreh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazanov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawbry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardeli-Tzaraf, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barenholz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4665</span>– <span class="NLM_lpage">4673</span>, <span class="refDoi"> DOI: 10.1021/jm060237r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060237r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVKnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4665-4673&author=Y.+Najajrehauthor=E.+Khazanovauthor=S.+Jawbryauthor=Y.+Ardeli-Tzarafauthor=J.+M.+Perezauthor=J.+Kasparkovaauthor=V.+Brabecauthor=Y.+Barenholzauthor=D.+Gibson&title=Cationic+nonsymmetric+transplatinum+complexes+with+piperidinopiperidine+ligands.+Preparation%2C+characterization%2C+in+vitro+cytotoxicity%2C+in+vivo+toxicity%2C+and+anticancer+efficacy+studies&doi=10.1021%2Fjm060237r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic Nonsymmetric Transplatinum Complexes with Piperidinopiperidine Ligands. Preparation, Characterization, in Vitro Cytotoxicity, in Vivo Toxicity, and Anticancer Efficacy Studies</span></div><div class="casAuthors">Najajreh, Yousef; Khazanov, Elena; Jawbry, Seba; Ardeli-Tzaraf, Yael; Perez, Jose Manuel; Kasparkova, Jana; Brabec, Viktor; Barenholz, Yechezkel; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4665-4673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trans-[PtCl2(Am)(pip-pip)]·HCl where pip-pip is 4-piperidinopiperidine and Am is NH3, methylamine (MA), dimethylamine (DMA), n-propylamine (NPA), isopropylamine (IPA), n-butylamine (NBA), or cyclohexylamine (CHA) were prepd. and characterized, and their cytotoxic properties against ovarian and colon cancer cells were evaluated.  The trans-[PtCl2(NH3)(pip-pip)]·HCl was significantly more potent than cisplatin in all the cisplatin-resistant ovarian cancer cell lines and was nearly as cytotoxic as cisplatin against colon cancer cells.  In vivo studies in mice showed that the pip-pip complexes are significantly less toxic than cisplatin.  Cisplatin was more efficacious than both trans-[PtCl2(NH3)(pip-pip)]·HCl and trans-[PtCl2(NBA)(pip-pip)]·HCl in the A2780 and A2780cisR tumor xenograft models, consistent with its lower IC50 values in A2780 cells but contrary to the higher IC50 values in A2780cisR cells.  In the colon cancer cell studies, trans-[PtCl2(NH3)(pip-pip)]·HCl was slightly less potent than cisplatin in the in vitro studies but had efficacy comparable to that of cisplatin in the in vivo xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXAEEGCV4K1bVg90H21EOLACvtfcHk0likhsFO0uu5sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVKnt7g%253D&md5=3059319466d4a5458ecc413a91242b5e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm060237r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060237r%26sid%3Dliteratum%253Aachs%26aulast%3DNajajreh%26aufirst%3DY.%26aulast%3DKhazanov%26aufirst%3DE.%26aulast%3DJawbry%26aufirst%3DS.%26aulast%3DArdeli-Tzaraf%26aufirst%3DY.%26aulast%3DPerez%26aufirst%3DJ.%2BM.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DBarenholz%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DCationic%2520nonsymmetric%2520transplatinum%2520complexes%2520with%2520piperidinopiperidine%2520ligands.%2520Preparation%252C%2520characterization%252C%2520in%2520vitro%2520cytotoxicity%252C%2520in%2520vivo%2520toxicity%252C%2520and%2520anticancer%2520efficacy%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4665%26epage%3D4673%26doi%3D10.1021%2Fjm060237r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushwaha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cron, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, D.</span></span> <span> </span><span class="NLM_article-title">USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1</span>. <i>Canc. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1080/15384047.2014.1002358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1080%2F15384047.2014.1002358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25692226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWqtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=392-401&author=D.+Kushwahaauthor=C.+O%E2%80%99Learyauthor=K.+R.+Cronauthor=P.+Deraskaauthor=K.+Zhuauthor=A.+D.+D%E2%80%99Andreaauthor=D.+Kozono&title=USP9X+inhibition+promotes+radiation-induced+apoptosis+in+non-small+cell+lung+cancer+cells+expressing+mid-to-high+MCL1&doi=10.1080%2F15384047.2014.1002358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1</span></div><div class="casAuthors">Kushwaha, Deepa; O'Leary, Colin; Cron, Kyle R.; Deraska, Peter; Zhu, Kaya; D'Andrea, Alan D.; Kozono, David</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Background and Purpose: Radiotherapy (RT) is vital for the treatment of locally advanced non-small cell lung cancer (NSCLC), yet its delivery is limited by tolerances of adjacent organs.  We sought therefore to identify and characterize gene targets whose inhibition may improve RT.  Materials and Methods: Whole genome pooled shRNA cytotoxicity screens were performed in A549 and NCI-H460 using a retroviral library of 74,705 sequences.  Cells were propagated with or without daily radiation Monday-Friday.  Radiosensitization by top differential dropout hits was assessed by clonogenic assays.  Apoptosis was assessed using a caspase 3/7 cell-based activity assay and by annexin V-FITC and PI staining.  MCL1 expression was assessed by qPCR and Western blotting.  Results: USP9X, a deubiquitinase, was a top hit among druggable gene products.  WP1130, a small mol. USP9X inhibitor, showed synergistic cytotoxicity with IR.  MCL1, an anti-apoptotic protein deubiquitinated by USP9X, decreased with USP9X inhibition and IR.  This was accompanied by increases in caspase 3/7 activity and apoptosis.  In a panel of NSCLC lines, MCL1 and USP9X protein and gene expression levels were highly correlated.  Lines showing high levels of MCL1 expression were the most sensitive to USP9X inhibition.  Conclusions: These data support the use of MCL1 expression as a predictive biomarker for USP9X inhibitors in NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbivXsJTov1rVg90H21EOLACvtfcHk0likhsFO0uu5sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWqtL7I&md5=9bf9ed83171978a35ee234f5832b253d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F15384047.2014.1002358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2014.1002358%26sid%3Dliteratum%253Aachs%26aulast%3DKushwaha%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DC.%26aulast%3DCron%26aufirst%3DK.%2BR.%26aulast%3DDeraska%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DKozono%26aufirst%3DD.%26atitle%3DUSP9X%2520inhibition%2520promotes%2520radiation-induced%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520expressing%2520mid-to-high%2520MCL1%26jtitle%3DCanc.%2520Biol.%2520Ther.%26date%3D2015%26volume%3D16%26spage%3D392%26epage%3D401%26doi%3D10.1080%2F15384047.2014.1002358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of SHELX</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/s0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2Fs0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0likhsFO0uu5sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2Fs0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2159</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/jm5012484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2159-2179&author=Z.-F.+Chenauthor=Q.-P.+Qinauthor=J.-L.+Qinauthor=Y.-C.+Liuauthor=K.-B.+Huangauthor=Y.-L.+Liauthor=T.+Mengauthor=G.-H.+Zhangauthor=Y.+Pengauthor=X.-J.+Luoauthor=H.+Liang&title=Stabilization+of+G-quadruplex+DNA%2C+inhibition+of+telomerase+activity%2C+and+tumor+cell+apoptosis+by+organoplatinum%28II%29+complexes+with+oxoisoaporphine&doi=10.1021%2Fjm5012484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine</span></div><div class="casAuthors">Chen, Zhen-Feng; Qin, Qi-Pin; Qin, Jiao-Lan; Liu, Yan-Cheng; Huang, Ke-Bin; Li, Yu-Lan; Meng, Ting; Zhang, Guo-Hai; Peng, Yan; Luo, Xu-Jian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2159-2179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two G-quadruplex ligands [Pt(La)(DMSO)Cl] (Pt1) and [Pt(Lb)(DMSO)Cl] (Pt2) have been synthesized and fully characterized.  The two complexes are more selective for SK-OV-3/DDP tumor cells vs. normal cells (HL-7702).  Both Pt1 and Pt2 could be a telomerase inhibitor targeting G-quadruplex DNA.  This is the first report demonstrating that telomeric, c-myc, and bcl-2 G-quadruplexes and caspase-3/9 preferred to bind with Pt2 rather than Pt1, which also can induce senescence and apoptosis.  The different biol. behavior of Pt1 and Pt2 may correlate with the presence of a 6-hydroxyl group in Lb.  Importantly, Pt1 and Pt2 exhibited higher safety in vivo and more effective inhibitory effects on tumor growth in the HCT-8 and NCI-H460 xenograft mouse model, compared with cisplatin.  Taken together, these mechanistic insights indicate that both Pt1 and Pt2 display low toxicity and could be novel anticancer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotaQYbKtnemLVg90H21EOLACvtfcHk0likhsFO0uu5sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shtbc%253D&md5=c12cdfc7a7b59c49be5487c9cad402c1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm5012484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012484%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.-F.%26aulast%3DQin%26aufirst%3DQ.-P.%26aulast%3DQin%26aufirst%3DJ.-L.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DHuang%26aufirst%3DK.-B.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DG.-H.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-J.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DStabilization%2520of%2520G-quadruplex%2520DNA%252C%2520inhibition%2520of%2520telomerase%2520activity%252C%2520and%2520tumor%2520cell%2520apoptosis%2520by%2520organoplatinum%2528II%2529%2520complexes%2520with%2520oxoisoaporphine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2159%26epage%3D2179%26doi%3D10.1021%2Fjm5012484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. C.</span></span> <i>Molecular Operating Environment (MOE)</i>, <span class="NLM_year">2016</span>; 08.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+C.+Group&title=Molecular+Operating+Environment+%28MOE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DGroup%26aufirst%3DC.%2BC.%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haolan  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Hudie  Wei</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MCL-1 in cancer: current status and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01079-1" title="DOI URL">https://doi.org/10.1186/s13045-021-01079-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01079-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01079-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeting%252BMCL-1%252Bin%252Bcancer%25253A%252Bcurrent%252Bstatus%252Band%252Bperspectives%26aulast%3DWang%26aufirst%3DHaolan%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Luo</span>, <span class="hlFld-ContribAuthor ">Xinqiang  Song</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive overview of β-carbolines and its derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113688. <a href="https://doi.org/10.1016/j.ejmech.2021.113688" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113688%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Boverview%252Bof%252B%2525CE%2525B2-carbolines%252Band%252Bits%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DLuo%26aufirst%3DBo%26date%3D2021%26volume%3D224%26spage%3D113688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mónica  Sancho</span>, <span class="hlFld-ContribAuthor ">Diego  Leiva</span>, <span class="hlFld-ContribAuthor ">Estefanía  Lucendo</span>, <span class="hlFld-ContribAuthor ">Mar  Orzáez</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding MCL1: from cellular function and regulation to pharmacological inhibition. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>90 </em><a href="https://doi.org/10.1111/febs.16136" title="DOI URL">https://doi.org/10.1111/febs.16136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.16136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.16136%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DUnderstanding%252BMCL1%25253A%252Bfrom%252Bcellular%252Bfunction%252Band%252Bregulation%252Bto%252Bpharmacological%252Binhibition%26aulast%3DSancho%26aufirst%3DM%25C3%25B3nica%26date%3D2021%26date%3D2021%26volume%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Po  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Pei-Pei  Qiao</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Jin-Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Jin-Zhong  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei-Jun  Du</span>, <span class="hlFld-ContribAuthor ">Jing-Yuan  Xu</span>, <span class="hlFld-ContribAuthor ">Shi-Ping  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper based metallonucleases as potential antitumor drugs: Synthesis, Structure, in vitro Cytotoxicity and Apoptosis inducing properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1236 </em>, 130278. <a href="https://doi.org/10.1016/j.molstruc.2021.130278" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130278%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DCopper%252Bbased%252Bmetallonucleases%252Bas%252Bpotential%252Bantitumor%252Bdrugs%25253A%252BSynthesis%25252C%252BStructure%25252C%252Bin%252Bvitro%252BCytotoxicity%252Band%252BApoptosis%252Binducing%252Bproperties%26aulast%3DZhang%26aufirst%3DYong-Po%26date%3D2021%26volume%3D1236%26spage%3D130278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusuf Oloruntoyin  Ayipo</span>, <span class="hlFld-ContribAuthor ">Wahab Adesina  Osunniran</span>, <span class="hlFld-ContribAuthor ">Mohd Nizam  Mordi</span>. </span><span class="cited-content_cbyCitation_article-title">Metal complexes of β-carboline: Advances in anticancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>432 </em>, 213746. <a href="https://doi.org/10.1016/j.ccr.2020.213746" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213746%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DMetal%252Bcomplexes%252Bof%252B%2525CE%2525B2-carboline%25253A%252BAdvances%252Bin%252Banticancer%252Btherapeutics%26aulast%3DAyipo%26aufirst%3DYusuf%2BOloruntoyin%26date%3D2021%26volume%3D432%26spage%3D213746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Single-crystal X-ray structures of complexes <b>12–17</b> and <b>19–21</b>. The solvent molecules and hydrogen atoms were omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>1–11</b>; (a–c) 10% Pd/C, Anisole, Reflux, 24 h; (d) NaH, DMF, r.t., 1 h</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Complexes <b>12–21</b>; (a) Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O, EtOH, 80 °C</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked structures of complexes <b>12</b> (A), <b>13</b> (B), and <b>14</b> (C) and ligand <b>4</b> (D) with the Mcl-1 protein. Docking simulations of the compounds with the Mcl-1 protein (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WIX">3WIX</a>) were carried out with MOE version 2016.08.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CETSA. (A) Mcl-1 melting curve determination in NCI-H929 cells. (B) Isothermal CETSA experiment in NCI-H929 cells treated with complex <b>14</b> at 57 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Complex <b>14</b> induced apoptosis in a Bax/Bak-dependent manner. (A) Immunoblotting was used to confirm the expression levels of Bak and Bax in K562 cells. (B) Induction of apoptosis in Bak/Bax-deficient K562 cells by complex <b>14</b>. (C) Induction of apoptosis in Bak/Bax-deficient K562 cells by staurosporine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Impact of complex <b>14</b> on the interaction of Mcl-1 with Bax and Bak. (A) K562 cells were treated with complex <b>14</b> (0, 1, 2, or 4 μM) for 4 h. The immunoprecipitates were analyzed by western blot for Mcl-1, Bax, and Bak. (B) Total inputs were analyzed by western blot for Mcl-1, Bax, and Bak.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Western blot analysis of cytochrome <i>c</i> release and PARP cleavage in complex <b>14</b> (0, 1, 2, or 4 μM, 6 h)-treated NCI-H460 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Caspase-3/9 activity in NCI-H460 cells treated with complex <b>13</b> or <b>14</b> for 6 h. (A) Caspase-3 activation was assayed by flow cytometry. (B) Caspase-9 activation was assayed by flow cytometry. (C) Induction of apoptosis in NCI-H460 cells treated with complex <b>14</b> in either the absence or presence of the caspase inhibitor QVD-OPh. (D) NCI-H460 cells were treated with complex <b>14</b> for 4, 6, or 8 h and analyzed by flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute toxicity of complexes <b>13</b> and <b>14</b>. Kunming mice (<i>n</i> = 10, half male and half female) were grouped and treated intraperitoneally with either complex <b>13</b> or complex <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Safety profile of complexes <b>13</b> and <b>14</b> in a mouse model. (A) Body weight evaluation of Kunming mice (<i>n</i> = 6, half male and half female) that were treated intraperitoneally with vehicle, complex <b>13</b> (10 mg/kg, once a day), or complex <b>14</b> (10 mg/kg, once a day). (B) Weights of hearts, livers, and kidneys from treated Kunming mice at the end point. (C) H&E-stained sections (400×, scale bar: 100 μm) of hearts, livers, and kidneys from treated Kunming mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <i>In vivo</i> antitumor efficacy of complexes 13 and <b>14</b> in an NCI-H460 non-small-cell lung cancer xenograft mouse model. (A) Effects of intraperitoneally administered complex <b>13</b> and complex <b>14</b> on the growth of NCI-H460 tumors in mice. (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001. (B) Body weights of control and treated NCI-H460 xenograft model mice. (C) TGI rates of complexes <b>13</b> and <b>14</b>. (D) Tissue distribution of complexes <b>13</b> and <b>14</b> in the NCI-H460 xenograft mouse model. (E) H&E staining of tumor tissue from treated nude mice (200×, scale bar: 200 μm). (F) TUNEL staining of tumor tissue from treated nude mice (200×, scale bar: 200 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/medium/jm9b02047_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Kaplan–Meier survival analysis. (A) Tumor volumes of NCI-H460 xenograft mice treated with vehicle or complex <b>14</b> (5, 10, or 15 mg/kg, once a day). (B) Survival of complex <b>14</b> (5, 10, or 15 mg/kg, once a day)- <i>vs</i> vehicle-treated mice with NCI-H460 xenografts. (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02047/20200903/images/large/jm9b02047_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02047&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llambi, F.</span></span> <span> </span><span class="NLM_article-title">Cell death signaling</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a006080</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1101%2Fcshperspect.a006080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=26626938" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=a006080&author=D.+R.+Greenauthor=F.+Llambi&title=Cell+death+signaling&doi=10.1101%2Fcshperspect.a006080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006080%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DLlambi%26aufirst%3DF.%26atitle%3DCell%2520death%2520signaling%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2015%26volume%3D7%26spage%3Da006080%26doi%3D10.1101%2Fcshperspect.a006080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szlavik, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragno, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Toumelin-Braizat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanrion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moujalled, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csekei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paczal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radics, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proszenyak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studeny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lysiak-Auvity, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galbraith, L. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guasconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauquil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guigal-Stephan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geneste, O.</span></span> <span> </span><span class="NLM_article-title">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>538</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1038/nature19830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature19830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27760111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=538&publication_year=2016&pages=477-482&author=A.+Kotschyauthor=Z.+Szlavikauthor=J.+Murrayauthor=J.+Davidsonauthor=A.+L.+Maragnoauthor=G.+Le+Toumelin-Braizatauthor=M.+Chanrionauthor=G.+L.+Kellyauthor=J.-N.+Gongauthor=D.+M.+Moujalledauthor=A.+Brunoauthor=M.+Csekeiauthor=A.+Paczalauthor=Z.+B.+Szaboauthor=S.+Siposauthor=G.+Radicsauthor=A.+Proszenyakauthor=B.+Balintauthor=L.+Ondiauthor=G.+Blaskoauthor=A.+Robertsonauthor=A.+Surgenorauthor=P.+Dokurnoauthor=I.+Chenauthor=N.+Matassovaauthor=J.+Smithauthor=C.+Pedderauthor=C.+Grahamauthor=A.+Studenyauthor=G.+Lysiak-Auvityauthor=A.-M.+Girardauthor=F.+Grav%C3%A9author=D.+Segalauthor=C.+D.+Riffkinauthor=G.+Pomilioauthor=L.+C.+A.+Galbraithauthor=B.+J.+Aubreyauthor=M.+S.+Brennanauthor=M.+J.+Heroldauthor=C.+Changauthor=G.+Guasconiauthor=N.+Cauquilauthor=F.+Melchioreauthor=N.+Guigal-Stephanauthor=B.+Lockhartauthor=F.+Collandauthor=J.+A.+Hickmanauthor=A.+W.+Robertsauthor=D.+C.+S.+Huangauthor=A.+H.+Weiauthor=A.+Strasserauthor=G.+Lesseneauthor=O.+Geneste&title=The+MCL1+inhibitor+S63845+is+tolerable+and+effective+in+diverse+cancer+models&doi=10.1038%2Fnature19830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</span></div><div class="casAuthors">Kotschy Andras; Szlavik Zoltan; Csekei Marton; Paczal Attila; Szabo Zoltan B; Sipos Szabolcs; Radics Gabor; Proszenyak Agnes; Balint Balazs; Ondi Levente; Blasko Gabor; Murray James; Davidson James; Robertson Alan; Surgenor Allan; Dokurno Pawel; Chen Ijen; Matassova Natalia; Smith Julia; Pedder Christopher; Graham Christopher; Maragno Ana Leticia; Le Toumelin-Braizat Gaetane; Chanrion Maia; Bruno Alain; Studeny Aurelie; Lysiak-Auvity Gaelle; Girard Anne-Marie; Grave Fabienne; Guasconi Ghislaine; Cauquil Nicolas; Colland Frederic; Hickman John A; Geneste Olivier; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Kelly Gemma L; Gong Jia-Nan; Segal David; Riffkin Chris D; Galbraith Laura C A; Aubrey Brandon J; Brennan Margs S; Herold Marco J; Chang Catherine; Roberts Andrew W; Huang David C S; Strasser Andreas; Lessene Guillaume; Moujalled Donia M; Pomilio Giovanna; Wei Andrew H; Aubrey Brandon J; Roberts Andrew W; Melchiore Fabien; Guigal-Stephan Nolwen; Lockhart Brian; Roberts Andrew W; Wei Andrew H; Lessene Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">538</span>
        (<span class="NLM_cas:issue">7626</span>),
    <span class="NLM_cas:pages">477-482</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Avoidance of apoptosis is critical for the development and sustained growth of tumours.  The pro-survival protein myeloid cell leukemia 1 (MCL1) is overexpressed in many cancers, but the development of small molecules targeting this protein that are amenable for clinical testing has been challenging.  Here we describe S63845, a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1.  Our mechanistic studies demonstrate that S63845 potently kills MCL1-dependent cancer cells, including multiple myeloma, leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway.  In vivo, S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers.  Moreover, MCL1 inhibition, either alone or in combination with other anti-cancer drugs, proved effective against several solid cancer-derived cell lines.  These results point towards MCL1 as a target for the treatment of a wide range of tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7C_gQBh3bx0EgZCMqtRBifW6udTcc2ebX1nsrnZmuxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1aquw%253D%253D&md5=c435a7621b84063133e41e0cdbad3ac8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature19830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19830%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26aulast%3DSzlavik%26aufirst%3DZ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DJ.%26aulast%3DMaragno%26aufirst%3DA.%2BL.%26aulast%3DLe%2BToumelin-Braizat%26aufirst%3DG.%26aulast%3DChanrion%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DGong%26aufirst%3DJ.-N.%26aulast%3DMoujalled%26aufirst%3DD.%2BM.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DCsekei%26aufirst%3DM.%26aulast%3DPaczal%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DZ.%2BB.%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DRadics%26aufirst%3DG.%26aulast%3DProszenyak%26aufirst%3DA.%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DOndi%26aufirst%3DL.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPedder%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DC.%26aulast%3DStudeny%26aufirst%3DA.%26aulast%3DLysiak-Auvity%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DA.-M.%26aulast%3DGrav%25C3%25A9%26aufirst%3DF.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGalbraith%26aufirst%3DL.%2BC.%2BA.%26aulast%3DAubrey%26aufirst%3DB.%2BJ.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGuasconi%26aufirst%3DG.%26aulast%3DCauquil%26aufirst%3DN.%26aulast%3DMelchiore%26aufirst%3DF.%26aulast%3DGuigal-Stephan%26aufirst%3DN.%26aulast%3DLockhart%26aufirst%3DB.%26aulast%3DColland%26aufirst%3DF.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DGeneste%26aufirst%3DO.%26atitle%3DThe%2520MCL1%2520inhibitor%2520S63845%2520is%2520tolerable%2520and%2520effective%2520in%2520diverse%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D538%26spage%3D477%26epage%3D482%26doi%3D10.1038%2Fnature19830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis signaling pathways for anticancer therapy</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3389/fonc.2011.00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.3389%2Ffonc.2011.00023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=22655234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC38notFWgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=23&author=S.+Fulda&title=Targeting+apoptosis+signaling+pathways+for+anticancer+therapy&doi=10.3389%2Ffonc.2011.00023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis signaling pathways for anticancer therapy</span></div><div class="casAuthors">Fulda Simone</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment approaches for cancer, for example chemotherapy, radiotherapy, or immunotherapy, primarily act by inducing cell death in cancer cells.  Consequently, the inability to trigger cell death pathways or alternatively, evasion of cancer cells to the induction of cell death pathways can result in resistance of cancers to current treatment protocols.  Therefore, in order to overcome treatment resistance a better understanding of the underlying mechanisms that regulate cell death and survival pathways in cancers and in response to cancer therapy is necessary to develop molecular-targeted therapies.  This strategy should lead to more effective and individualized treatment strategies that selectively target deregulated signaling pathways in a tumor type- and patient-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGOjJJch7cs5SWdIdmEou5fW6udTcc2ebX1nsrnZmuxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38notFWgsw%253D%253D&md5=7314a863cc22f7fc8b88494e47b33d4b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2011.00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2011.00023%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTargeting%2520apoptosis%2520signaling%2520pathways%2520for%2520anticancer%2520therapy%26jtitle%3DFront.%2520Oncol.%26date%3D2011%26volume%3D1%26spage%3D23%26doi%3D10.3389%2Ffonc.2011.00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span></span> <span> </span><span class="NLM_article-title">Small molecules targeting Mcl-1: The search for a silver bullet in cancer therapy</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">778</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1039/c5md00582e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC5MD00582E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=778-787&author=D.+Nhuauthor=G.+Lesseneauthor=D.+C.+S.+Huangauthor=C.+J.+Burns&title=Small+molecules+targeting+Mcl-1%3A+The+search+for+a+silver+bullet+in+cancer+therapy&doi=10.1039%2Fc5md00582e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC5MD00582E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00582E%26sid%3Dliteratum%253Aachs%26aulast%3DNhu%26aufirst%3DD.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DSmall%2520molecules%2520targeting%2520Mcl-1%253A%2520The%2520search%2520for%2520a%2520silver%2520bullet%2520in%2520cancer%2520therapy%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D778%26epage%3D787%26doi%3D10.1039%2Fc5md00582e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span> <span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0lia14xbZwfEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span> <span> </span><span class="NLM_article-title">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1987</span>, <span class="refDoi"> DOI: 10.1111/bph.12431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1111%2Fbph.12431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=24117105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1973-1987&author=M.+J.+Royauthor=A.+Vomauthor=P.+E.+Czabotarauthor=G.+Lessene&title=Cell+death+and+the+mitochondria%3A+therapeutic+targeting+of+the+BCL-2+family-driven+pathway&doi=10.1111%2Fbph.12431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway</span></div><div class="casAuthors">Roy, M. J.; Vom, A.; Czabotar, P. E.; Lessene, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1973-1987</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The principal biol. role of mitochondria is to supply energy to cells; although intriguingly, evolution has bestowed another essential function upon these cellular organelles: under physiol. stress, mitochondria become the cornerstone of apoptotic cell death.  Specifically, mitochondrial outer membrane permeabilization (MOMP) allows cell death factors such as cytochrome c to be released into the cytoplasm, thus inducing caspase activation and the eventual destruction of essential cellular components.  Proteins of the B-cell lymphoma 2 (BCL-2) family control the tightly regulated pathway that causes MOMP.  The equil. between pro-survival and pro-apoptotic members of the BCL-2 family dictates the fate of cells, the homeostasis of organs and, by extension, the health of whole organisms.  Dysregulation of this equil. is involved in a large no. of diseases such as cancer, autoimmunity and neurodegenerative conditions.  Modulating the activity of the BCL-2 family of proteins with small mols. or peptides is an attractive but challenging therapeutic goal.  This review highlights the latest developments in this field and provides evidence that this strategy is likely to have a pos. effect on the treatment of still poorly addressed medical conditions.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6jmhqr3darVg90H21EOLACvtfcHk0lgIkTzOUKMqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqurg%253D&md5=001a31bfa87a2f4864bd8606a9e61ab4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fbph.12431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12431%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DM.%2BJ.%26aulast%3DVom%26aufirst%3DA.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DCell%2520death%2520and%2520the%2520mitochondria%253A%2520therapeutic%2520targeting%2520of%2520the%2520BCL-2%2520family-driven%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1973%26epage%3D1987%26doi%3D10.1111%2Fbph.12431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbridge, A. R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">3939</span>– <span class="NLM_lpage">3946</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-09-601567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1182%2Fblood-2014-09-601567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25368374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFegsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3939-3946&author=S.+Grabowauthor=A.+R.+D.+Delbridgeauthor=L.+J.+Valenteauthor=A.+Strasser&title=MCL-1+but+not+BCL-XL+is+critical+for+the+development+and+sustained+expansion+of+thymic+lymphoma+in+p53-deficient+mice&doi=10.1182%2Fblood-2014-09-601567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice</span></div><div class="casAuthors">Grabow, Stephanie; Delbridge, Alex R. D.; Valente, Liz J.; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3939-3946</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Apoptosis plays a role in normal lymphopoiesis and lymphoid malignancies.  Pro-survival MCL-1 is essential for survival of T-cell progenitors, BCL-XL for immature thymocytes, and BCL-2 for mature T cells.  Conversely, little is known about the regulators that are required for the survival of T-cell lymphomas.  We used constitutive and conditionally gene-targeted mice to investigate which pro-survival BCL-2 family member is required for the sustained survival of thymic lymphomas initiated by loss of p53.  Constitutive loss of a single Mcl-1 allele delayed tumor onset.  In contrast, lymphomas emerging in p53-/- mice in which Mcl-1 could be conditionally deleted had been selected for retention of MCL-1 expression.  In contrast, complete loss of BCL-XL had no impact on lymphoma development in p53-/- mice.  These results demonstrate that thymic lymphomas elicited by loss of p53 must arise from cancer-initiating cells that require MCL-1 for their survival.  Acute deletion of both Mcl-1 alleles abrogated the expansion of p53-/- lymphomas in mice, whereas inducible loss of BCL-XL had little impact.  This reveals that MCL-1 is essential for the sustained survival of these malignant cells and suggests that targeting MCL-1 may be an attractive strategy for the treatment of T-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7j4ji48usKLVg90H21EOLACvtfcHk0lgIkTzOUKMqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFegsg%253D%253D&md5=3d3071861e23771bf38a760308dfd886</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-09-601567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-09-601567%26sid%3Dliteratum%253Aachs%26aulast%3DGrabow%26aufirst%3DS.%26aulast%3DDelbridge%26aufirst%3DA.%2BR.%2BD.%26aulast%3DValente%26aufirst%3DL.%2BJ.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DMCL-1%2520but%2520not%2520BCL-XL%2520is%2520critical%2520for%2520the%2520development%2520and%2520sustained%2520expansion%2520of%2520thymic%2520lymphoma%2520in%2520p53-deficient%2520mice%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26spage%3D3939%26epage%3D3946%26doi%3D10.1182%2Fblood-2014-09-601567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spinner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispatzu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkhbaatar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höckendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pechloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikenwalder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansmann, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newrzela, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span> <span> </span><span class="NLM_article-title">Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1530</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fleu.2016.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27055871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1ejsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1520-1530&author=S.+Spinnerauthor=G.+Crispatzuauthor=J.-H.+Yiauthor=E.+Munkhbaatarauthor=P.+Mayerauthor=U.+H%C3%B6ckendorfauthor=N.+M%C3%BCllerauthor=Z.+Liauthor=T.+Schaderauthor=H.+Bendzauthor=S.+Hartmannauthor=M.+Yabalauthor=K.+Pechloffauthor=M.+Heikenwalderauthor=G.+L.+Kellyauthor=A.+Strasserauthor=C.+Peschelauthor=M.-L.+Hansmannauthor=J.+Rulandauthor=U.+Kellerauthor=S.+Newrzelaauthor=M.+Herlingauthor=P.+J.+Jost&title=Re-activation+of+mitochondrial+apoptosis+inhibits+T-cell+lymphoma+survival+and+treatment+resistance&doi=10.1038%2Fleu.2016.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance</span></div><div class="casAuthors">Spinner, S.; Crispatzu, G.; Yi, J.-H.; Munkhbaatar, E.; Mayer, P.; Hoeckendorf, U.; Mueller, N.; Li, Z.; Schader, T.; Bendz, H.; Hartmann, S.; Yabal, M.; Pechloff, K.; Heikenwalder, M.; Kelly, G. L.; Strasser, A.; Peschel, C.; Hansmann, M.-L.; Ruland, J.; Keller, U.; Newrzela, S.; Herling, M.; Jost, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1520-1530</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">T lymphocyte non-Hodgkin's lymphoma (T-NHL) represents an aggressive and largely therapy-resistant subtype of lymphoid malignancies.  As deregulated apoptosis is a frequent hallmark of lymphomagenesis, we analyzed gene expression profiles and protein levels of primary human T-NHL samples for various apoptotic regulators.  We identified the apoptotic regulator MCL-1 as the only pro-survival BCL-2 family member to be highly expressed throughout all human T-NHL subtypes.  Functional validation of pro-survival protein members of the BCL-2 family in two independent T-NHL mouse models identified that the partial loss of Mcl-1 significantly delayed T-NHL development in vivo.  Moreover, the inducible redn. of MCL-1 protein levels in lymphoma-burdened mice severely impaired the continued survival of T-NHL cells, increased their susceptibility to chemotherapeutics and delayed lymphoma progression.  Lymphoma viability remained unaffected by the genetic deletion or pharmacol. inhibition of all alternative BCL-2 family members.  Consistent with a therapeutic window for MCL-1 treatment within the context of the whole organism, we obsd. an only minimal toxicity after systemic heterozygous loss of Mcl-1 in vivo.  We conclude that re-activation of mitochondrial apoptosis by blockade of MCL-1 represents a promising therapeutic strategy to treat T-cell lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSXD7w8Hwu1rVg90H21EOLACvtfcHk0ljGnNhfxCmDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1ejsLY%253D&md5=632c69921952fc9f222b2d72eb2fe6b6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.49%26sid%3Dliteratum%253Aachs%26aulast%3DSpinner%26aufirst%3DS.%26aulast%3DCrispatzu%26aufirst%3DG.%26aulast%3DYi%26aufirst%3DJ.-H.%26aulast%3DMunkhbaatar%26aufirst%3DE.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DH%25C3%25B6ckendorf%26aufirst%3DU.%26aulast%3DM%25C3%25BCller%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DBendz%26aufirst%3DH.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DYabal%26aufirst%3DM.%26aulast%3DPechloff%26aufirst%3DK.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DG.%2BL.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DHansmann%26aufirst%3DM.-L.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DNewrzela%26aufirst%3DS.%26aulast%3DHerling%26aufirst%3DM.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26atitle%3DRe-activation%2520of%2520mitochondrial%2520apoptosis%2520inhibits%2520T-cell%2520lymphoma%2520survival%2520and%2520treatment%2520resistance%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D1520%26epage%3D1530%26doi%3D10.1038%2Fleu.2016.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trounson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappaport, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span> <span> </span><span class="NLM_article-title">Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1101/gad.182980.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1101%2Fgad.182980.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=22279045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFOjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=120-125&author=S.+P.+Glaserauthor=E.+F.+Leeauthor=E.+Trounsonauthor=P.+Bouilletauthor=A.+Weiauthor=W.+D.+Fairlieauthor=D.+J.+Izonauthor=J.+Zuberauthor=A.+R.+Rappaportauthor=M.+J.+Heroldauthor=W.+S.+Alexanderauthor=S.+W.+Loweauthor=L.+Robbauthor=A.+Strasser&title=Anti-apoptotic+Mcl-1+is+essential+for+the+development+and+sustained+growth+of+acute+myeloid+leukemia&doi=10.1101%2Fgad.182980.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia</span></div><div class="casAuthors">Glaser, Stefan P.; Lee, Erinna F.; Trounson, Evelyn; Bouillet, Philippe; Wei, Andrew; Fairlie, W. Douglas; Izon, David J.; Zuber, Johannes; Rappaport, Amy R.; Herold, Marco J.; Alexander, Warren S.; Lowe, Scott W.; Robb, Lorraine; Strasser, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-125</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Acute myeloid leukemia (AML) frequently relapses after initial treatment.  Drug resistance in AML has been attributed to high levels of the anti-apoptotic Bcl-2 family members Bcl-xL and Mcl-1.  Here we report that removal of Mcl-1, but not loss or pharmacol. blockade of Bcl-xL, Bcl-2, or Bcl-w, caused the death of transformed AML and could cure disease in AML-afflicted mice.  Enforced expression of selective inhibitors of prosurvival Bcl-2 family members revealed that Mcl-1 is crit. for survival of human AML cells.  Thus, targeting of Mcl-1 or regulators of its expression may be a useful strategy for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6z2Lgi2YuK7Vg90H21EOLACvtfcHk0ljGnNhfxCmDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFOjs78%253D&md5=5f0cc61da50fddb262d30e243a7e6837</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.182980.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.182980.111%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DTrounson%26aufirst%3DE.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DIzon%26aufirst%3DD.%2BJ.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DRappaport%26aufirst%3DA.%2BR.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DW.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DRobb%26aufirst%3DL.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DAnti-apoptotic%2520Mcl-1%2520is%2520essential%2520for%2520the%2520development%2520and%2520sustained%2520growth%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D120%26epage%3D125%26doi%3D10.1101%2Fgad.182980.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffkin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span> <span> </span><span class="NLM_article-title">Hierarchy for targeting pro-survival BCL2 family proteins in multiple myeloma: pivotal role of MCL1</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1834</span>– <span class="NLM_lpage">1844</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-03-704908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1182%2Fblood-2016-03-704908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27465916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCjtr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=1834-1844&author=J.-N.+Gongauthor=T.+Khongauthor=D.+Segalauthor=Y.+Yaoauthor=C.+D.+Riffkinauthor=J.-M.+Garnierauthor=S.+L.+Khawauthor=G.+Lesseneauthor=A.+Spencerauthor=M.+J.+Heroldauthor=A.+W.+Robertsauthor=D.+C.+S.+Huang&title=Hierarchy+for+targeting+pro-survival+BCL2+family+proteins+in+multiple+myeloma%3A+pivotal+role+of+MCL1&doi=10.1182%2Fblood-2016-03-704908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1</span></div><div class="casAuthors">Gong, Jia-Nan; Khong, Tiffany; Segal, David; Yao, Yuan; Riffkin, Chris D.; Garnier, Jean-Marc; Lin, Khaw Seong; Lessene, Guillaume; Spencer, Andrew; Herold, Marco J.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1834-1844</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">New therapeutic targets are needed to address the poor prognosis of patients with high-risk multiple myeloma.  Myeloma cells usually express a range of the prosurvival BCL2 proteins.  To define the hierarchy of their relative importance for maintaining the survival of myeloma cells, we targeted each of them in a large panel of cell lines, using pharmacol. inhibitors or gene editing or by peptide-based approaches, alone or in combination.  The majority of well-established immortalized cell lines (17/25) or low-passage myeloma cell lines (5/7) are readily killed when MCL1 is targeted, even including those cell lines sensitive to BCL2 inhibition.  Targeting MCL1 also constrained the growth of myeloma in vivo.  We also identified a previously unrecognized subset of myeloma that is highly BCLXL-dependent, and has the potential for cotargeting MCL1 and BCLXL.  As MCL1 is pivotal for maintaining survival of most myelomas, it should be prioritized for targeting in the clinic once high-quality, validated inhibitors become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu0tJVIusFMrVg90H21EOLACvtfcHk0lisYwdeUsHwOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCjtr%252FF&md5=b84e7e664e0bc34e4507803935c20551</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-03-704908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-03-704908%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DJ.-N.%26aulast%3DKhong%26aufirst%3DT.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DRiffkin%26aufirst%3DC.%2BD.%26aulast%3DGarnier%26aufirst%3DJ.-M.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DSpencer%26aufirst%3DA.%26aulast%3DHerold%26aufirst%3DM.%2BJ.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26atitle%3DHierarchy%2520for%2520targeting%2520pro-survival%2520BCL2%2520family%2520proteins%2520in%2520multiple%2520myeloma%253A%2520pivotal%2520role%2520of%2520MCL1%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D1834%26epage%3D1844%26doi%3D10.1182%2Fblood-2016-03-704908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, R. S.</span></span> <span> </span><span class="NLM_article-title">Bcl-2 family proteins in breast development and cancer: Could Mcl-1 targeting overcome therapeutic resistance?</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3519</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.18632%2Foncotarget.2792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25784482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnls1ShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3519-3530&author=M.+M.+Williamsauthor=R.+S.+Cook&title=Bcl-2+family+proteins+in+breast+development+and+cancer%3A+Could+Mcl-1+targeting+overcome+therapeutic+resistance%3F&doi=10.18632%2Foncotarget.2792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?</span></div><div class="casAuthors">Williams Michelle M; Cook Rebecca S; Cook Rebecca S</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3519-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Apoptosis, cell death executed by caspases, is essential to normal breast development and homeostasis.  Pro-apoptotic and anti-apoptotic signals are tightly regulated in normal breast epithelial cells.  Dysregulation of this balance is required for breast tumorigenesis and increases acquired resistance to treatments, including molecularly targeted therapies, radiation and chemotherapies.  The pro-apoptotic or anti-apoptotic Bcl-2 family members interact with each other to maintain mitochondrial integrity and regulate cellular commitment to apoptosis.  Among the anti-apoptotic Bcl-2 family members, Mcl-1 is uniquely regulated by numerous oncogenic signaling pathways.  This review will focus on the role of Bcl-2 family proteins in normal breast development, breast tumorigenesis and acquired resistance to breast cancer treatment strategies, while highlighting Mcl-1 as a promising target to improve breast cancer tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvDoMDseirLH6HPRus0rAafW6udTcc2eaJESGp15WHcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnls1ShsQ%253D%253D&md5=22e6af0dd2e25832cedc3dffac2e5a84</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2792%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%2BM.%26aulast%3DCook%26aufirst%3DR.%2BS.%26atitle%3DBcl-2%2520family%2520proteins%2520in%2520breast%2520development%2520and%2520cancer%253A%2520Could%2520Mcl-1%2520targeting%2520overcome%2520therapeutic%2520resistance%253F%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D3519%26epage%3D3530%26doi%3D10.18632%2Foncotarget.2792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barretina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mc Henry, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinchback, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligon, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prensner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liefeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yecies, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demichelis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nucera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonescu, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">True, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span> <span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1038/nature08822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+Mc+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.-J.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.-S.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers&doi=10.1038%2Fnature08822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0liOdYv5tiZk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DMc%2BHenry%26aufirst%3DK.%2BT.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.-J.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905%26doi%3D10.1038%2Fnature08822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helgason, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminker, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueber, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>471</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nature09779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature09779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=21368834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1Cku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=110-114&author=I.+E.+Wertzauthor=S.+Kusamauthor=C.+Lamauthor=T.+Okamotoauthor=W.+Sandovalauthor=D.+J.+Andersonauthor=E.+Helgasonauthor=J.+A.+Ernstauthor=M.+Ebyauthor=J.+Liuauthor=L.+D.+Belmontauthor=J.+S.+Kaminkerauthor=K.+M.+O%E2%80%99Rourkeauthor=K.+Pujaraauthor=P.+B.+Kohliauthor=A.+R.+Johnsonauthor=M.+L.+Chiuauthor=J.+R.+Lillauthor=P.+K.+Jacksonauthor=W.+J.+Fairbrotherauthor=S.+Seshagiriauthor=M.+J.+C.+Ludlamauthor=K.+G.+Leongauthor=E.+C.+Dueberauthor=H.+Maeckerauthor=D.+C.+S.+Huangauthor=V.+M.+Dixit&title=Sensitivity+to+antitubulin+chemotherapeutics+is+regulated+by+MCL1+and+FBW7&doi=10.1038%2Fnature09779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7</span></div><div class="casAuthors">Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Okamoto, Toru; Sandoval, Wendy; Anderson, Daniel J.; Helgason, Elizabeth; Ernst, James A.; Eby, Mike; Liu, Jinfeng; Belmont, Lisa D.; Kaminker, Josh S.; O'Rourke, Karen M.; Pujara, Kanan; Kohli, Pawan Bir; Johnson, Adam R.; Chiu, Mark L.; Lill, Jennie R.; Jackson, Peter K.; Fairbrother, Wayne J.; Seshagiri, Somasekar; Ludlam, Mary J. C.; Leong, Kevin G.; Dueber, Erin C.; Maecker, Heather; Huang, David C. S.; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7336</span>),
    <span class="NLM_cas:pages">110-114</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules have pivotal roles in fundamental cellular processes and are targets of antitubulin chemotherapeutics.  Microtubule-targeted agents such as Taxol and vincristine are prescribed widely for various malignancies, including ovarian and breast adenocarcinomas, non-small-cell lung cancer, leukemias and lymphomas.  These agents arrest cells in mitosis and subsequently induce cell death through poorly defined mechanisms.  The strategies that resistant tumor cells use to evade death induced by antitubulin agents are also unclear.  Here we show that the pro-survival protein MCL1 is a crucial regulator of apoptosis triggered by antitubulin chemotherapeutics.  During mitotic arrest, MCL1 protein levels decline markedly, through a post-translational mechanism, potentiating cell death.  Phosphorylation of MCL1 directs its interaction with the tumor-suppressor protein FBW7, which is the substrate-binding component of a ubiquitin ligase complex.  The polyubiquitylation of MCL1 then targets it for proteasomal degrdn.  The degrdn. of MCL1 was blocked in patient-derived tumor cells that lacked FBW7 or had loss-of-function mutations in FBW7, conferring resistance to antitubulin agents and promoting chemotherapeutic-induced polyploidy.  Addnl., primary tumor samples were enriched for FBW7 inactivation and elevated MCL1 levels, underscoring the prominent roles of these proteins in oncogenesis.  Our findings suggest that profiling the FBW7 and MCL1 status of tumors, in terms of protein levels, mRNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFiH1HCl46H7Vg90H21EOLACvtfcHk0ljHj5sfss2q-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1Cku7g%253D&md5=9b06764b31a4b2e4597c76e9138b0a34</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09779%26sid%3Dliteratum%253Aachs%26aulast%3DWertz%26aufirst%3DI.%2BE.%26aulast%3DKusam%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DSandoval%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DHelgason%26aufirst%3DE.%26aulast%3DErnst%26aufirst%3DJ.%2BA.%26aulast%3DEby%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBelmont%26aufirst%3DL.%2BD.%26aulast%3DKaminker%26aufirst%3DJ.%2BS.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BM.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DChiu%26aufirst%3DM.%2BL.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DLeong%26aufirst%3DK.%2BG.%26aulast%3DDueber%26aufirst%3DE.%2BC.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DSensitivity%2520to%2520antitubulin%2520chemotherapeutics%2520is%2520regulated%2520by%2520MCL1%2520and%2520FBW7%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D110%26epage%3D114%26doi%3D10.1038%2Fnature09779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Z.</span></span> <span> </span><span class="NLM_article-title">Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting MCL-1 gene in pancreatic carcinoma cell</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1064</span>, <span class="refDoi"> DOI: 10.1007/s00280-008-0697-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1007%2Fs00280-008-0697-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18297287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaju7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1055-1064&author=S.-H.+Weiauthor=K.+Dongauthor=F.+Linauthor=X.+Wangauthor=B.+Liauthor=J.-j.+Shenauthor=Q.+Zhangauthor=R.+Wangauthor=H.-Z.+Zhang&title=Inducing+apoptosis+and+enhancing+chemosensitivity+to+gemcitabine+via+RNA+interference+targeting+MCL-1+gene+in+pancreatic+carcinoma+cell&doi=10.1007%2Fs00280-008-0697-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell</span></div><div class="casAuthors">Wei, San-Hua; Dong, Ke; Lin, Fang; Wang, Xi; Li, Bin; Shen, Jian-jun; Zhang, Qing; Wang, Rui; Zhang, Hui-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1055-1064</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Resistance to chemotherapy is a major cause of treatment failure and poor prognosis in pancreatic carcinoma.  Myeloid cell leukemia-1 (Mcl-1) is highly up-regulated in pancreatic carcinoma and is assocd. with the anti-apoptosis and the resistance to chemotherapy drugs.  Suppression of Mcl-1 would be an approach to induce apoptosis and enhance the chemosensitivity.  Methods: In this study, three pancreatic cancer cell lines (PANC-1, BxPC-3 and SW1900) stably expressing shRNAs targeting Mcl-1 gene were established and gene expression inhibition was assessed by Real-Time QPCR and Western blotting.  The effects of Mcl-1 downregulation mediated by RNAi were explored in vitro and in vivo.  Results: We showed that the specific downregulation of Mcl-1 strikingly inhibited cell growth, colony formation, cell cycle arrest and induced apoptosis in pancreatic cancer cells in vitro, and markedly decreased the tumorigenicity in a mouse xenograft model.  Moreover, knockdown of Mcl-1 significantly increased the chemosensitivity to Gemcitabine in pancreatic carcinoma cells.  Conclusions: Our data suggests that the specific downregulation of Mcl-1 by RNAi is a promising approach to induce apoptosis and enhance the chemosensitivity for pancreatic carcinoma gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqCKHcBd_GybVg90H21EOLACvtfcHk0ljHj5sfss2q-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaju7%252FI&md5=0048e8f6955dedf442aa0328ba6ebfcb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00280-008-0697-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-008-0697-7%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.-H.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DJ.-j.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.-Z.%26atitle%3DInducing%2520apoptosis%2520and%2520enhancing%2520chemosensitivity%2520to%2520gemcitabine%2520via%2520RNA%2520interference%2520targeting%2520MCL-1%2520gene%2520in%2520pancreatic%2520carcinoma%2520cell%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D62%26spage%3D1055%26epage%3D1064%26doi%3D10.1007%2Fs00280-008-0697-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricci, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span> <span> </span><span class="NLM_article-title">MCL-1: a gateway to TRAIL sensitization</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2062</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-07-6278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1158%2F0008-5472.CAN-07-6278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18381408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2062-2064&author=S.-H.+Kimauthor=M.+S.+Ricciauthor=W.+S.+El-Deiry&title=MCL-1%3A+a+gateway+to+TRAIL+sensitization&doi=10.1158%2F0008-5472.can-07-6278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mcl-1: A Gateway to TRAIL Sensitization</span></div><div class="casAuthors">Kim, Seok-Hyun; Ricci, M. Stacey; El-Deiry, Wafik S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2062-2064</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The proapoptotic cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is being evaluated presently as a selective anticancer agent, but its limited effects against cancer cell lines has raised some concerns about its ultimate clin. utility.  Here, we review recent findings that cancer cell sensitivity to TRAIL is greatly increased when the Bcl-2 family protein Mcl-1 is down-regulated by the Raf/vascular endothelial growth factor kinase inhibitor sorafenib, a Food and Drug Administration-approved cancer drug.  Using the TRAIL-sorafenib combination as a tactic to more effectively kill cancer cells may provide an effective tool to attack a variety of human cancers that are largely presently untreatable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyxFXqGsPbibVg90H21EOLACvtfcHk0ljtfFqAFg70Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb4%253D&md5=3beede491d2bb0dc671fcf36060ee341</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6278%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DRicci%26aufirst%3DM.%2BS.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26atitle%3DMCL-1%253A%2520a%2520gateway%2520to%2520TRAIL%2520sensitization%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2062%26epage%3D2064%26doi%3D10.1158%2F0008-5472.can-07-6278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan-Lappe, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarthy, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span> <span> </span><span class="NLM_article-title">Influence of BCL-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-06-2203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1158%2F0008-5472.CAN-06-2203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=17283153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.-C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+BCL-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737&doi=10.1158%2F0008-5472.can-06-2203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737</span></div><div class="casAuthors">Tahir, Stephen K.; Yang, Xiufen; Anderson, Mark G.; Morgan-Lappe, Susan E.; Sarthy, Aparna V.; Chen, Jun; Warner, Robert B.; Ng, Shi-Chung; Fesik, Stephen W.; Elmore, Steve W.; Rosenberg, Saul H.; Tse, Christin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1176-1183</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-737 is a novel and potent Bcl-2 antagonist with single-agent activity against small-cell lung cancer (SCLC) cell lines.  Here, we evaluated the contribution of Bcl-2 family members to the in vitro cellular response of several SCLC cell lines to ABT-737.  Relatively higher levels of Bcl-2, Bcl-XL, Bim and Noxa, and lower levels of Mcl-1 characterized naive SCLC cell lines that were sensitive to ABT-737.  Conversely, a progressive decrease in the relative levels of Bcl-2 and Noxa and a progressive increase in Mcl-1 levels characterized the increased resistance of H146 cells following chronic exposure to ABT-737.  Knockdown of Mcl-1 with small interfering RNA sensitized 2 resistant SCLC cell lines H196 and DMS114 to ABT-737 by enhancing the induction of apoptosis.  Likewise, up-regulation of Noxa sensitized H196 cells to ABT-737.  Combination treatment with DNA-damaging agents was extremely synergistic with ABT-737 and was assocd. with the down-regulation of Mcl-1 and the up-regulation of Noxa, Puma, and Bim in H196 cells.  Thus, SCLC cells sensitive to ABT-737 expressed the target proteins Bcl-2 and Bcl-XL, whereas Mcl-1 and factors regulating Mcl-1 function seem to contribute to the overall resistance of SCLC cells to ABT-737.  Overall, these observations provide further insight as to the mechanistic bases for ABT-737 efficacy in SCLC and will be helpful for profiling patients and aiding in the rational design of combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVmNPxcT2cAbVg90H21EOLACvtfcHk0liSykmB8ryq1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb8%253D&md5=f621db8247defb237e1b4772e8bcaa20</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2203%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.-C.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520BCL-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183%26doi%3D10.1158%2F0008-5472.can-06-2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christov, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerasamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogarty, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis Millin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhraja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opferman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arteaga, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savona, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia-1 (Mcl-1) inhibitors that demonstrate in vivo activity in mouse xenograft models of human cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3971</span>– <span class="NLM_lpage">3988</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01991</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01991" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtlWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3971-3988&author=T.+Leeauthor=P.+P.+Christovauthor=S.+Shawauthor=J.+C.+Tarrauthor=B.+Zhaoauthor=N.+Veerasamyauthor=K.+O.+Jeonauthor=J.+J.+Millsauthor=Z.+Bianauthor=J.+L.+Sensintaffarauthor=A.+L.+Arnoldauthor=S.+A.+Fogartyauthor=E.+Perryauthor=H.+E.+Ramseyauthor=R.+S.+Cookauthor=M.+Hollingsheadauthor=M.+Davis+Millinauthor=K.-m.+Leeauthor=B.+Kossauthor=A.+Budhrajaauthor=J.+T.+Opfermanauthor=K.+Kimauthor=C.+L.+Arteagaauthor=W.+J.+Mooreauthor=E.+T.+Olejniczakauthor=M.+R.+Savonaauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia-1+%28Mcl-1%29+inhibitors+that+demonstrate+in+vivo+activity+in+mouse+xenograft+models+of+human+cancer&doi=10.1021%2Facs.jmedchem.8b01991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer</span></div><div class="casAuthors">Lee, Taekyu; Christov, Plamen P.; Shaw, Subrata; Tarr, James C.; Zhao, Bin; Veerasamy, Nagarathanam; Jeon, Kyu Ok; Mills, Jonathan J.; Bian, Zhiguo; Sensintaffar, John L.; Arnold, Allison L.; Fogarty, Stuart A.; Perry, Evan; Ramsey, Haley E.; Cook, Rebecca S.; Hollingshead, Melinda; Davis Millin, Myrtle; Lee, Kyung-min; Koss, Brian; Budhraja, Amit; Opferman, Joseph T.; Kim, Kwangho; Arteaga, Carlos L.; Moore, William J.; Olejniczak, Edward T.; Savona, Michael R.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3971-3988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of myeloid cell leukemia-1 (Mcl-1) in cancers correlates with high tumor grade and poor survival.  Addnl., Mcl-1 drives intrinsic and acquired resistance to many cancer therapeutics, including B cell lymphoma 2 family inhibitors, proteasome inhibitors, and antitubulins.  Therefore, Mcl-1 inhibition could serve as a strategy to target cancers that require Mcl-1 to evade apoptosis.  Herein, we describe the use of structure-based design to discover a novel compd. (42) that robustly and specifically inhibits Mcl-1 in cell culture and animal xenograft models.  Compd. 42 binds to Mcl-1 with picomolar affinity and inhibited growth of Mcl-1-dependent tumor cell lines in the nanomolar range.  Compd. 42 also inhibited the growth of hematol. and triple neg. breast cancer xenografts at well-tolerated doses.  These findings highlight the use of structure-based design to identify small mol. Mcl-1 inhibitors and support the use of 42 as a potential treatment strategy to block Mcl-1 activity and induce apoptosis in Mcl-1-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzJLMFWtbKl7Vg90H21EOLACvtfcHk0liSykmB8ryq1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtlWitb0%253D&md5=a3e80ec8c20cc39a71c78beb85d2ec90</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01991%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DChristov%26aufirst%3DP.%2BP.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVeerasamy%26aufirst%3DN.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DMills%26aufirst%3DJ.%2BJ.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DFogarty%26aufirst%3DS.%2BA.%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DH.%2BE.%26aulast%3DCook%26aufirst%3DR.%2BS.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DDavis%2BMillin%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.-m.%26aulast%3DKoss%26aufirst%3DB.%26aulast%3DBudhraja%26aufirst%3DA.%26aulast%3DOpferman%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DSavona%26aufirst%3DM.%2BR.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia-1%2520%2528Mcl-1%2529%2520inhibitors%2520that%2520demonstrate%2520in%2520vivo%2520activity%2520in%2520mouse%2520xenograft%2520models%2520of%2520human%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3971%26epage%3D3988%26doi%3D10.1021%2Facs.jmedchem.8b01991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerasamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogarty, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Optimization of potent and selective tricyclic indole diazepinone myeloid cell leukemia-1 inhibitors using structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01155</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01155" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2410-2421&author=S.+Shawauthor=Z.+Bianauthor=B.+Zhaoauthor=J.+C.+Tarrauthor=N.+Veerasamyauthor=K.+O.+Jeonauthor=J.+Belmarauthor=A.+L.+Arnoldauthor=S.+A.+Fogartyauthor=E.+Perryauthor=J.+L.+Sensintaffarauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Optimization+of+potent+and+selective+tricyclic+indole+diazepinone+myeloid+cell+leukemia-1+inhibitors+using+structure-based+design&doi=10.1021%2Facs.jmedchem.7b01155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design</span></div><div class="casAuthors">Shaw, Subrata; Bian, Zhiguo; Zhao, Bin; Tarr, James C.; Veerasamy, Nagarathanam; Jeon, Kyu Ok; Belmar, Johannes; Arnold, Allison L.; Fogarty, Stuart A.; Perry, Evan; Sensintaffar, John L.; Camper, DeMarco V.; Rossanese, Olivia W.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2410-2421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family of proteins, has emerged as an attractive target for cancer therapy.  Mcl-1 upregulation is often found in many human cancers and is assocd. with high tumor grade, poor survival, and resistance to chemotherapy.  Here, we describe a series of potent and selective tricyclic indole diazepinone Mcl-1 inhibitors that were discovered and further optimized using structure-based design.  These compds. exhibit picomolar binding affinity and mechanism-based cellular efficacy, including growth inhibition and caspase induction in Mcl-1-sensitive cells.  Thus, they represent useful compds. to study the implication of Mcl-1 inhibition in cancer and serve as potentially useful starting points toward the discovery of anti-Mcl-1 therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6DFBno6H-LVg90H21EOLACvtfcHk0ljqHu_eAp66cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVyktA%253D%253D&md5=719511e2b52849e2bff5cf1de6d6c2be</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01155%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DVeerasamy%26aufirst%3DN.%26aulast%3DJeon%26aufirst%3DK.%2BO.%26aulast%3DBelmar%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DFogarty%26aufirst%3DS.%2BA.%26aulast%3DPerry%26aufirst%3DE.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOptimization%2520of%2520potent%2520and%2520selective%2520tricyclic%2520indole%2520diazepinone%2520myeloid%2520cell%2520leukemia-1%2520inhibitors%2520using%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2410%26epage%3D2421%26doi%3D10.1021%2Facs.jmedchem.7b01155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd1343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnrd1343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=15060526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein-protein+interactions%3A+progressing+towards+the+dream&doi=10.1038%2Fnrd1343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span></div><div class="casAuthors">Arkin, Michelle R.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions have a key role in most biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is difficult, owing to issues such as the lack of well-defined binding pockets.  Nevertheless, there was important progress in this endeavor in recent years.  Here, the authors use illustrative examples to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MiFDdLJu27Vg90H21EOLACvtfcHk0ljqHu_eAp66cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D&md5=3e102c6207be420b4232056b4acdea12</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1343%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317%26doi%3D10.1038%2Fnrd1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelz, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2054</span>– <span class="NLM_lpage">2066</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01660</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01660" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVygsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2054-2066&author=N.+F.+Pelzauthor=Z.+Bianauthor=B.+Zhaoauthor=S.+Shawauthor=J.+C.+Tarrauthor=J.+Belmarauthor=C.+Greggauthor=D.+V.+Camperauthor=C.+M.+Goodwinauthor=A.+L.+Arnoldauthor=J.+L.+Sensintaffarauthor=A.+Fribergauthor=O.+W.+Rossaneseauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+2-indole-acylsulfonamide+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods&doi=10.1021%2Facs.jmedchem.5b01660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods</span></div><div class="casAuthors">Pelz, Nicholas F.; Bian, Zhiguo; Zhao, Bin; Shaw, Subrata; Tarr, James C.; Belmar, Johannes; Gregg, Claire; Camper, DeMarco V.; Goodwin, Craig M.; Arnold, Allison L.; Sensintaffar, John L.; Friberg, Anders; Rossanese, Olivia W.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2054-2066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia-1 (Mcl-1) is a member of the Bcl-2 family of proteins responsible for the regulation of programmed cell death.  Amplification of Mcl-1 is a common genetic aberration in human cancer whose overexpression contributes to the evasion of apoptosis and is one of the major resistance mechanisms for many chemotherapies.  Mcl-1 mediates its effects primarily through interactions with pro-apoptotic BH3 contg. proteins that achieve high affinity for the target by utilizing four hydrophobic pockets in its binding groove.  Here we describe the discovery of Mcl-1 inhibitors using fragment-based methods and structure-based design.  These novel inhibitors exhibit low nanomolar binding affinities to Mcl-1 and >500-fold selectivity over Bcl-xL.  X-ray structures of lead Mcl-1 inhibitors when complexed to Mcl-1 provided detailed information on how these small-mols. bind to the target and were used extensively to guide compd. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2AYHv7Eaw57Vg90H21EOLACvtfcHk0ljqHu_eAp66cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVygsbs%253D&md5=e667fa5bc866d29ad02d6d52c679f47a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01660%26sid%3Dliteratum%253Aachs%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DBian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DBelmar%26aufirst%3DJ.%26aulast%3DGregg%26aufirst%3DC.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DGoodwin%26aufirst%3DC.%2BM.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%25202-indole-acylsulfonamide%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2054%26epage%3D2066%26doi%3D10.1021%2Facs.jmedchem.5b01660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2180</span>– <span class="NLM_lpage">2194</span>, <span class="refDoi"> DOI: 10.1021/jm501258m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501258m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2180-2194&author=M.+Brunckoauthor=L.+Wangauthor=G.+S.+Sheppardauthor=D.+C.+Phillipsauthor=S.+K.+Tahirauthor=J.+Xueauthor=S.+Ericksonauthor=S.+Fidanzeauthor=E.+Fryauthor=L.+Hasvoldauthor=G.+J.+Jenkinsauthor=S.+Jinauthor=R.+A.+Judgeauthor=P.+J.+Kovarauthor=D.+Madarauthor=P.+Nimmerauthor=C.+Parkauthor=A.+M.+Petrosauthor=S.+H.+Rosenbergauthor=M.+L.+Smithauthor=X.+Songauthor=C.+Sunauthor=Z.-F.+Taoauthor=X.+Wangauthor=Y.+Xiaoauthor=H.+Zhangauthor=C.+Tseauthor=J.+D.+Leversonauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Structure-guided+design+of+a+series+of+MCL-1+inhibitors+with+high+affinity+and+selectivity&doi=10.1021%2Fjm501258m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity</span></div><div class="casAuthors">Bruncko, Milan; Wang, Le; Sheppard, George S.; Phillips, Darren C.; Tahir, Stephen K.; Xue, John; Erickson, Scott; Fidanze, Steve; Fry, Elizabeth; Hasvold, Lisa; Jenkins, Gary J.; Jin, Sha; Judge, Russell A.; Kovar, Peter J.; Madar, David; Nimmer, Paul; Park, Chang; Petros, Andrew M.; Rosenberg, Saul H.; Smith, Morey L.; Song, Xiaohong; Sun, Chaohong; Tao, Zhi-Fu; Wang, Xilu; Xiao, Yu; Zhang, Haichao; Tse, Chris; Leverson, Joel D.; Elmore, Steven W.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2180-2194</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (MCL-1) is a BCL-2 family protein that has been implicated in the progression and survival of multiple tumor types.  Herein the authors report a series of MCL-1 inhibitors that emanated from a high throughput screening (HTS) hit and progressed via iterative cycles of structure-guided design.  Advanced compds. from this series exhibited subnanomolar affinity for MCL-1 and excellent selectivity over other BCL-2 family proteins as well as multiple kinases and GPCRs.  In a MCL-1 dependent human tumor cell line, administration of compd. I rapidly induced caspase activation with assocd. loss in cell viability.  The small mols. described herein thus comprise effective tools for studying MCL-1 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohu29VX9mE0bVg90H21EOLACvtfcHk0li8EoW4oZs6fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGjt70%253D&md5=e8c575a04fecaf47e4a9fc5c8348e034</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501258m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501258m%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DErickson%26aufirst%3DS.%26aulast%3DFidanze%26aufirst%3DS.%26aulast%3DFry%26aufirst%3DE.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DJenkins%26aufirst%3DG.%2BJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520series%2520of%2520MCL-1%2520inhibitors%2520with%2520high%2520affinity%2520and%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2180%26epage%3D2194%26doi%3D10.1021%2Fjm501258m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1590</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fcddis.2014.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25590800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=J.+D.+Leversonauthor=H.+Zhangauthor=J.+Chenauthor=S.+K.+Tahirauthor=D.+C.+Phillipsauthor=J.+Xueauthor=P.+Nimmerauthor=S.+Jinauthor=M.+Smithauthor=Y.+Xiaoauthor=P.+Kovarauthor=A.+Tanakaauthor=M.+Brunckoauthor=G.+S.+Sheppardauthor=L.+Wangauthor=S.+Gierkeauthor=L.+Kategayaauthor=D.+J.+Andersonauthor=C.+Wongauthor=J.+Eastham-Andersonauthor=M.+J.+C.+Ludlamauthor=D.+Sampathauthor=W.+J.+Fairbrotherauthor=I.+Wertzauthor=S.+H.+Rosenbergauthor=C.+Tseauthor=S.+W.+Elmoreauthor=A.+J.+Souers&title=Potent+and+selective+small-molecule+MCL-1+inhibitors+demonstrate+on-target+cancer+cell+killing+activity+as+single+agents+and+in+combination+with+ABT-263+%28navitoclax%29&doi=10.1038%2Fcddis.2014.561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)</span></div><div class="casAuthors">Leverson, J. D.; Zhang, H.; Chen, J.; Tahir, S. K.; Phillips, D. C.; Xue, J.; Nimmer, P.; Jin, S.; Smith, M.; Xiao, Y.; Kovar, P.; Tanaka, A.; Bruncko, M.; Sheppard, G. S.; Wang, L.; Gierke, S.; Kategaya, L.; Anderson, D. J.; Wong, C.; Eastham-Anderson, J.; Ludlam, M. J. C.; Sampath, D.; Fairbrother, W. J.; Wertz, I.; Rosenberg, S. H.; Tse, C.; Elmore, S. W.; Souers, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1590</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The anti-apoptotic protein MCL-1 is a key regulator of cancer cell survival and a known resistance factor for small-mol. BCL-2 family inhibitors such as ABT-263 (navitoclax), making it an attractive therapeutic target.  However, directly inhibiting this target requires the disruption of high-affinity protein-protein interactions, and therefore designing small mols. potent enough to inhibit MCL-1 in cells has proven extremely challenging.  Here, we describe a series of indole-2-carboxylic acids, exemplified by the compd. A-1210477, that bind to MCL-1 selectively and with sufficient affinity to disrupt MCL-1-BIM complexes in living cells.  A-1210477 induces the hallmarks of intrinsic apoptosis and demonstrates single agent killing of multiple myeloma and non-small cell lung cancer cell lines demonstrated to be MCL-1 dependent by BH3 profiling or siRNA rescue expts.  As predicted, A-1210477 synergizes with the BCL-2/BCL-XL inhibitor navitoclax to kill a variety of cancer cell lines.  This work represents the first description of small-mol. MCL-1 inhibitors with sufficient potency to induce clear on-target cellular activity.  It also demonstrates the utility of these mols. as chem. tools for dissecting the basic biol. of MCL-1 and the promise of small-mol. MCL-1 inhibitors as potential therapeutics for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprNysoaS5QY7Vg90H21EOLACvtfcHk0li8EoW4oZs6fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGrurg%253D&md5=8ceb779fc6868fc0828757364d529e34</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.561%26sid%3Dliteratum%253Aachs%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGierke%26aufirst%3DS.%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DWertz%26aufirst%3DI.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small-molecule%2520MCL-1%2520inhibitors%2520demonstrate%2520on-target%2520cancer%2520cell%2520killing%2520activity%2520as%2520single%2520agents%2520and%2520in%2520combination%2520with%2520ABT-263%2520%2528navitoclax%2529%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2014.561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tron, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam Hendricks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secrist, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">5341</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07551-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fs41467-018-07551-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=30559424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5341&author=A.+E.+Tronauthor=M.+A.+Belmonteauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+H.+Boiseauthor=E.+Chiarparinauthor=J.+Cidadoauthor=K.+J.+Embreyauthor=E.+Ganglauthor=F.+D.+Gibbonsauthor=G.+P.+Gregoryauthor=D.+Hargreavesauthor=J.+Adam+Hendricksauthor=J.+W.+Johannesauthor=R.+W.+Johnstoneauthor=S.+L.+Kazmirskiauthor=J.+G.+Kettleauthor=M.+L.+Lambauthor=S.+M.+Matulisauthor=A.+K.+Nookaauthor=M.+J.+Packerauthor=B.+Pengauthor=P.+B.+Rawlinsauthor=D.+W.+Robbinsauthor=A.+G.+Schullerauthor=N.+Suauthor=W.+Yangauthor=Q.+Yeauthor=X.+Zhengauthor=J.+P.+Secristauthor=E.+A.+Clarkauthor=D.+M.+Wilsonauthor=S.+E.+Fawellauthor=A.+W.+Hird&title=Discovery+of+Mcl-1-specific+inhibitor+AZD5991+and+preclinical+activity+in+multiple+myeloma+and+acute+myeloid+leukemia&doi=10.1038%2Fs41467-018-07551-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia</span></div><div class="casAuthors">Tron, Adriana E.; Belmonte, Matthew A.; Adam, Ammar; Aquila, Brian M.; Boise, Lawrence H.; Chiarparin, Elisabetta; Cidado, Justin; Embrey, Kevin J.; Gangl, Eric; Gibbons, Francis D.; Gregory, Gareth P.; Hargreaves, David; Hendricks, J. Adam; Johannes, Jeffrey W.; Johnstone, Ricky W.; Kazmirski, Steven L.; Kettle, Jason G.; Lamb, Michelle L.; Matulis, Shannon M.; Nooka, Ajay K.; Packer, Martin J.; Peng, Bo; Rawlins, Philip B.; Robbins, Daniel W.; Schuller, Alwin G.; Su, Nancy; Yang, Wenzhan; Ye, Qing; Zheng, Xiaolan; Secrist, J. Paul; Clark, Edwin A.; Wilson, David M.; Fawell, Stephen E.; Hird, Alexander W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5341</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers.  High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 inhibitors as anticancer drugs.  Here, we describe AZD5991, a rationally designed macrocyclic mol. with high selectivity and affinity for Mcl-1 currently in clin. development.  Our studies demonstrate that AZD5991 binds directly to Mcl-1 and induces rapid apoptosis in cancer cells, most notably myeloma and acute myeloid leukemia, by activating the Bak-dependent mitochondrial apoptotic pathway.  AZD5991 shows potent antitumor activity in vivo with complete tumor regression in several models of multiple myeloma and acute myeloid leukemia after a single tolerated dose as monotherapy or in combination with bortezomib or venetoclax.  Based on these promising data, a Phase I clin. trial has been launched for evaluation of AZD5991 in patients with hematol. malignancies (NCT03218683).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLv1vdwF2TY7Vg90H21EOLACvtfcHk0liAhqSs_6StBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersLjK&md5=10ccf1fda947aca212bede3927eaabfa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07551-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07551-w%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DA.%2BE.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DCidado%26aufirst%3DJ.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DG.%2BP.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DAdam%2BHendricks%26aufirst%3DJ.%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DKazmirski%26aufirst%3DS.%2BL.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMatulis%26aufirst%3DS.%2BM.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobbins%26aufirst%3DD.%2BW.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DClark%26aufirst%3DE.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DHird%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520Mcl-1-specific%2520inhibitor%2520AZD5991%2520and%2520preclinical%2520activity%2520in%2520multiple%2520myeloma%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D5341%26doi%3D10.1038%2Fs41467-018-07551-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. H.</span></span> <span> </span><span class="NLM_article-title">Molecular medicine and neurodegenerative diseases</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6668</span>– <span class="NLM_lpage">6671</span>, <span class="refDoi"> DOI: 10.1039/c4cs90065k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC4CS90065K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25105517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6668-6671&author=C.+J.+Changauthor=B.+F.+Cravattauthor=D.+S.+Johnsonauthor=M.+H.+Lim&title=Molecular+medicine+and+neurodegenerative+diseases&doi=10.1039%2Fc4cs90065k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular medicine and neurodegenerative diseases</span></div><div class="casAuthors">Chang, Christopher J.; Cravatt, Benjamin F.; Johnson, Douglas S.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6668-6671</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews on mol. medicine and neurodegenerative diseases, several areas within the neurodegenerative field are explored, including mechanistic/structural studies of neurodegenerative processes, pathol. relevant biol. pathways/factors, as well as the development of chem. tools, diagnostic/imaging agents, and potential therapeutic agents.  The article discusses the use of metal complexes for inhibiting Aβ aggregation formation and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Yqbx9EHw2LVg90H21EOLACvtfcHk0liAhqSs_6StBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt7nL&md5=2f7b204cfd572a5f6eea222c66418548</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC4CS90065K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS90065K%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DMolecular%2520medicine%2520and%2520neurodegenerative%2520diseases%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6668%26epage%3D6671%26doi%3D10.1039%2Fc4cs90065k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehninger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spreckelmeyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Can, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alborzinia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span> <span> </span><span class="NLM_article-title">Rhodium(I) N-heterocyclic carbene bioorganometallics as in-vitro antiproliferative agents with distinct effects on cellular signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9591</span>– <span class="NLM_lpage">9600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFSmtL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9591-9600&author=L.+Oehningerauthor=S.+Spreckelmeyerauthor=P.+Holenyaauthor=S.+M.+Meierauthor=S.+Canauthor=H.+Alborziniaauthor=J.+Schurauthor=B.+K.+Kepplerauthor=S.+W%C3%B6lflauthor=I.+Ott&title=Rhodium%28I%29+N-heterocyclic+carbene+bioorganometallics+as+in-vitro+antiproliferative+agents+with+distinct+effects+on+cellular+signaling&doi=10.1021%2Facs.jmedchem.5b01159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling</span></div><div class="casAuthors">Oehninger, Luciano; Spreckelmeyer, Sarah; Holenya, Pavlo; Meier, Samuel M.; Can, Suzan; Alborzinia, Hamed; Schur, Julia; Keppler, Bernhard K.; Woelfl, Stefan; Ott, Ingo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9591-9600</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallics with N-heterocyclic carbene (NHC) ligands have triggered major interest in inorg. medicinal chem.  Complexes of the type Rh(I)(NHC)(COD)X (X = Cl, I; COD = cyclooctadiene; NHC = dimethylbenzimidazolylidene) represent a promising type of new metallodrugs that have been explored by advanced biomedical methods only recently.  In this work, the authors have synthesized and characterized several complexes of this type.  As obsd. by mass spectrometry, these complexes remained stable over at least 3 h in aq. soln., after which hydrolysis of the halido ligands occurred and release of the NHC ligand was evident.  Effects against mitochondria and general cell tumor metab. were noted at higher concns., whereas phosphorylation of HSP27, p38, ERK1/2, FAK, and p70S6K was induced substantially already at lower exposure levels.  Regarding the antiproliferative activity in tumor cells, a clear preference for iodido over chlorido secondary ligands was noted, as well as effects of the substituents of the NHC ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqFzee2Mpc_rVg90H21EOLACvtfcHk0ljSqEjsx0m_yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFSmtL7F&md5=95998efe4a6a20c535397e675723274d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01159%26sid%3Dliteratum%253Aachs%26aulast%3DOehninger%26aufirst%3DL.%26aulast%3DSpreckelmeyer%26aufirst%3DS.%26aulast%3DHolenya%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DS.%2BM.%26aulast%3DCan%26aufirst%3DS.%26aulast%3DAlborzinia%26aufirst%3DH.%26aulast%3DSchur%26aufirst%3DJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DW%25C3%25B6lfl%26aufirst%3DS.%26aulast%3DOtt%26aufirst%3DI.%26atitle%3DRhodium%2528I%2529%2520N-heterocyclic%2520carbene%2520bioorganometallics%2520as%2520in-vitro%2520antiproliferative%2520agents%2520with%2520distinct%2520effects%2520on%2520cellular%2520signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9591%26epage%3D9600%26doi%3D10.1021%2Facs.jmedchem.5b01159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13965</span>– <span class="NLM_lpage">13975</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.18632%2Foncotarget.7369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=26883110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtlWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13965-13975&author=L.-J.+Liuauthor=B.+Heauthor=J.+A.+Milesauthor=W.+Wangauthor=Z.+Maoauthor=W.+I.+Cheauthor=J.-J.+Luauthor=X.-P.+Chenauthor=A.+J.+Wilsonauthor=D.-L.+Maauthor=C.-H.+Leung&title=Inhibition+of+the+p53%2FhDM2+protein-protein+interaction+by+cyclometallated+iridium%28III%29+compounds&doi=10.18632%2Foncotarget.7369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds</span></div><div class="casAuthors">Liu Li-Juan; Che Weng Ian; Lu Jin-Jian; Chen Xiu-Ping; Leung Chung-Hang; He Bingyong; Wang Wanhe; Mao Zhifeng; Ma Dik-Lung; Miles Jennifer A; Wilson Andrew J; Miles Jennifer A; Wilson Andrew J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">13965-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inactivation of the p53 transcription factor by mutation or other mechanisms is a frequent event in tumorigenesis.  One of the major endogenous negative regulators of p53 in humans is hDM2, a ubiquitin E3 ligase that binds to p53 causing proteasomal p53 degradation.  In this work, a library of organometallic iridium(III) compounds were synthesized and evaluated for their ability to disrupt the p53/hDM2 protein-protein interaction.  The novel cyclometallated iridium(III) compound 1 [Ir(eppy)2(dcphen)](PF6) (where eppy = 2-(4-ethylphenyl)pyridine and dcphen = 4, 7-dichloro-1, 10-phenanthroline) blocked the interaction of p53/hDM2 in human amelanotic melanoma cells.  Finally, 1 exhibited anti-proliferative activity and induced apoptosis in cancer cell lines consistent with inhibition of the p53/hDM2 interaction.  Compound 1 represents the first reported organometallic p53/hDM2 protein-protein interaction inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcjS03BbQ78YJKJbLTgsvCfW6udTcc2eYmeIkGkWBF8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtlWjsw%253D%253D&md5=3cfd840ffe2f65e039a200efbb70608a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7369%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DMiles%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DChe%26aufirst%3DW.%2BI.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DInhibition%2520of%2520the%2520p53%252FhDM2%2520protein-protein%2520interaction%2520by%2520cyclometallated%2520iridium%2528III%2529%2520compounds%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D13965%26epage%3D13975%26doi%3D10.18632%2Foncotarget.7369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David Wang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">5400</span>– <span class="NLM_lpage">5408</span>, <span class="refDoi"> DOI: 10.1039/c5sc02321a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC5SC02321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=28757943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=5400-5408&author=H.-J.+Zhongauthor=L.+Luauthor=K.-H.+Leungauthor=C.+C.+L.+Wongauthor=C.+Pengauthor=S.-C.+Yanauthor=D.-L.+Maauthor=Z.+Caiauthor=H.-M.+David+Wangauthor=C.-H.+Leung&title=An+iridium%28III%29-based+irreversible+protein-protein+interaction+inhibitor+of+BRD4+as+a+potent+anticancer+agent&doi=10.1039%2Fc5sc02321a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span></div><div class="casAuthors">Zhong, Hai-Jing; Lu, Lihua; Leung, Ka-Ho; Wong, Catherine C. L.; Peng, Chao; Yan, Siu-Cheong; Ma, Dik-Lung; Cai, Zongwei; David Wang, Hui-Min; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5400-5408</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy.  In this study, an iridium(III) complex is reported as the first metal-based, irreversible inhibitor of BRD4.  Complex 1a is able to antagonize the BRD4-acetylated histone protein-protein interaction (PPI) in vitro, and to bind BRD4 and down-regulate c-myc oncogenic expression in cellulo.  Chromatin immunopptn. (ChIP) anal. revealed that 1a could modulate the interaction between BRD4 and chromatin in melanoma cells, particular at the MYC promoter.  Finally, the complex showed potent activity against melanoma xenografts in an in vivo mouse model.  To our knowledge, this is the first report of a Group 9 metal complex inhibiting the PPI of a member of the bromodomain and extraterminal domain (BET) family.  We envision that complex 1a may serve as a useful scaffold for the development of more potent epigenetic agents against cancers such as melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMXspNfXFlbVg90H21EOLACvtfcHk0ljSqEjsx0m_yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E&md5=ae176cbfd3621dd7939c234d643db84e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC5SC02321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC02321A%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DK.-H.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DS.-C.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DDavid%2BWang%26aufirst%3DH.-M.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DAn%2520iridium%2528III%2529-based%2520irreversible%2520protein-protein%2520interaction%2520inhibitor%2520of%2520BRD4%2520as%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D5400%26epage%3D5408%26doi%3D10.1039%2Fc5sc02321a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span> <span> </span><span class="NLM_article-title">A metal-based Tumour Necrosis Factor-Alpha converting enzyme inhibitor</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3973</span>– <span class="NLM_lpage">3976</span>, <span class="refDoi"> DOI: 10.1039/c4cc09251a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1039%2FC4CC09251A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25610924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVSmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=3973-3976&author=C.-H.+Leungauthor=L.-J.+Liuauthor=L.+Luauthor=B.+Heauthor=D.+W.+J.+Kwongauthor=C.-Y.+Wongauthor=D.-L.+Ma&title=A+metal-based+Tumour+Necrosis+Factor-Alpha+converting+enzyme+inhibitor&doi=10.1039%2Fc4cc09251a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A metal-based tumour necrosis factor-alpha converting enzyme inhibitor</span></div><div class="casAuthors">Leung, Chung-Hang; Liu, Li-Juan; Lu, Lihua; He, Bingyong; Kwong, Daniel W. J.; Wong, Chun-Yuen; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3973-3976</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report herein a novel iridium(III) complex as an anti-TNF-α agent and the first metal-based inhibitor of TACE enzymic activity.  The complex inhibited TNF-α secretion and p38 phosphorylation in human monocytic THP-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9MYGAwPt2bVg90H21EOLACvtfcHk0lgw-0kRMIdl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVSmsw%253D%253D&md5=61b79255befd9fa2080cb2b1beddea51</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4CC09251A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09251A%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.-H.%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DWong%26aufirst%3DC.-Y.%26aulast%3DMa%26aufirst%3DD.-L.%26atitle%3DA%2520metal-based%2520Tumour%2520Necrosis%2520Factor-Alpha%2520converting%2520enzyme%2520inhibitor%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D3973%26epage%3D3976%26doi%3D10.1039%2Fc4cc09251a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">An iridium (III) complex inhibits JMJD2 activities and acts as a potential epigenetic modulator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6697</span>– <span class="NLM_lpage">6703</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KitL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6697-6703&author=L.-J.+Liuauthor=L.+Luauthor=H.-J.+Zhongauthor=B.+Heauthor=D.+W.+J.+Kwongauthor=D.-L.+Maauthor=C.-H.+Leung&title=An+iridium+%28III%29+complex+inhibits+JMJD2+activities+and+acts+as+a+potential+epigenetic+modulator&doi=10.1021%2Facs.jmedchem.5b00375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator</span></div><div class="casAuthors">Liu, Li-Juan; Lu, Lihua; Zhong, Hai-Jing; He, Bingyong; Kwong, Daniel W. J.; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6697-6703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel iridium(III) complex was synthesized and evaluated for its ability to target JMJD2 enzymic activity.  The iridium(III) complex can inhibit JMJD2 activity and was selective for JMJD2 activity over JARID, JMJD3, and HDAC activities.  Moreover, it suppressed the trimethylation of the p21 promoter on H3K9me3 and interrupted the JMJD2D-H3K9me3 interactions in human cells, suggesting that it could act as an epigenetic modulator.  To our knowledge, this complex represents the first metal-based JMJD2 inhibitor reported in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsrA54CBHkgbVg90H21EOLACvtfcHk0lgw-0kRMIdl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KitL7L&md5=047f66cc1c1b063b4a20f3abcf50a151</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00375%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.-J.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DAn%2520iridium%2520%2528III%2529%2520complex%2520inhibits%2520JMJD2%2520activities%2520and%2520acts%2520as%2520a%2520potential%2520epigenetic%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6697%26epage%3D6703%26doi%3D10.1021%2Facs.jmedchem.5b00375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">A rhodium (III)-based inhibitor of autotaxin with antiproliferative activity</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.bbagen.2016.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27888146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOisLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=256-263&author=T.-S.+Kangauthor=W.+Wangauthor=H.-J.+Zhongauthor=J.-X.+Liangauthor=C.-N.+Koauthor=J.-J.+Luauthor=X.-P.+Chenauthor=D.-L.+Maauthor=C.-H.+Leung&title=A+rhodium+%28III%29-based+inhibitor+of+autotaxin+with+antiproliferative+activity&doi=10.1016%2Fj.bbagen.2016.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity</span></div><div class="casAuthors">Kang, Tian-Shu; Wang, Wanhe; Zhong, Hai-Jing; Liang, Jia-Xin; Ko, Chung-Nga; Lu, Jin-Jian; Chen, Xiu-Ping; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-263</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer of the skin is by far the most common of all cancers.  Melanoma accounts for only about 1% of skin cancers but causes a large majority of skin cancer deaths.  Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), regulates physiol. and pathol. functions of lysophosphatidic acid (LPA), and is thus an important therapeutic target.  The authors synthesized ten metal-based complexes and a novel cyclometalated rhodium(III) complex I was identified as an ATX enzymic inhibitor using multiple methods, including ATX enzymic assay, thermal shift assay, western immunoblotting and so on.  Protein thermal shift assays showed that I increased the melting temp. (Tm) of ATX by 3.5°.  I also reduced ATX-LPA mediated downstream survival signal pathway proteins such as ERK and AKT, and inhibited the activation of the transcription factor nuclear factor κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3).  I also exhibited strong antiproliferative activity against A2058 melanoma cells (IC50 = 0.58 μM).  Structure-activity relationship indicated that both the rhodium(III) center and the auxiliary ligands of complex I are important for bioactivity.  1 Represents a promising scaffold for the development of small-mol. ATX inhibitors for antitumor applications.  To the knowledge, complex I is the first metal-based ATX inhibitor reported to date.  Rhodium complexes will have the increased attention in therapeutic and bioanal. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8K2YuTAocLVg90H21EOLACvtfcHk0lgw-0kRMIdl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOisLvP&md5=0acbda56c782955d9dd28c3b383a2166</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DT.-S.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DH.-J.%26aulast%3DLiang%26aufirst%3DJ.-X.%26aulast%3DKo%26aufirst%3DC.-N.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DA%2520rhodium%2520%2528III%2529-based%2520inhibitor%2520of%2520autotaxin%2520with%2520antiproliferative%2520activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D256%26epage%3D263%26doi%3D10.1016%2Fj.bbagen.2016.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellaisamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C.-H.</span></span> <span> </span><span class="NLM_article-title">A rhodium(III)-based inhibitor of lysine-specific histone demethylase 1 as an epigenetic modulator in prostate cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2603</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00133</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00133" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVajtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2597-2603&author=C.+Yangauthor=W.+Wangauthor=J.-X.+Liangauthor=G.+Liauthor=K.+Vellaisamyauthor=C.-Y.+Wongauthor=D.-L.+Maauthor=C.-H.+Leung&title=A+rhodium%28III%29-based+inhibitor+of+lysine-specific+histone+demethylase+1+as+an+epigenetic+modulator+in+prostate+cancer+cells&doi=10.1021%2Facs.jmedchem.7b00133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells</span></div><div class="casAuthors">Yang, Chao; Wang, Wanhe; Liang, Jia-Xin; Li, Guodong; Vellaisamy, Kasipandi; Wong, Chun-Yuen; Ma, Dik-Lung; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2597-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report herein a novel rhodium(III) complex 1 (I) as a new LSD1 targeting agent and epigenetic modulator.  Complex 1 disrupted the interaction of LSD1-H3K4me2 in human prostate carcinoma cells, and enhanced the amplification of p21, FOXA2 and BMP2 gene promoters.  Complex 1 was selective for LSD1 over other histone demethylases, such as KDM2b, KDM7 and MAO activities, and also showed anti-proliferative activity towards human cancer cells.  To date, complex 1 is the first metal-based inhibitor of LSD1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobbBaU5SOfBrVg90H21EOLACvtfcHk0lgVWAnjPS_Ccg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVajtr8%253D&md5=6c9c9729423cf36a645c0f77ccf186b9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00133%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DJ.-X.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DVellaisamy%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DC.-Y.%26aulast%3DMa%26aufirst%3DD.-L.%26aulast%3DLeung%26aufirst%3DC.-H.%26atitle%3DA%2520rhodium%2528III%2529-based%2520inhibitor%2520of%2520lysine-specific%2520histone%2520demethylase%25201%2520as%2520an%2520epigenetic%2520modulator%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2597%26epage%3D2603%26doi%3D10.1021%2Facs.jmedchem.7b00133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span> <span> </span><span class="NLM_article-title">Advances in copper complexes as anticancer agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">815</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/cr400135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2013&pages=815-862&author=C.+Santiniauthor=M.+Pelleiauthor=V.+Gandinauthor=M.+Porchiaauthor=F.+Tisatoauthor=C.+Marzano&title=Advances+in+copper+complexes+as+anticancer+agents&doi=10.1021%2Fcr400135x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr400135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400135x%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DPellei%26aufirst%3DM.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DPorchia%26aufirst%3DM.%26aulast%3DTisato%26aufirst%3DF.%26aulast%3DMarzano%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520copper%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D114%26spage%3D815%26epage%3D862%26doi%3D10.1021%2Fcr400135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrott, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistrik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gursky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozdian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moudry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaclavkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrobel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouckova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlacek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miklovicova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span> <span> </span><span class="NLM_article-title">Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1038/nature25016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnature25016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=29211715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=194-199&author=Z.+Skrottauthor=M.+Mistrikauthor=K.+K.+Andersenauthor=S.+Friisauthor=D.+Majeraauthor=J.+Gurskyauthor=T.+Ozdianauthor=J.+Bartkovaauthor=Z.+Turiauthor=P.+Moudryauthor=M.+Krausauthor=M.+Michalovaauthor=J.+Vaclavkovaauthor=P.+Dzubakauthor=I.+Vrobelauthor=P.+Pouckovaauthor=J.+Sedlacekauthor=A.+Miklovicovaauthor=A.+Kuttauthor=J.+Liauthor=J.+Mattovaauthor=C.+Driessenauthor=Q.+P.+Douauthor=J.+Olsenauthor=M.+Hajduchauthor=B.+Cvekauthor=R.+J.+Deshaiesauthor=J.+Bartek&title=Alcohol-abuse+drug+disulfiram+targets+cancer+via+p97+segregase+adaptor+NPL4&doi=10.1038%2Fnature25016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4</span></div><div class="casAuthors">Skrott, Zdenek; Mistrik, Martin; Andersen, Klaus Kaae; Friis, Soeren; Majera, Dusana; Gursky, Jan; Ozdian, Tomas; Bartkova, Jirina; Turi, Zsofia; Moudry, Pavel; Kraus, Marianne; Michalova, Martina; Vaclavkova, Jana; Dzubak, Petr; Vrobel, Ivo; Pouckova, Pavla; Sedlacek, Jindrich; Miklovicova, Andrea; Kutt, Anne; Li, Jing; Mattova, Jana; Driessen, Christoph; Dou, Q. Ping; Olsen, Joergen; Hajduch, Marian; Cvek, Boris; Deshaies, Raymond J.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">194-199</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Cancer incidence is rising and this global challenge is further exacerbated by tumor resistance to available medicines.  A promising approach to meet the need for improved cancer treatment is drug repurposing.  Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alc.-aversion drug that has been shown to be effective against diverse cancer types in preclin. studies.  Our nationwide epidemiol. study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis.  Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumors and candidate biomarkers to analyze its effect on cells and tissues.  Finally, our functional and biophys. analyses reveal the mol. target of disulfiram's tumor-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_sAn4LKB57Vg90H21EOLACvtfcHk0lgVWAnjPS_Ccg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbrN&md5=b53235723e8478ab49b7d569d0dd35ac</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature25016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25016%26sid%3Dliteratum%253Aachs%26aulast%3DSkrott%26aufirst%3DZ.%26aulast%3DMistrik%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DK.%2BK.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DMajera%26aufirst%3DD.%26aulast%3DGursky%26aufirst%3DJ.%26aulast%3DOzdian%26aufirst%3DT.%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DTuri%26aufirst%3DZ.%26aulast%3DMoudry%26aufirst%3DP.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DMichalova%26aufirst%3DM.%26aulast%3DVaclavkova%26aufirst%3DJ.%26aulast%3DDzubak%26aufirst%3DP.%26aulast%3DVrobel%26aufirst%3DI.%26aulast%3DPouckova%26aufirst%3DP.%26aulast%3DSedlacek%26aufirst%3DJ.%26aulast%3DMiklovicova%26aufirst%3DA.%26aulast%3DKutt%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMattova%26aufirst%3DJ.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DOlsen%26aufirst%3DJ.%26aulast%3DHajduch%26aufirst%3DM.%26aulast%3DCvek%26aufirst%3DB.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DAlcohol-abuse%2520drug%2520disulfiram%2520targets%2520cancer%2520via%2520p97%2520segregase%2520adaptor%2520NPL4%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D194%26epage%3D199%26doi%3D10.1038%2Fnature25016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">Recent insights into synthetic β-carbolines with anti-cancer activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.05.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.ejmech.2017.05.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=28583770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=48-73&author=S.+Kumarauthor=A.+Singhauthor=K.+Kumarauthor=V.+Kumar&title=Recent+insights+into+synthetic+%CE%B2-carbolines+with+anti-cancer+activities&doi=10.1016%2Fj.ejmech.2017.05.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into synthetic β-carbolines with anti-cancer activities</span></div><div class="casAuthors">Kumar, Sumit; Singh, Amandeep; Kumar, Kewal; Kumar, Vipan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-73</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cancer, an uncontrolled and rapid proliferation of abnormal cells, has become one of the leading cause of death worldwide.  The development of resistance among the numerous drugs in clin. use has provided strong impetus for the identification and development of novel cancer therapeutics.  β-Carbolines constitute an important class of pharmacol. active scaffolds known to exert their anticancer activities via diverse mechanisms.  The purpose of present review article is to update the readers on the current developments in β-carbolines with an emphasis on synthetic strategies, structure-activity relationships, mechanism of action and in vivo studies wherever possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrii8G14_qYYbVg90H21EOLACvtfcHk0lh7QaPUUKgD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVCisLk%253D&md5=b0be525833f91e39834efae7b8ff5466</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.05.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DRecent%2520insights%2520into%2520synthetic%2520%25CE%25B2-carbolines%2520with%2520anti-cancer%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D142%26spage%3D48%26epage%3D73%26doi%3D10.1016%2Fj.ejmech.2017.05.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1016%2Fj.ejmech.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=15725494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=249-257&author=R.+Caoauthor=W.+Pengauthor=H.+Chenauthor=X.+Houauthor=H.+Guanauthor=Q.+Chenauthor=Y.+Maauthor=A.+Xu&title=Synthesis+and+in+vitro+cytotoxic+evaluation+of+1%2C3-bisubstituted+and+1%2C3%2C9-trisubstituted+beta-carboline+derivatives&doi=10.1016%2Fj.ejmech.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro cytotoxic evaluation of 1,3-disubstituted and 1,3,9-trisubstituted β-carboline derivatives</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Chen, Hongsheng; Hou, Xuerui; Guan, Huaji; Chen, Qi; Ma, Yan; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel 1,3-disubstituted and 1,3,9-trisubstituted β-carbolines was synthesized from L-tryptophan.  Cytotoxic activities of these compds. were investigated in vitro.  The results showed that 1,3,9-trisubstituted β-carbolines had higher cytotoxic activities in vitro than the corresponding 1,3-disubstituted compds.  The 1,3,9-trisubstituted β-carbolines with a Me substituent at position 1 displayed more potent cytotoxic activities, I being the most potent compds. of this series with IC50 4 uM against BGC-823 cell lines.  These data suggested that (1) the cytotoxic potencies of β-carbolines were enhanced by the introduction of appropriate substituents into position 1 and position 9 in β-carboline; (2) the β-carboline structure might be an important basis for the design and synthesis of new antitumor drugs; (3) the Me substituent at position 1, the pentafluorobenzyl group at position 9 and the ethoxycarbonyl substituent at position 3 were the optimal combination for the improvement of cytotoxic activity of the β-carboline derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_WNRnc760LVg90H21EOLACvtfcHk0lh7QaPUUKgD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12itL0%253D&md5=255bcb5cd796c56df5ef90176b6b5141</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxic%2520evaluation%2520of%25201%252C3-bisubstituted%2520and%25201%252C3%252C9-trisubstituted%2520beta-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D249%26epage%3D257%26doi%3D10.1016%2Fj.ejmech.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+the+most+important+efficiency+metric+in+medicinal+chemistry&doi=10.4155%2Ffmc.12.208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0lh7QaPUUKgD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520the%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D113%26epage%3D115%26doi%3D10.4155%2Ffmc.12.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abulwerdi, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mady, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span> <span> </span><span class="NLM_article-title">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4111</span>– <span class="NLM_lpage">4133</span>, <span class="refDoi"> DOI: 10.1021/jm500010b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500010b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4111-4133&author=F.+A.+Abulwerdiauthor=C.+Liaoauthor=A.+S.+Madyauthor=J.+Gavinauthor=C.+Shenauthor=T.+Cierpickiauthor=J.+A.+Stuckeyauthor=H.+D.+H.+Showalterauthor=Z.+Nikolovska-Coleska&title=3-Substituted-N-%284-Hydroxynaphthalen-1-yl%29arylsulfonamides+as+a+novel+class+of+selective+Mcl-1+inhibitors%3A+structure-based+design%2C+synthesis%2C+SAR%2C+and+biological+evaluation&doi=10.1021%2Fjm500010b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation</span></div><div class="casAuthors">Abulwerdi, Fardokht A.; Liao, Chenzhong; Mady, Ahmed S.; Gavin, Jordan; Shen, Chenxi; Cierpicki, Tomasz; Stuckey, Jeanne A.; Showalter, H. D. Hollis; Nikolovska-Coleska, Zaneta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4111-4133</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mcl-1, an antiapoptotic member of the Bcl-2 family of proteins, is a validated and attractive target for cancer therapy.  Overexpression of Mcl-1 in many cancers results in disease progression and resistance to current chemotherapeutics.  Utilizing high-throughput screening, compd. I was identified as a selective Mcl-1 inhibitor and its binding to the BH3 binding groove of Mcl-1 was confirmed by several different, but complementary, biochem. and biophys. assays.  Guided by structure-based drug design and supported by NMR expts., comprehensive SAR studies were undertaken and a potent and selective inhibitor, compd. II, was designed which binds to Mcl-1 with a Ki of 180 nM.  Biol. characterization of II showed that it disrupts the interaction of endogenous Mcl-1 and biotinylated Noxa-BH3 peptide, causes cell death through a Bak/Bax-dependent mechanism, and selectively sensitizes Eμ-myc lymphomas overexpressing Mcl-1, but not Eμ-myc lymphoma cells overexpressing Bcl-2.  Treatment of human leukemic cell lines with compd. II resulted in cell death through activation of caspase-3 and induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd24MDP_8ww7Vg90H21EOLACvtfcHk0lh7QaPUUKgD4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgt7c%253D&md5=56174b467eba7dba4bdc33c75bfce473</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500010b%26sid%3Dliteratum%253Aachs%26aulast%3DAbulwerdi%26aufirst%3DF.%2BA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26atitle%3D3-Substituted-N-%25284-Hydroxynaphthalen-1-yl%2529arylsulfonamides%2520as%2520a%2520novel%2520class%2520of%2520selective%2520Mcl-1%2520inhibitors%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520SAR%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4111%26epage%3D4133%26doi%3D10.1021%2Fjm500010b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span> <span> </span><span class="NLM_article-title">3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): Structure-based design and structure–activity relationship studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1021/jm101181u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101181u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1101-1105&author=Z.+Zhangauthor=G.+Wuauthor=F.+Xieauthor=T.+Songauthor=X.+Chang&title=3-Thiomorpholin-8-oxo-8H-acenaphtho%5B1%2C2-b%5Dpyrrole-9-carbonitrile+%28S1%29+based+molecules+as+potent%2C+dual+inhibitors+of+B-cell+lymphoma+2+%28Bcl-2%29+and+myeloid+cell+leukemia+sequence+1+%28Mcl-1%29%3A+Structure-based+design+and+structure%E2%80%93activity+relationship+studies&doi=10.1021%2Fjm101181u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) Based Molecules as Potent, Dual Inhibitors of B-Cell Lymphoma 2 (Bcl-2) and Myeloid Cell Leukemia Sequence 1 (Mcl-1): Structure-Based Design and Structure-Activity Relationship Studies</span></div><div class="casAuthors">Zhang, Zhichao; Wu, Guiye; Xie, Feibo; Song, Ting; Chang, Xilong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1101-1105</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">the authors recently described the discovery of a dual inhibitor of Bcl-2 and Mcl-1, 3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (3, S1).  Here the authors report a structure-guided design in combination with structure-activity relationship studies to exploit the difference in the p2 binding pocket of Bcl-2 and Mcl-1, from which a novel dual inhibitor 3-(4-aminophenylthio)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (6h) was obtained, which showed significant enhanced IC50 value against Mcl-1 (5 nM), greater Mcl-1/Bak disruption potential, and accordingly a 10-fold increased cytotoxicity over 3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokuLvoBDBxBbVg90H21EOLACvtfcHk0lix5I762mlzKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVeiuw%253D%253D&md5=08ad63a3a7bfb4afd477f63572d2f16c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm101181u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101181u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%26atitle%3D3-Thiomorpholin-8-oxo-8H-acenaphtho%255B1%252C2-b%255Dpyrrole-9-carbonitrile%2520%2528S1%2529%2520based%2520molecules%2520as%2520potent%252C%2520dual%2520inhibitors%2520of%2520B-cell%2520lymphoma%25202%2520%2528Bcl-2%2529%2520and%2520myeloid%2520cell%2520leukemia%2520sequence%25201%2520%2528Mcl-1%2529%253A%2520Structure-based%2520design%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1101%26epage%3D1105%26doi%3D10.1021%2Fjm101181u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udompholkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jossart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Covalent inhibitors of protein–protein interactions targeting lysine, tyrosine, or histidine residues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5616</span>– <span class="NLM_lpage">5627</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5616-5627&author=L.+Gambiniauthor=C.+Baggioauthor=P.+Udompholkulauthor=J.+Jossartauthor=A.+F.+Salemauthor=J.+J.+P.+Perryauthor=M.+Pellecchia&title=Covalent+inhibitors+of+protein%E2%80%93protein+interactions+targeting+lysine%2C+tyrosine%2C+or+histidine+residues&doi=10.1021%2Facs.jmedchem.9b00561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues</span></div><div class="casAuthors">Gambini, Luca; Baggio, Carlo; Udompholkul, Parima; Jossart, Jennifer; Salem, Ahmed F.; Perry, J. Jefferson P.; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5616-5627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently reported a series of Lys-covalent agents targeting the BIR3 domain of the X-linked inhibitor of apoptosis protein (XIAP) using a benzamide-sulfonyl fluoride warhead.  Using XIAP as a model system, we further investigated a variety of addnl. warheads that can be easily incorporated into binding peptides and analyzed their ability to form covalent adducts with lysine and other amino acids, including tyrosine, histidine, serine, and threonine, using biochem. and biophys. assays.  Moreover, we tested aq., plasma stability, cell permeability, and cellular efficacy of the most effective agents.  These studies identified aryl-fluoro sulfates as likely the most suitable electrophiles to effectively form covalent adducts with Lys, Tyr, and His residues, given that these agents were cell permeable and stable in aq. buffer and in plasma.  Our studies contain a no. of general findings that open new possible avenues for the design of potent covalent protein-protein interaction antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gJvmpArk6LVg90H21EOLACvtfcHk0lix5I762mlzKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOkur0%253D&md5=820cf16d34a3230e9629991a3bca240d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00561%26sid%3Dliteratum%253Aachs%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DBaggio%26aufirst%3DC.%26aulast%3DUdompholkul%26aufirst%3DP.%26aulast%3DJossart%26aufirst%3DJ.%26aulast%3DSalem%26aufirst%3DA.%2BF.%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DCovalent%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520targeting%2520lysine%252C%2520tyrosine%252C%2520or%2520histidine%2520residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5616%26epage%3D5627%26doi%3D10.1021%2Facs.jmedchem.9b00561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahisa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazuka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9635</span>– <span class="NLM_lpage">9645</span>, <span class="refDoi"> DOI: 10.1021/jm401170c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401170c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9635-9645&author=Y.+Tanakaauthor=K.+Aikawaauthor=G.+Nishidaauthor=M.+Hommaauthor=S.+Sogabeauthor=S.+Igakiauthor=Y.+Hayanoauthor=T.+Sameshimaauthor=I.+Miyahisaauthor=T.+Kawamotoauthor=M.+Tawadaauthor=Y.+Imaiauthor=M.+Inazukaauthor=N.+Choauthor=Y.+Imaedaauthor=T.+Ishikawa&title=Discovery+of+potent+Mcl-1%2FBcl-xL+dual+inhibitors+by+using+a+hybridization+strategy+based+on+structural+analysis+of+target+proteins&doi=10.1021%2Fjm401170c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins</span></div><div class="casAuthors">Tanaka, Yuta; Aikawa, Katsuji; Nishida, Goushi; Homma, Misaki; Sogabe, Satoshi; Igaki, Shigeru; Hayano, Yumi; Sameshima, Tomoya; Miyahisa, Ikuo; Kawamoto, Tomohiro; Tawada, Michiko; Imai, Yumi; Inazuka, Masakazu; Cho, Nobuo; Imaeda, Yasuhiro; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9635-9645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mcl-1 and Bcl-xL are crucial regulators of apoptosis, therefore dual inhibitors of both proteins could serve as promising new anticancer drugs.  To design Mcl-1/Bcl-xL dual inhibitors, we performed structure-guided analyses of the corresponding selective Mcl-1 and Bcl-xL inhibitors.  A cocrystal structure of a pyrazolo-[1,5-a]-pyridine deriv. with Mcl-1 protein was successfully detd. and revealed the protein-ligand binding mode.  The key structure for Bcl-xL inhibition was further confirmed through the substructural anal. of ABT-263, a representative Bcl-xL/Bcl-2/Bcl-w inhibitor developed by Abbott Labs.  On the basis of the structural data from this anal., we designed hybrid compds. by tethering the Mcl-1 and Bcl-xL inhibitors together.  The results of X-ray crystallog. anal. of hybrid compd. 10 in complexes with both Mcl-1 and Bcl-xL demonstrated its binding mode with each protein.  Following further optimization, compd. 11 showed potent Mcl-1/Bcl-xL dual inhibitory activity (Mcl-1, IC50 = 0.088 μM; and Bcl-xL, IC50 = 0.0037 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydBzhRc5fGrVg90H21EOLACvtfcHk0ljJbBHK38FzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7bP&md5=53b60cdb559e6b402f9cc3f96fbb8d9d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm401170c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401170c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DAikawa%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DG.%26aulast%3DHomma%26aufirst%3DM.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DIgaki%26aufirst%3DS.%26aulast%3DHayano%26aufirst%3DY.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DMiyahisa%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DInazuka%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520potent%2520Mcl-1%252FBcl-xL%2520dual%2520inhibitors%2520by%2520using%2520a%2520hybridization%2520strategy%2520based%2520on%2520structural%2520analysis%2520of%2520target%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9635%26epage%3D9645%26doi%3D10.1021%2Fjm401170c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekumar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0ljJbBHK38FzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akçay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tentarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimster, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Q.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1038%2Fnchembio.2174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=27595327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKqtb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=931-936&author=G.+Ak%C3%A7ayauthor=M.+A.+Belmonteauthor=B.+Aquilaauthor=C.+Chuaquiauthor=A.+W.+Hirdauthor=M.+L.+Lambauthor=P.+B.+Rawlinsauthor=N.+Suauthor=S.+Tentarelliauthor=N.+P.+Grimsterauthor=Q.+Su&title=Inhibition+of+Mcl-1+through+covalent+modification+of+a+noncatalytic+lysine+side+chain&doi=10.1038%2Fnchembio.2174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain</span></div><div class="casAuthors">Akcay, Gizem; Belmonte, Matthew A.; Aquila, Brian; Chuaqui, Claudio; Hird, Alexander W.; Lamb, Michelle L.; Rawlins, Philip B.; Su, Nancy; Tentarelli, Sharon; Grimster, Neil P.; Su, Qibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-936</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeted covalent inhibition of disease-assocd. proteins has become a powerful methodol. in the field of drug discovery, leading to the approval of new therapeutics.  Nevertheless, current approaches are often limited owing to their reliance on a cysteine residue to generate the covalent linkage.  Here the authors used aryl boronic acid carbonyl warheads to covalently target a noncatalytic lysine side chain, and generated to the knowledge the first reversible covalent inhibitors for Mcl-1, a protein-protein interaction (PPI) target that has proven difficult to inhibit via traditional medicinal chem. strategies.  These covalent binders exhibited improved potency in comparison to noncovalent congeners, as demonstrated in biochem. and cell-based assays.  The authors identified Lys234 as the residue involved in covalent modification, via point mutation.  The covalent binders discovered in this study will serve as useful starting points for the development of Mcl-1 therapeutics and probes to interrogate Mcl-1-dependent biol. phenomena.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUd1TOo4XkarVg90H21EOLACvtfcHk0ljJbBHK38FzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKqtb3P&md5=bda5720579a9b5e6027632d2cffba2e1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2174%26sid%3Dliteratum%253Aachs%26aulast%3DAk%25C3%25A7ay%26aufirst%3DG.%26aulast%3DBelmonte%26aufirst%3DM.%2BA.%26aulast%3DAquila%26aufirst%3DB.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DTentarelli%26aufirst%3DS.%26aulast%3DGrimster%26aufirst%3DN.%2BP.%26aulast%3DSu%26aufirst%3DQ.%26atitle%3DInhibition%2520of%2520Mcl-1%2520through%2520covalent%2520modification%2520of%2520a%2520noncatalytic%2520lysine%2520side%2520chain%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D931%26epage%3D936%26doi%3D10.1038%2Fnchembio.2174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Deactivation of Mcl-1 by dual-function small-molecule inhibitors targeting the Bcl-2 homology 3 domain and facilitating Mcl-1 ubiquitination</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">14250</span>– <span class="NLM_lpage">14256</span>, <span class="refDoi"> DOI: 10.1002/anie.201606543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1002%2Fanie.201606543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Slt7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=14250-14256&author=T.+Songauthor=Z.+Wangauthor=F.+Jiauthor=Y.+Fengauthor=Y.+Fanauthor=G.+Chaiauthor=X.+Liauthor=Z.+Liauthor=Z.+Zhang&title=Deactivation+of+Mcl-1+by+dual-function+small-molecule+inhibitors+targeting+the+Bcl-2+homology+3+domain+and+facilitating+Mcl-1+ubiquitination&doi=10.1002%2Fanie.201606543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Deactivation of Mcl-1 by Dual-Function Small-Molecule Inhibitors Targeting the Bcl-2 Homology 3 Domain and Facilitating Mcl-1 Ubiquitination</span></div><div class="casAuthors">Song, Ting; Wang, Ziqian; Ji, Fangling; Feng, Yingang; Fan, Yudan; Chai, Gaobo; Li, Xiangqian; Li, Zhiqiang; Zhang, Zhichao</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14250-14256</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">By means of limited proteolysis assay, three-dimensional NMR, X-ray crystallog. and alanine mutations, a dynamic region at the Q221R222N223 motif in the Bcl-2 homol. 3 (BH3) domain of Mcl-1 has been identified as a conformational switch which controls Mcl-1 ubiquitination.  NoxaBH3 binding biases the QRN motif toward a helical conformation, thus leading to an enhanced in vitro ubiquitination of Mcl-1.  In contrast, BimBH3 binding biases the QRN motif toward a nonhelical conformation, thus leading to the inhibition of ubiquitination.  A dual function Mcl-1 inhibitor, which locates at the BH3 domain of Mcl-1 and forms hydrogen bond with His224 to drive a helical QRN conformation, so that it not only interferes with the pro-apoptotic partners, but also facilitates Mcl-1 ubiquitination in living cells, is described.  As a result, this inhibitor manifests a more effective apoptosis induction in Mcl-1-dependent cancer cells than other inhibitors exhibiting a similar binding affinity with it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB49Pd1nHcrVg90H21EOLACvtfcHk0li73V7m2BwzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Slt7fO&md5=35c7cdc47a2e58b3bd3dc4310ec41d1e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606543%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DChai%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDeactivation%2520of%2520Mcl-1%2520by%2520dual-function%2520small-molecule%2520inhibitors%2520targeting%2520the%2520Bcl-2%2520homology%25203%2520domain%2520and%2520facilitating%2520Mcl-1%2520ubiquitination%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D14250%26epage%3D14256%26doi%3D10.1002%2Fanie.201606543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najajreh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazanov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawbry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardeli-Tzaraf, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barenholz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4665</span>– <span class="NLM_lpage">4673</span>, <span class="refDoi"> DOI: 10.1021/jm060237r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060237r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVKnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4665-4673&author=Y.+Najajrehauthor=E.+Khazanovauthor=S.+Jawbryauthor=Y.+Ardeli-Tzarafauthor=J.+M.+Perezauthor=J.+Kasparkovaauthor=V.+Brabecauthor=Y.+Barenholzauthor=D.+Gibson&title=Cationic+nonsymmetric+transplatinum+complexes+with+piperidinopiperidine+ligands.+Preparation%2C+characterization%2C+in+vitro+cytotoxicity%2C+in+vivo+toxicity%2C+and+anticancer+efficacy+studies&doi=10.1021%2Fjm060237r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic Nonsymmetric Transplatinum Complexes with Piperidinopiperidine Ligands. Preparation, Characterization, in Vitro Cytotoxicity, in Vivo Toxicity, and Anticancer Efficacy Studies</span></div><div class="casAuthors">Najajreh, Yousef; Khazanov, Elena; Jawbry, Seba; Ardeli-Tzaraf, Yael; Perez, Jose Manuel; Kasparkova, Jana; Brabec, Viktor; Barenholz, Yechezkel; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4665-4673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trans-[PtCl2(Am)(pip-pip)]·HCl where pip-pip is 4-piperidinopiperidine and Am is NH3, methylamine (MA), dimethylamine (DMA), n-propylamine (NPA), isopropylamine (IPA), n-butylamine (NBA), or cyclohexylamine (CHA) were prepd. and characterized, and their cytotoxic properties against ovarian and colon cancer cells were evaluated.  The trans-[PtCl2(NH3)(pip-pip)]·HCl was significantly more potent than cisplatin in all the cisplatin-resistant ovarian cancer cell lines and was nearly as cytotoxic as cisplatin against colon cancer cells.  In vivo studies in mice showed that the pip-pip complexes are significantly less toxic than cisplatin.  Cisplatin was more efficacious than both trans-[PtCl2(NH3)(pip-pip)]·HCl and trans-[PtCl2(NBA)(pip-pip)]·HCl in the A2780 and A2780cisR tumor xenograft models, consistent with its lower IC50 values in A2780 cells but contrary to the higher IC50 values in A2780cisR cells.  In the colon cancer cell studies, trans-[PtCl2(NH3)(pip-pip)]·HCl was slightly less potent than cisplatin in the in vitro studies but had efficacy comparable to that of cisplatin in the in vivo xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXAEEGCV4K1bVg90H21EOLACvtfcHk0li73V7m2BwzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVKnt7g%253D&md5=3059319466d4a5458ecc413a91242b5e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm060237r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060237r%26sid%3Dliteratum%253Aachs%26aulast%3DNajajreh%26aufirst%3DY.%26aulast%3DKhazanov%26aufirst%3DE.%26aulast%3DJawbry%26aufirst%3DS.%26aulast%3DArdeli-Tzaraf%26aufirst%3DY.%26aulast%3DPerez%26aufirst%3DJ.%2BM.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DBarenholz%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DCationic%2520nonsymmetric%2520transplatinum%2520complexes%2520with%2520piperidinopiperidine%2520ligands.%2520Preparation%252C%2520characterization%252C%2520in%2520vitro%2520cytotoxicity%252C%2520in%2520vivo%2520toxicity%252C%2520and%2520anticancer%2520efficacy%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4665%26epage%3D4673%26doi%3D10.1021%2Fjm060237r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushwaha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cron, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, D.</span></span> <span> </span><span class="NLM_article-title">USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1</span>. <i>Canc. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1080/15384047.2014.1002358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1080%2F15384047.2014.1002358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=25692226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWqtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=392-401&author=D.+Kushwahaauthor=C.+O%E2%80%99Learyauthor=K.+R.+Cronauthor=P.+Deraskaauthor=K.+Zhuauthor=A.+D.+D%E2%80%99Andreaauthor=D.+Kozono&title=USP9X+inhibition+promotes+radiation-induced+apoptosis+in+non-small+cell+lung+cancer+cells+expressing+mid-to-high+MCL1&doi=10.1080%2F15384047.2014.1002358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1</span></div><div class="casAuthors">Kushwaha, Deepa; O'Leary, Colin; Cron, Kyle R.; Deraska, Peter; Zhu, Kaya; D'Andrea, Alan D.; Kozono, David</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Background and Purpose: Radiotherapy (RT) is vital for the treatment of locally advanced non-small cell lung cancer (NSCLC), yet its delivery is limited by tolerances of adjacent organs.  We sought therefore to identify and characterize gene targets whose inhibition may improve RT.  Materials and Methods: Whole genome pooled shRNA cytotoxicity screens were performed in A549 and NCI-H460 using a retroviral library of 74,705 sequences.  Cells were propagated with or without daily radiation Monday-Friday.  Radiosensitization by top differential dropout hits was assessed by clonogenic assays.  Apoptosis was assessed using a caspase 3/7 cell-based activity assay and by annexin V-FITC and PI staining.  MCL1 expression was assessed by qPCR and Western blotting.  Results: USP9X, a deubiquitinase, was a top hit among druggable gene products.  WP1130, a small mol. USP9X inhibitor, showed synergistic cytotoxicity with IR.  MCL1, an anti-apoptotic protein deubiquitinated by USP9X, decreased with USP9X inhibition and IR.  This was accompanied by increases in caspase 3/7 activity and apoptosis.  In a panel of NSCLC lines, MCL1 and USP9X protein and gene expression levels were highly correlated.  Lines showing high levels of MCL1 expression were the most sensitive to USP9X inhibition.  Conclusions: These data support the use of MCL1 expression as a predictive biomarker for USP9X inhibitors in NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbivXsJTov1rVg90H21EOLACvtfcHk0li73V7m2BwzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWqtL7I&md5=9bf9ed83171978a35ee234f5832b253d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F15384047.2014.1002358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2014.1002358%26sid%3Dliteratum%253Aachs%26aulast%3DKushwaha%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DC.%26aulast%3DCron%26aufirst%3DK.%2BR.%26aulast%3DDeraska%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DKozono%26aufirst%3DD.%26atitle%3DUSP9X%2520inhibition%2520promotes%2520radiation-induced%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520expressing%2520mid-to-high%2520MCL1%26jtitle%3DCanc.%2520Biol.%2520Ther.%26date%3D2015%26volume%3D16%26spage%3D392%26epage%3D401%26doi%3D10.1080%2F15384047.2014.1002358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of SHELX</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/s0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2Fs0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0li73V7m2BwzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2Fs0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2159</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/jm5012484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2159-2179&author=Z.-F.+Chenauthor=Q.-P.+Qinauthor=J.-L.+Qinauthor=Y.-C.+Liuauthor=K.-B.+Huangauthor=Y.-L.+Liauthor=T.+Mengauthor=G.-H.+Zhangauthor=Y.+Pengauthor=X.-J.+Luoauthor=H.+Liang&title=Stabilization+of+G-quadruplex+DNA%2C+inhibition+of+telomerase+activity%2C+and+tumor+cell+apoptosis+by+organoplatinum%28II%29+complexes+with+oxoisoaporphine&doi=10.1021%2Fjm5012484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine</span></div><div class="casAuthors">Chen, Zhen-Feng; Qin, Qi-Pin; Qin, Jiao-Lan; Liu, Yan-Cheng; Huang, Ke-Bin; Li, Yu-Lan; Meng, Ting; Zhang, Guo-Hai; Peng, Yan; Luo, Xu-Jian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2159-2179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two G-quadruplex ligands [Pt(La)(DMSO)Cl] (Pt1) and [Pt(Lb)(DMSO)Cl] (Pt2) have been synthesized and fully characterized.  The two complexes are more selective for SK-OV-3/DDP tumor cells vs. normal cells (HL-7702).  Both Pt1 and Pt2 could be a telomerase inhibitor targeting G-quadruplex DNA.  This is the first report demonstrating that telomeric, c-myc, and bcl-2 G-quadruplexes and caspase-3/9 preferred to bind with Pt2 rather than Pt1, which also can induce senescence and apoptosis.  The different biol. behavior of Pt1 and Pt2 may correlate with the presence of a 6-hydroxyl group in Lb.  Importantly, Pt1 and Pt2 exhibited higher safety in vivo and more effective inhibitory effects on tumor growth in the HCT-8 and NCI-H460 xenograft mouse model, compared with cisplatin.  Taken together, these mechanistic insights indicate that both Pt1 and Pt2 display low toxicity and could be novel anticancer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotaQYbKtnemLVg90H21EOLACvtfcHk0licYLjQdQy_0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shtbc%253D&md5=c12cdfc7a7b59c49be5487c9cad402c1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm5012484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012484%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.-F.%26aulast%3DQin%26aufirst%3DQ.-P.%26aulast%3DQin%26aufirst%3DJ.-L.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DHuang%26aufirst%3DK.-B.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DG.-H.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-J.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DStabilization%2520of%2520G-quadruplex%2520DNA%252C%2520inhibition%2520of%2520telomerase%2520activity%252C%2520and%2520tumor%2520cell%2520apoptosis%2520by%2520organoplatinum%2528II%2529%2520complexes%2520with%2520oxoisoaporphine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2159%26epage%3D2179%26doi%3D10.1021%2Fjm5012484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. C.</span></span> <i>Molecular Operating Environment (MOE)</i>, <span class="NLM_year">2016</span>; 08.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+C.+Group&title=Molecular+Operating+Environment+%28MOE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DGroup%26aufirst%3DC.%2BC.%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WIX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WIX','PDB','3WIX'); return false;">PDB: 3WIX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02047">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81411"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02047?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02047</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures, <sup>1</sup>H NMR spectra, <sup>13</sup>C NMR spectra, ESI-MS data, X-ray crystal data (CCDC no: 1894320–1894328), UV–vis spectra, stability values for the copper complexes, LD<sub>50</sub> values of the tested compounds, pharmacokinetic study data, mass spectra of the complexes in blood, additional data from the binding experiments, additional data regarding the cellular IC<sub>50</sub> values, references, and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_001.pdf">jm9b02047_si_001.pdf (2.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_002.csv">jm9b02047_si_002.csv (3.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02047/suppl_file/jm9b02047_si_003.pdf">jm9b02047_si_003.pdf (152.51 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02047&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02047%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02047" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999536b9733c4c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
